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ABSTRACT 
 
                    ALTERATIONS TO MATERNAL BEHAVIOR AND BRAIN BY             
   EXOGENOUS  ESTROGEN EXPOSURE 
 
                                                  SEPTEMBER 2016 
 
                         MARY CATHERINE CATANESE, B.A. ENGLISH, UNIVERSITY     
                            OF MASSACHUSETTS, AMHERST 
 
                      Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST  
 
                      Directed by: Professor LAURA N. VANDENBERG  
                                            Professor R. THOMAS ZOELLER  
 
 
Maternal care is critical for the development and long-term success of offspring. 
Poor maternal care can have profound effects on offspring that can last into adult 
life. Despite our understanding of the role of endogenous estrogen in maternal 
behavior, the potential effects of exogenous estrogens (xenoestrogens) on 
maternal behavior and brain remain poorly understood. 
 
The active synthetic estrogen in contraceptive pills, 17α-ethinyl estradiol (EE2), is 
widely used as a positive control for estrogenicity in endocrinology and toxicology 
studies. Another xenoestrogen, bisphenol A (BPA) alters a broad range of 
physiological processes including neural development and reproduction. Due to 
public health concerns with BPA, alternative compounds have been developed 
for use in consumer products. One replacement, bisphenol S (BPS), has not 
been examined extensively, but has shown estrogenic properties. Biomonitoring 
studies indicate that human exposures to BPS are likely to be widespread. 
 
	 ix 
Among studies that have reported effects of endocrine disruptors on maternal 
behavior, none have concurrently examined effects on the regions of the brain 
important to maternal behaviors. Thus, one of the major goals of this dissertation 
sought to address this gap in current knowledge.  
 
We hypothesized that low doses of two xenoestrogens, EE2 and BPS, would 
disrupt maternal behavior and affect regions of the brain important for maternal 
behavior. We further hypothesized that neurogenesis might be one of the critical 
mechanisms underlying estrogen regulated maternal behavior and that 
xenoestrogen exposures during pregnancy induce alterations to neurogenesis.  
 
We investigated the effects of low dose exogenous estrogens on mice during 
pregnancy and lactation (the F0 generation), and on females exposed during 
gestation and the perinatal period (the F1 generation). The work summarized in 
this dissertation indicates that low doses of the synthetic estrogens EE2 and BPS 
alter aspects of behavior and brain in pregnant/lactating females, providing 
evidence that adults are susceptible to the disruptive effects of these compounds 
during these vulnerable periods. Our findings also suggest that females are 
vulnerable to exposures during gestation/perinatal development, and these 
exposures are sufficient to influence the display of maternal behavior later in life. 
Finally, our results indicate that neurogenesis can be disrupted by xenoestrogen 
exposures. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
PREVIOUSLY PUBLISHED AS: 
BEYOND A MEANS OF EXPOSURE: A NEW VIEW OF THE MOTHER IN 
TOXICOLOGY RESEARCH  
Mary C. Catanese, Alexander Suvorov and Laura N. Vandenberg 
Toxicology Research. (2015) vol 4: 592-612. 
 
Abstract 
	
 Toxicological studies generally view pregnant animals as a conduit 
through which gestational exposure of offspring to chemicals can be 
achieved, allowing for the study of developmental toxicity. One class of 
compounds, endocrine disrupting chemicals (EDCs), has been shown to 
interfere with hormone signalling in a number of in vivo models, with effects 
that are more pronounced when exposures occur during development. Yet, 
evidence has also accumulated that the traditional means of assessing the 
health effects of EDCs, using test guidelines, are not sufficient to fully capture 
the effects of these compounds. Our work has focused on the effects of EDCs 
on more complex, integrated endpoints than the ones typically examined in 
test guidelines (such as organ weight, histopathology, number of live/dead 
offspring.) Here, we review evidence that EDCs interfere with the display of 
maternal behaviours, integrated endpoints affected by multiple hormones and 
		 2 
other signalling molecules. We discuss a number of assays that can be easily 
conducted to assess the effects of environmental chemicals on maternal 
behaviours, as well as molecular assays of the medial preoptic area (MPOA) 
of the hypothalamus, considered one of the principal regions in the brain 
responsible for maternal responsiveness. We propose that studies of 
emerging EDCs of concern should examine maternal behaviours in 
developmental toxicity tests, and when effects are observed, the maternal 
brain should be examined as well. We further advise that researchers avoid 
viewing the mother as simply a means of exposing the group of interest (i.e. 
the offspring), and instead recognize how the mother can greatly influence the 
behavioural phenotype and health of her offspring. 
 
Introduction 
 
Endocrine disrupting chemicals (EDCs) are compounds that interfere with 
hormone signalling (Zoeller et al. 2012) by affecting the synthesis, secretion, 
transport, binding, action, or elimination of natural hormones (Kavlock et al. 
1996). Because the endocrine system is responsible for coordinating the 
systems of the body from conception until death, EDCs have the potential to 
affect virtually all organs of the body (Diamanti-Kandarakis et al. 2009). 
Although the endocrine system is often considered a mechanism by which the 
body maintains homeostasis, hormones are essential for the development of 
organs including the male and female reproductive tract, the brain, metabolic 
machinery, and others. Thus, the function of the endocrine system extends far 
 	 3 
beyond maintaining health in adulthood, and disruptions to hormone signaling 
can have long-lasting effects on the individual. 
The study of EDCs is conducted at the intersection of a number of 
scientific disciplines including toxicology, endocrinology, environmental health, 
ecology, risk assessment and medicine. From the field of endocrinology, a 
number of principles have been proposed to guide the study of EDCs 
(Vandenberg et al. 2012; Vandenberg et al. 2013b). These include: (1) 
Hormones are responsible for coordinating the systems of the body, thus 
disruptions to one part of the endocrine system can have wide-reaching 
effects; (2) Hormones act via specific interactions with receptors, thus only 
cells that express a hormone receptor will be affected by that hormone (or 
chemicals that disrupt that hormone’s signaling in some way); (3) Hormones 
act at low doses, often at part-per-billion or part-per-trillion concentrations, 
and thus EDCs are also expected to act at low doses; (4) Hormones often 
have non-linear, and even non-monotonic dose responses, and similar non-
monotonic responses have been observed for EDCs in cultured cells, 
laboratory animals, and human populations; (5) Hormones have different 
effects at different life stages. During critical periods of development, 
hormones can alter the differentiation of cells and the organization of organs, 
whereas in most adult stages hormones induce ‘activational’ responses – 
where the effect is observed only as long as the exposure occurs (Silbergeld 
et al. 2002). 
 
		 4 
Identifying the best methods to assess the effects of EDCs 
Although the term ‘endocrine disruptor’ was originally coined more than 
two decades ago, compared to the fields of toxicology and endocrinology, this 
is a relatively new research arena (Wingspread Participants 1992). Even the 
definition of an endocrine disruptor continues to be debated (Bergman et al. 
2013a; Dietrich et al. 2013; Gore et al. 2013), and scientists have expressed 
great concern over the methods used to determine the endocrine disrupting 
properties of environmental chemicals, measure EDCs in human tissues and 
fluids, and understand the range of adverse outcomes that can be induced by 
these compounds (Calafat and Needham 2008; Knudsen et al. 2013; 
Mahadevan et al. 2011; Myers et al. 2009; Needham et al. 2008; Schug et al. 
2013; Sun et al. 2012). Yet, in spite of these concerns, tremendous advances 
have been made in the past decade to improve the identification and 
assessment of EDCs.  
 Overall, the issue of methodologies for assessing endocrine disruption 
can be split into two categories: determining whether a compound is an EDC, 
and determining the effects induced by that EDC on laboratory animals, 
wildlife, and humans. Once the effects of a compound have been established, 
it must be determined whether the affected endpoints are considered adverse, 
and whether they are relevant to human diseases. These determinations have 
contributed to significant debates, which have been discussed in more detail 
elsewhere (Bergman et al. 2013c; Lamb et al. 2014; Woodruff et al. 2008).       
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Determining the endocrine disrupting properties of environmental 
chemicals 
 Although by definition an EDC can disrupt any of the dozens of 
signalling molecules that are considered hormones, most EDCs identified to 
date interfere with receptor binding, mimic the actions of androgens, 
oestrogen, and thyroid hormone, or alter steroidogenic or xenobiotic 
metabolizing enzymes (Diamanti-Kandarakis et al. 2009; Vandenberg et al. 
2012). [Some important exceptions include chemicals that alter metabolism 
via the PPARγ receptor and glucocorticoid signalling, among others (Grun 
and Blumberg 2006; Guillette 2006; Tabb and Blumberg 2006).] Because at 
least some EDCs appear to have promiscuous effects on more than one 
hormone receptor (Guillette 2006; Nordeen et al. 2013; Vandenberg et al. 
2009), it is likely that the current focus on androgen, oestrogen, and thyroid 
hormone signalling is too narrow to capture the true extent of endocrine 
disruption from environmental chemicals. 
The US Environmental Protection Agency (EPA) developed a two-
tiered screening program (Figure 1) to be used as a way to determine whether 
a compound has the potential to be an endocrine disruptor as a part of the 
Endocrine Disruptor Screening Program (EDSP) (Borgert et al. 2011). EDSP 
tier 1 includes in vitro and in vivo assays that allow for the identification of 
chemicals that have the potential to interact with the endocrine system (EPA 
2013). The US EPA has ‘validated’ the use of these assays with four coded 
pesticides or pesticide ingredients, and showed how a ‘weight-of-evidence’ 
		 6 
analysis would be conducted from the results of these eleven EDSP tier 1 
assays (EPA 2013; Vandenberg and Bowler 2014); according to the EPA, 
making a conclusion about the endocrine disrupting properties of a 
compound, however, requires more than Tier 1 assays. Because of concerns 
about the specificity and sensitivity of the EDSP Tier 1 assays (also discussed 
in more depth below) (Zoeller et al. 2012), numerous groups have proposed 
alternative methods to determine whether a compound has endocrine 
disrupting properties. High-throughput assays like the ones included in the 
National Toxicology Program’s Tox21 and the US EPA’s ToxCast are a 
starting point (Reif et al. 2010), although groups continue to develop more 
complex assays for EDCs (Schug et al. 2013; Stossi et al. 2014; Vandenberg 
and Catanese 2014).  
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Fig 1.1: Standard guideline assays used to assess the endocrine disrupting 
properties of test compounds. The EDSP Tier 1 guidelines include cell 
fraction, in vitro and in vivo assays (A), which are typically followed by 
additional studies such as the reproductive toxicity and developmental toxicity 
assays (B).  
 
 
		 8 
Using test guidelines and non-guideline endpoints to assess endocrine 
disruption 
 Toxicology research, and especially research that will be used for 
chemical safety assessment purposes, depends heavily on the use of 
guideline studies, i.e. studies that follow heavily prescribed methods to assess 
acknowledged adverse outcomes (Tyl 2009, 2010). There are a wide range of 
guideline assays that have been validated in laboratories around the world. 
Other than the assays included in the EDSP Tier 1, the guideline assays used 
most frequently for the assessment of EDCs, are the developmental and 
reproductive toxicity assays (Figure 1), and one-generation and two-
generation toxicity assays. For example, OECD test guideline 414 provides 
guidance and protocols for assessing prenatal developmental toxicity 
(OECD/OCDE 2001). Using this test guideline, researchers administer test 
compounds to pregnant rats from gestational day 5 through gestational day 
15, and then kill the dams on gestational day 16. Each dam is assessed to 
determine the weight of the uterus and cervix, the number of corpora lutea in 
the ovary, the number of viable and non-viable (resorbed) foetuses, and the 
number of implantation sites. The foetuses are weighed, sexed, and 
examined for external, skeletal and soft-tissue alterations. Overall, this assay 
provides information about whether compounds produce overt congenital 
defects, and its relatively simplistic nature allows the methods to be used in 
laboratories around the world.  
 	 9 
 Although guideline assays have been touted as the best, most 
reproducible means of determining whether a compound has specific types of 
toxicity (Tyl 2009, 2010), there is some evidence that these assays are not 
always reproducible. For example, during the validation of the uterotrophic 
assay (OECD guideline 440), multiple EDCs were tested using several dosing 
protocols. For the ten labs that tested nonylphenol with the immature rat and 
subcutaneous dosing, one identified the lowest observed effective 
concentration (LOEC) as 35 mg/kg/day, five as 80 mg/kg/day, and one at 100 
mg/kg/day (Kanno et al. 2003b). The remaining three laboratories were 
unable to identify a LOEC: one did not include the highest dose, one failed to 
conduct the study appropriately (i.e. did not weigh the animals), and the third 
found no effect at any of the five doses administered (5 – 100 mg/kg/day). 
These results, and others from the validation of this test guideline (Kanno et 
al. 2001; Kanno et al. 2003a, b), illustrate that there can be issues with 
reproducibility, even when test guidelines are used. 
 Other issues with the use of guideline assays have been raised, 
especially related to the assessment of EDCs (Vandenberg and Bowler 2014; 
Zoeller et al. 2012). Some of these issues include concerns that the most 
sensitive endpoints are not being assessed (Markey et al. 2001), that modern 
and state-of-the-art techniques have not been incorporated or considered, 
that the endpoints assessed in guidelines do not map to human diseases, as 
well as the concern that many human diseases are not considered in any test 
guideline (Myers et al. 2009).  It has also been noted that some endpoints, 
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while widely considered relevant for the assessment of endocrine disruptors, 
are too difficult for contract laboratories to run, and thus cannot be developed 
into validated guideline assays (Borrell 2010). For this reason and others, 
some of the most striking work on EDCs has not involved test guidelines.  
 Studies using non-guideline endpoints have revealed that EDCs can 
contribute to diseases that are not typically assessed in developmental or 
reproductive toxicity assays (Bergman et al. 2013a; Bergman et al. 2013c; 
Bergman Å 2013; Diamanti-Kandarakis et al. 2009; Gore et al. 2006b; Heindel 
2008). Although the use of non-standardized assays and protocols has made 
the assessment of some of these studies more challenging from a regulatory 
perspective (Beronius et al. 2014; Chapin et al. 2008), assessments that 
examine the effects of specific EDCs on non-guideline endpoints across 
multiple studies have shown high levels of consistency for some (Vandenberg 
et al. 2013c). Many of the most sensitive endpoints are considered ‘integrated’ 
endpoints, i.e. biological phenomena that are influenced by multiple signaling 
pathways, including several different hormones (Gore et al. 2006b; Gore 
2010; Schug et al. 2013). 
Two criticisms of non-guideline endpoints are that it can be difficult to 
determine whether they represent adverse outcomes or if they are relevant to 
human diseases (Tyl 2008, 2009). The issue of whether an endpoint 
represents an adverse effect relies heavily on how this term is defined and 
interpreted (Vandenberg et al. 2013b). From the perspective of endocrinology, 
any compound that disrupts hormone signaling will have adverse effects – on 
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at least some individuals such as those exposed during a critical period of 
development – and therefore many endocrinologists would argue that all 
disruptions to hormone signaling should be considered hazardous as a default 
assumption; thus, from an endocrine perspective, endpoints that themselves 
are not adverse, but are indicative of abnormal hormone signaling, are 
sufficient to indicate that other adverse outcomes should be expected (Gore 
et al. 2006b; Zoeller et al. 2012). In contrast, many toxicologists approach the 
question of adverse effects from a very specific viewpoint of toxicity and 
pathology, and thus would argue that an acknowledged adverse effect must 
be demonstrated to even conclude that a compound is an EDC (Nohynek et 
al. 2013; Rhomberg and Goodman 2012).  
 
State-of-the-art non-guideline endpoints 
 CLARITY-BPA is an ongoing project designed to compare the effects 
of two synthetic oestrogens, ethinyl estradiol and bisphenol A (BPA), on both 
guideline and non-guideline endpoints (Birnbaum et al. 2012). In a 
collaboration involving academic scientists and government scientists from 
the US National Institute of Environmental Health Sciences, the US National 
Toxicology Program, and the US National Center for Toxicological Research 
(NCTR) at the Food and Drug Administration (FDA), animals are exposed to 
these two EDCs following established test guidelines. Scientists at the NCTR 
laboratory are then using guideline endpoints and academic collaborators are 
using non-guideline endpoints to assess toxicity in the same animals. The 
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non-guideline endpoints encompass a wide range of organ systems and cell 
types including metabolic endpoints, the mammary gland, cardiovascular 
function, ovarian health, brain development, brain sexual differentiation, and 
neurobehaviours. In pilot studies performed by NCTR to determine several 
feasibility factors for the CLARITY-BPA study, guideline endpoints revealed 
very few effects of BPA (Delclos et al. 2014) whereas non-guideline endpoints 
assessed in the laboratories of academic collaborators identified significant 
effects of BPA on brain development endpoints (Cao et al. 2013; Rebuli et al. 
2014). The NCTR’s pilot study also revealed that the FDA had difficulties 
controlling BPA exposures; even the negative (so-called unexposed) control 
animals were exposed to BPA (Churchwell et al. 2014). This result confirms 
that dependence on test guidelines is not sufficient to guarantee correct study 
conduct, or even appropriate study design (Hunt et al. 2014; Vandenberg et 
al. 2014; vom Saal et al. 2010).  
 More than a decade’s worth of research examining non-guideline 
endpoints has revealed the sensitivity of the developing brain and 
neurobehaviours to EDCs (Frye et al. 2012; Gore 2010; Patisaul and Adewale 
2009). The brain and behaviour represent integrated endpoints, affected by 
compounds that interfere with oestrogen, androgen and thyroid hormone 
signalling, among others. The remainder of this review will focus on maternal 
behavior and the maternal brain, two integrated endpoints that are affected by 
at least some EDCs.  
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Maternal behaviour 
Maternal behaviour aims at caring for conspecific young and increasing 
their survival (Dulac et al. 2014). Severe disruption of maternal behaviour may 
ultimately cause death of offspring, but even mild changes can have profound 
and long-term effects on the health, emotional and cognitive development of 
progeny. There is a vast literature on health consequences of child 
maltreatment (Gilbert et al. 2009) including physical, emotional and sexual 
abuse and physical, educational and emotional neglect. Childhood abuse and 
neglect are associated with increased vulnerability to several 
psychopathologies (Gilbert et al. 2009; Kaffman and Meaney 2007) and other 
medical morbidities such as obesity, ischemic heart disease, cancer, chronic 
lung disease, and liver disease (Felitti et al. 1998). Recent studies of “zero 
parenting” children in Romanian orphanages show dramatic deficiencies in 
many psychiatric outcomes (Bos et al. 2011; McDermott et al. 2012), impaired 
memory and executive functions (Bos et al. 2009), decreased brain electrical 
activity (Marshall et al. 2008), and a significant decrease in brain tissue 
volume (McLaughlin et al. 2014; Sheridan et al. 2012). Poor parental bonding 
- not considered abuse or neglect - is also associated with increased risk for 
several psychological vulnerabilities (Canetti et al. 1997).  
Our current understanding of maternal behaviour derives from several 
decades of research, much of which was conducted in rodents; demonstration 
of the endocrine basis and underlying neural systems involved in maternal 
responsiveness has emerged from controlled experimental behavioural 
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assessments of rats. Maternal behaviour in rats comprises both active and 
passive components such as pup retrieval, nest building, nursing, and licking 
and grooming of pups (Numan and Insel 2003; Wiesner and Sheard 1933). 
The initial active components appear immediately after parturition, during 
which time the dam delivers her young and cleans the pups (Dollinger et al. 
1980; Fleming and Anderson 1987; Lonstein and Morrell 2007). Nursing 
ensues soon thereafter, elicited by olfactory cues from pups and active 
suckling (Fleming and Anderson 1987; Fleming 1989). Many of these same 
components of maternal behaviour are also observed in mice and other 
mammals (Numan and Insel 2003). 
 
Behavioural assays 
 
 There are four types of maternal behaviours that are commonly 
assessed in controlled laboratory experiments: pup retrieval, nest building, 
nursing posture and anogenital licking and grooming. Although some of these 
features have been evaluated using mostly qualitative measures, new 
approaches have attempted to examine these endpoints with quantitative, 
unambiguous measures (Kuroda and Tsuneoka 2013). A fifth behaviour, the 
defence of pups from intruders, is a form of maternal aggression intended to 
protect the pups from infanticide by intruders (Gandelman 1972). In mice, 
maternal aggression can be diminished with oestrogen supplementation, 
although this treatment also decreases lactation (Svare and Gandelman 
1975). Relatively few studies examine this aspect of maternal behaviour 
(Lonstein and Gammie 2002). 
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 1. Pup grouping and pup retrieval 
One aspect of good maternal care is the ability of the dam to group her 
pups together, allowing her to protect them, provide them with warmth, and 
nurse them in a group. Prior to assessing pup retrieval, experimenters should 
first observe whether the pups are grouped together (Kuroda and Tsuneoka 
2013). Next, the pups should be removed from the nest and scattered 
throughout the cage (Bridges et al. 1985). In some protocols, all pups are 
scattered whereas in other protocols, only three pups from each litter are 
scattered to the three corners of the cage not occupied by the nest. The 
latency to approach and sniff the pups is recorded, as is the time to retrieve 
each pup and group the pups in the nest. The latency to return to the nest and 
nurse for at least one to two minutes is also recorded. If the dams require 
more than 10 minutes to retrieve all pups, the experimenter should return 
them to the nest. In our experiments, on day 2 of lactation, we find that 
untreated CD-1 mouse dams quickly retrieve their pups, with complete 
retrieval of the litter typically accomplished within 5-6 minutes (Figure 2). As 
others have also reported (Kuroda and Tsuneoka 2013), pup retrieval times 
improve over the next few days of lactation. We have noted a small 
percentage of mice that do not retrieve their pups but instead move the 
nesting material to where the litter self-groups; although this behaviour is rare, 
these mothers appear to use this method of grouping their litters throughout 
lactation.  
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Fig 1.2: Pup retrieval assays reveal improved times to complete retrievals in 
untreated CD-1 mouse dams (A). While average time to retrieve all pups was 
3.9 minutes on lactational day 2, this was reduced to 2.6 minutes on 
lactational day 5. B) This pattern was not replicated in dams treated with 
200µg/kg/day BDE-47 from pregnancy day 8 through weaning. Here, average 
time to complete retrievals on lactational day 2 was 2.2 minutes, an 
improvement relative to controls. But average time to complete retrievals on 
lactational day 5 was 2.8 minutes, similar to untreated dams, but worse than 
these same females performed just three days earlier. 
 
 
 
 
 
 	 17 
 2. Nest building 
Nest building is considered an active maternal behaviour; in mice, it is 
dependent on appropriate ratios of oestrogen and progesterone and can be 
blocked by treatment with androgens or high doses of oestrogen (Lisk 1971; 
Lisk et al. 1973). Virgin rats and mice build flat nests for sleeping, while 
pregnant females build a larger “brood nest” which is thought to protect the 
young and contribute to thermoregulation (Deacon 2006; Kuroda et al. 2011). 
Maternal nest building in mice is influenced by a number of factors such as 
the presence of pups after parturition (Gandelman 1973c), maternal 
experience (Bond et al. 2002; Broida and Svare 1982), along with its 
importance for thermoregulatory control. Nest building in mice is affected by 
alterations in hormone levels during pregnancy (Broida and Svare 1983; Lisk 
et al. 1969; Lisk 1971). Strain differences have also been observed in nest 
building in non-maternal mice (Lynch 1980) and in mice during pregnancy 
(Broida and Svare 1982).  The strain differences during pregnancy were not 
altered with maternal experience or cross-fostering, suggesting a role for 
strain in concentrations of circulating steroid hormones or sensitivity to these 
hormones (Broida and Svare 1982).  
     For qualitative measures, a number of different scales have been 
developed to assess nest quality (Deacon 2006). Broida and Svare proposed 
a four point scale in pregnancy-related nest-building, which has been used by 
other groups (Bond et al. 2002; Broida and Svare 1982).  In this scale, a score 
of 1 indicates no nest, 2 indicates shallow, “saucer” shaped nests with a 
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circular or semi-circular arrangement and the pups located within the nest.  
Increasing quality is measured with a score of 3, which is given to deeper 
nests with higher edges surrounding the pups. A score of 4 indicates an 
enclosed nest with a base of shavings and protective covering; in this 
category, the nest base must be raised compared to the rest of the covering in 
the cage (Bond et al. 2002; Broida and Svare 1982). A study using this 
scoring system revealed that pregnant and lactating mice built better quality 
nests than virgin and non-pregnant females (Bond et al. 2002). Strain 
differences were also revealed. 
Hess and colleagues recently proposed a 5 point scoring system for 
nest quality in a study designed to investigate environmental enrichment in 
the laboratory (Hess et al. 2008). This system was developed for non-
maternal nest building, after observations of nests that did not have 
corresponding scores available in one system (Deacon 2006) and quantitative 
limitations with the Broida and Svare scale.  While the Hess scale was 
developed for non-maternal mice, this scale appears well-suited for 
adaptation to assess maternal nests (Hess et al. 2008).  In the Hess Scale, a 
Score of 0 is assigned when the animal has not manipulated nesting material. 
Score 1 is given when nests are not well focused, but can still be 
distinguished from the rest of the cage. Score 2 nests are flat whereas Score 
3 nests have the appearance of a shallow soup bowl, with a scooped bottom 
but no coverage over the top of the nest. Score 4 nests have some coverage 
of nesting material over the top of the bowl, with a half-sphere or incomplete 
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dome. Finally, Score 5 nests are completely enclosed, such that the pups are 
barely visible. The Hess Scale also allows for fine-tuned assessments with 
fractional points assigned to incremental variations of nest structure between 
each whole number score. 
 In addition to scaled qualitative measures, quantitative measures can 
be performed after carefully removing the dam and pups. Nests that are 
constructed with high walls with greater structural stability are considered of 
higher quality, reflective of greater maternal care, compared to smaller and 
more loosely structured nests (Deacon 2006; Leon and Woodside 1983; 
Lonstein and Morrell 2007; Wiesner and Sheard 1933). The internal and 
external dimensions of the nest should be measured, as well as the depth of 
the nest at each wall. If dams are provided materials that have to be 
manipulated to build appropriate nests (i.e. wooden dowels that must be 
stripped and shredded by the mother), the total volume of nesting material 
can be determined by weighing the nest (Lisk 1971) or by weighing the 
unused material (i.e. the remaining dowel that is not shaved by the mother) 
(Denenberg et al. 1969). Dams typically do not defecate or urinate within the 
boundaries of the nest, and this can be assessed as well (Cummings et al. 
2010). In our experience, CD-1 mice given cotton nestlets build nests that 
would receive scores 3-4 via the Hess method, although we have seen fully 
enclosed nests (score 5) from a small number of dams. On lactational day 2, 
CD-1 mouse dams build nests that are typically 114mm in diameter, and have 
internal diameters of 56mm (Figure 3), with similar sizes on lactational day 5.   
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Fig 1.3: A typical nest from a vehicle-treated female CD-1 mouse on 
lactational day 2. Nests of a similar size and quality were observed in 
untreated females. Nests from both control groups were also similar on 
lactational day 5. Here, the blue circle indicates the internal dimensions of the 
nest and the red circle indicates the external dimensions. The diameter was 
measured as the widest points for both of these measures.  
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 3. Nursing behaviour  
Nursing behaviour comprises both active and passive nursing postures 
(Fleming 1986; Franks et al. 2003; Numan and Insel 2003). Early in the 
lactational period, both mouse and rat dams display two kinds of nursing 
postures (Cummings et al. 2010). Once the mother has gathered all of the 
pups in the nest and positioned them below her, the pups will root for a nipple 
and begin to suckle. This process induces her to establish a low crouching 
posture, where she moves very little, allowing for the pups to nurse. If nursing 
continues and the pups stimulate the ventral side of the dam, the mother will 
enter a high-crouch nursing posture, also known as kyphosis. In this posture, 
the dam has an arched back and rigid legs, and more room is created under 
the dam allowing the pups to nurse without the mother lying on them. The 
kyphosis posture is associated with the greatest milk production (Lonstein et 
al. 1998).  
 Later in the lactational period, the mother is less likely to exhibit either 
low or high crouching postures (Cummings et al. 2010). Instead, she will often 
lie on her side, allowing the pups to access her nipples and giving them room 
to move on their own. In both early and late lactation, a number of endpoints 
can be assessed to quantify the quality of nursing. Early in lactation, the pups 
can be individually examined to determine whether they have a milk band, 
indicative of nursing (Stern and Lonstein 2001). The pups should each be 
weighed to assess milk intake. Quantitative assessments, often collected 
during the dark phase when nursing behaviours are less variable, include the 
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amount of time spent on the nest (or away from the nest) as well as the 
nursing posture demonstrated by the dam over a period of several hours 
(Bertocchi et al. 2011). 
 
 4. Pup grooming and licking 
Another aspect of proper maternal care involves the cleaning of pups, 
which starts shortly after parturition when the dam licks each pup to remove 
the amniotic fluid and membranes, and eats both the placenta and the 
umbilical cord (Kristal 1980). This grooming is essential for the survival of both 
mouse and rat pups; retention of these tissues and fluids often causes foreign 
materials to stick to the pups, or even allows the pups to stick to one another 
(Kuroda et al. 2011). Licking also stimulates breathing in the newborn pups 
(Kuroda and Tsuneoka 2013).   
 After birth, the mother will lick and groom her pups routinely in two 
distinct ways: anogenital licking stimulates urination and defecation by the 
pups, and the urine is consumed by the mother to address her water needs; 
body licking cleans the remainder of the pup, providing tactile stimulation that 
is important for pup growth (Kuroda and Tsuneoka 2013). This stimulation 
activates growth hormone and suppresses corticosterone-dependent stress 
responses (Levine 2002). 
 Assessing pup licking and grooming typically occurs when examining 
nursing behaviours. When mothers are on the nest but not nursing, they are 
often found grooming their pups. For a period of several hours, the 
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experimenter can record the actions of the mother, including the type of 
grooming, at regular intervals.  
 
Control of maternal behaviour by signalling molecules 
Estradiol 
Decades of research have been devoted to unravelling the endocrine 
basis and the underlying neural systems involved in maternal behaviour. 
Many rodent studies have elucidated the underlying neuroanatomical circuitry 
and molecular mechanisms involved in maternal responsiveness. Importantly, 
much of this work has come from studies in rats; differences in the 
neuroendocrine basis of maternal behaviour exists between rats and mice, 
and these differences requires consideration from experimenters. As 
discussed further below, a significant body of information about maternal 
behavioural characteristics in mice has been obtained from genetically 
modified animals with hormone or hormone receptor knockouts. Data from 
these animals should be interpreted with care as many of the dams with gene 
knockouts are infertile or subfertile (and thus have other physiological aspects 
that could confound studies), or have altered behaviours and physiologies 
related to sleep, metabolism, and other factors that could influence maternal 
care.  
The hormones involved in pregnancy, parturition and lactation play 
integral roles in the onset of maternal behaviour in the rat (Moltz et al. 1970; 
Rosenblatt and Siegel 1975; Rosenblatt 1980; Rosenblatt et al. 1994; 
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Rosenblatt et al. 1998; Siegel and Rosenblatt 1975). The maintenance of 
pregnancy requires elevated levels of progesterone and low levels of estradiol 
(E2). The level and duration of progesterone during pregnancy is considered 
necessary to prime the dam for later sensitivity to E2 (Rosenblatt et al. 1994). 
Prior to the onset of parturition, progesterone levels fall rapidly, followed by a 
steep rise in both E2 and prolactin (PRL) (Rosenblatt 1980). The increase in 
E2 late in pregnancy is considered to be critical for triggering the onset of rat 
maternal behaviours, including pup care and nursing (Rosenblatt et al. 1988; 
Rosenblatt 1994).  If E2 signalling is blocked by anti-oestrogen implants 
(Ahdieh et al. 1987) or its effects are blocked by continued progesterone 
administration (Rosenblatt et al. 1998), maternal behaviour does not take 
place. However, ovariectomized and hysterectomized virgin females do 
exhibit maternal behaviour, and the latency to its onset can be reduced by 
hormone administration (Rosenblatt 1967; Siegel and Rosenblatt 1975).  
In the mouse, nulliparous females will exhibit what is considered 
“spontaneous” maternal behaviour after a brief exposure to pups. In the rat, 
adult nulliparous females can be induced to behave maternally only after a 
long exposure period of six to eight days, a process initially termed 
“concaveation” (Wiesner and Sheard 1933). This process was further 
described as “sensitization” by Leblond in relation to mice (CP Leblond 1938, 
1940), and still later measured in the rat by Rosenblatt (Rosenblatt 1967). 
Pup-stimulated maternal behaviour additionally involves an intermediary step 
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of tolerance of pup stimuli for “sensitization” to occur (Fleming and Luebke 
1981; Numan and Insel 2003).  
Due to the “spontaneous” nature of maternal behaviour in the mouse, 
its onset is considered to be independent of hormonal control. Evidence 
demonstrates that pup exposure is sufficient to induce pup retrieval and other 
maternal behaviours, even after circulating oestrogen levels are reduced by 
ovariectomy and/or genetic ablation of aromatase (Gandelman 1973a; 
Stolzenberg and Rissman 2011). It is interesting to note that while studies in 
nulliparous mice demonstrated that oestrogen was not required for the onset 
of maternal behaviour in ovariectomized adult females, ovariectomy at 
postnatal day 22 (i.e. prior to the onset of puberty) reduced the number of 
females that displayed maternal behaviour. These results suggest a role for 
oestrogen in the ontogeny of maternal behaviour in mice (Gandelman 1973a, 
b). Further, differences in maternal behaviour between virgin and lactating 
mice was recently shown; mice display more rapid pup retrieval and spend 
more time crouching over pups after parturition compared to virgin mice 
(Stolzenberg and Rissman 2011). It thus remains plausible that pregnancy 
hormones play a role in the onset of these behaviours. In humans, hormones 
are also implicated in maternal behaviours; an increase in E2 during 
parturition influences the maternal response, reinforces attention to newborn 
infants and plays a role in emotional responsiveness (Fleming 1989; Numan 
and Insel 2003; Numan 2006). 
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Progesterone 
Acute administration of progesterone can interfere with the inductive 
effects of E2 in the onset of rat maternal behaviour (Siegel and Rosenblatt 
1978), and progesterone treatment can inhibit maternal behaviours after 
pregnancy termination (Bridges et al. 1978; Numan 1978). However, 
progesterone implants in the ventromedial hypothalamus and other neural 
regions did not inhibit the onset of maternal responsiveness in rats (Numan 
1978). The progesterone antagonist, RU486, which acts at the level of the 
progesterone receptor, produced abnormal maternal care in mouse dams 
when treatment began prior to parturition, however, there were no differences 
seen if the injection was administered postpartum (Wang et al. 1995). The 
mechanisms underlying progesterone’s complex role in maternal behaviour 
are still not fully understood.   
 
Prolactin 
PRL is a peptide hormone secreted by the anterior pituitary gland with 
over 300 known functions including lobuloalveolar development of the 
mammary gland and milk secretion post-partum (Grattan 2002), and actions 
in the brain, most notably in the regulation of its own secretion (Bole-Feysot et 
al. 1998; Freeman et al. 2000). PRL was first discovered by Oscar Riddle, 
who became interested in its potential role in maternal behaviour in rats after 
finding that it was responsible for “broodiness” in fowl (Riddle et al. 1935). It 
was later found to play a role in the onset of maternal behaviour; PRL elicits 
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rapid responsiveness in hypophysectomied and ovariectomized virgin females 
that were also supplemented with E2 and progesterone (Bridges et al. 1985; 
Bridges and Ronsheim 1990). A number of studies have demonstrated a role 
for E2 in regulating PRL gene expression and synthesis (Shull and Gorski 
1985, 1986; Wiklund et al. 1981), as well as PRL-receptor expression in the 
hypothalamus (Shamgochian et al. 1995). These findings are also supported 
by studies of xenoestrogens in fish, which demonstrate that these compounds 
affect the expression of PRL in the pituitary gland via the ER (Elango et al. 
2006).  
Pituitary PRL release is increased during the final 24 hours of 
pregnancy in the rat (Grattan and Averill 1990, 1991), and levels remain 
elevated during lactation (Bridges et al. 2001; Bridges et al. 1990; Grattan and 
Kokay 2008). Transgenic mice with a null mutation of the PRL-receptor, as 
well as nulliparous heterozygous females, demonstrate deficits in maternal 
behaviours (Lucas et al. 1998); the heterozygous females display poor pup 
retrieval patterns, whereas homozygous females (who cannot maintain their 
own pregnancies and thus were tested in a pup-contact design), show higher 
latency to retrieve pups as well as reduced levels of crouching.  
 
Oxytocin 
Oxytocin (OT) is a nonapeptide hormone released from the 
paraventricular nucleus, and supraoptic nucleus of the hypothalamus into the 
posterior pituitary upon uterine contractions during childbirth and stimulation 
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by suckling (Higuchi et al. 1986; Moos et al. 1984; Moos et al. 1991). 
Increased levels of OT in plasma postpartum have been associated with 
mothers’ affiliative bonding with infants (Feldman et al. 2007).  
Oxytocin is restricted from crossing the blood brain barrier, thus, apart from its 
physiological function during labour and lactation, its role in maternal 
behaviour is most likely due to its action as a neurotransmitter (Leng et al. 
2008; Numan and Insel 2003). Both central and peripheral OT activity is 
mediated by the membrane associated G-protein coupled OT receptor, which 
is a member of the oxytocin-arginine vasopressin receptor family (de Wied et 
al. 1993). Intracerebroventricular (ICV) administration of OT induces maternal 
behaviour in virgin rats (Pedersen and Prange 1979), and ICV administration 
of anti-OT antiserum interferes with the onset of maternal responsiveness in 
E2 and progesterone primed virgin female rats (Fahrbach et al. 1985; 
Pedersen et al. 1985).  The level of maternal care in the rat can be measured 
by differences in maternal licking and grooming, and is directly responsible for 
the development of neural circuitry in offspring; increased licking and 
grooming affects both ERα and OT-receptor expression in the MPOA of rat 
pups (Champagne et al. 2001; Champagne et al. 2003; Francis et al. 2000; 
Pena et al. 2013) and ICV administration of an OT-receptor antagonist to 
neonatal pups abolishes the behavioural differences induced by high and low 
licking dams (Champagne et al. 2001). Further, in experiments designed to 
mimic the hormonal conditions at the end of pregnancy and beginning of 
lactation, E2 increased OT and OT-receptor mRNA expression in the rat 
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hypothalamus (Amico et al. 1997; Bale and Dorsa 1995). Using transgenic 
knockout mice, ERα was found to be essential for the induction of OT-
receptor binding, suggesting a role for this receptor in maternal behaviour 
(Young et al. 1998). 
 Although OT and the OT-receptor clearly play an important role in 
maternal behaviours, questions about specific effects remain, as studies with 
knockout mice for OT and OT-receptor have produced intriguing yet 
conflicting results. Early work on two different transgenic OT-knockout mice 
demonstrated normal parturition, a deficit in milk ejection, and normal 
maternal behaviour (Nishimori et al. 1996; Young et al. 1997). A potential 
compensatory role for the related peptide vasopressin was tested via infusion 
of an OT receptor antagonist centrally in OT knockout mice, with no changes 
in maternal behaviour detected (Young et al. 1997). More recently, studies 
examining maternal behaviour in both OT and OT-receptor knockout mice 
revealed normal maternal behaviour in the OT knockout dams, which was 
also explained by the possible activation of OT-receptor by vasopressin 
(Takayanagi et al. 2005).  Although OT-receptor knockout mice displayed 
normal nesting and crouching behaviours, these dams left their pups 
scattered in the cages and showed increased latency to retrieve pups. Poor 
maternal care could possibly be attributed to the dams’ inability to lactate, yet 
virgin OT-receptor knockout females also demonstrated deficits in maternal 
behaviour, indicating a neuroendocrine and behavioural basis for this lack of 
maternal care (Takayanagi et al. 2005). In a later study, maternal deficits were 
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observed in OT knockout females (Pedersen et al. 2006), however there was 
a difference in genetic background between the control and transgenic 
animals in this study, which may have confounded assessments of maternal 
behaviours known to be influenced by differences in strains (Chourbaji et al. 
2011). Many of the results from OT knockout mice contradict results in rats, 
which have suggested that the underlying neural control of maternal 
behaviour may be independent of OT. However, because mice are 
“spontaneously” maternal, OT may not have the same influence on the onset 
of maternal behaviour in these two species (Young et al. 1997). Further, OT 
receptor distribution differs amongst species (Insel et al. 1993). 
 More recently, two new mouse lines were generated to investigate the 
role of OT-receptor in maternal behaviour: a complete OT-receptor knockout, 
and a spatially conditional knockout, reducing OT-receptor expression in the 
forebrain only (Lee et al. 2008). Maternal behaviours were found to be 
unaffected, however in the conditional knockout, pup mortality at first 
parturition was 40%, compared to the complete knockout, where pup mortality 
was 10% (Macbeth et al. 2010).  The authors suggested that stress induced 
by fear could be a possible cause for high pup mortality rate. It is also 
important to note that the conditional knockout targets OT receptor in the 
lateral septum, hippocampus and ventral palladium, leaving expression in the 
MPOA intact (Lee et al. 2008). As E2-dependent OT receptor expression in 
specific regions of the rat brain including the MPOA show increased binding of 
the receptor during parturition (Pedersen et al. 1994) and OT receptor binding 
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in a number of regions including the MPOA has been correlated with 
variations in maternal care as well as oestrogen response in offspring in the 
rat (Champagne et al. 2001), interpretation of maternal behaviour in the 
conditional knockout is impeded by this limitation.  
 A more recent study by this group using the complete OT-receptor 
knockout also demonstrates the complication in interpreting data from OT 
knockout mice; ten of fifteen knockout dams abandoned their offspring and 
pups were found dead or were cannibalized, but those who did retrieve pups 
did not differ from controls (Rich et al. 2014). There were no differences in 
anxiety or depression like behaviour and the authors suggest a role for OT in 
sensitizing dams for the onset of maternal behaviour. Additional research is 
clearly needed to better understand the role of OT in maternal behaviours. 
 
Vasopressin 
Vasopressin, a peptide hormone produced in the pituitary that is often 
associated with kidney function, has also been shown to impact maternal 
behaviours (Bosch and Neumann 2008; Bosch et al. 2010; Kessler et al. 
2011). Initial evidence arose from studies in which infusion of vasopressin 
improved responsiveness (Pedersen et al. 1982) and anti-vasopressin 
antiserum in hormonally primed nulliparous rats caused increased latency for 
the onset of maternal behaviour (Pedersen et al. 1985). In a later study, 
infusion of a vasopressin receptor antagonist into the medial preoptic area 
(MPOA), a brain region with a central role in maternal behaviour, blocked pup 
		 32 
retrieval and nursing posture (Pedersen et al. 1994). Furthermore, extended 
vasopressin administration to the MPOA enhanced maternal behaviour, 
including increased arched back nursing (Bosch and Neumann 2008).  
 
Dopamine 
 Dopamine (DA) is perhaps the most well characterized 
neurotransmitter involved in maternal behaviour in rodents and is involved in 
both the onset and maintenance of maternal care in rats (Byrnes et al. 2002; 
Numan and Stolzenberg 2009; Stolzenberg et al. 2007). Indirect evidence 
also points to the possible involvement of the DA system in human mothering 
(Barrett and Fleming 2011). Dopaminergic mesolimbic circuits are required for 
active components of maternal behaviour such as pup retrieval and licking 
and grooming. Systemic injections of the mixed DA receptor antagonist 
haloperidol can eliminate retrieval and licking of pups in most rat dams, an 
effect which can be reversed by treatment with the DA agonist apomorphine 
(Giordano et al. 1990b; Stern and Taylor 1991).  
 Both the D1 and D2 receptors appear to be involved in mediating 
maternal behaviours as antagonists to either receptor alter rat maternal 
responses (Byrnes et al. 2002; Giordano et al. 1990b; Miller and Lonstein 
2005; Stern and Taylor 1991). Stolzenberg et al. (Stolzenberg et al. 2007) 
tested the DA-D1 agonist SKF38393 on D1 receptors in the nucleus 
accumbens (NAs) and MPOA, two regions with essential roles in maternal 
behaviour (discussed in more detail below). After pregnancy terminated rats 
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were injected with SKF383393 into either the NAs or the MPOA, immediate 
maternal behaviour was elicited in the dams.  The authors concluded that DA 
signalling may act as an alternate for oestrogenic stimulation of maternal 
behaviour. Further, PRL signalling is also DA-dependent. The secretion of 
PRL is regulated by DA inhibition from tubero-infundibular DA neurons located 
in the arcuate nucleus of the hypothalamus; these neurons activate D2-like 
receptors in PRL cells in the pituitary gland (Grattan 2002; Gudelsky and 
Porter 1980).   
 
Serotonin 
The importance of the neurotransmitter serotonin (5-HT) to maternal 
behaviour has emerged in recent decades. Increased concentrations of 5-
hydroxyindoleacetic, a metabolite of 5-HT, were found in the ventral striatum 
in rat dams when their pups are returned to the cage (Hansen et al. 1993). 
Further, lesions of serotonergic neurons in the median raphe nucleus led to 
short-term reduction in rat maternal behaviour (Barofsky et al. 1983) and 
knocking out the 5-HT 1B receptor increased hyperactivity and time spent out 
of the nest in mouse dams (Brunner et al. 1999). A later study of receptor 1A 
and 1B knockout mice found no differences in maternal responsiveness in 
KO1A mice, and only changes to entries into the nest in the KO1B dams 
(Weller et al. 2003). These results contrast somewhat to those obtained in 
studies designed to examine physiological effects of central blockade of 5-HT. 
Using genetic targeting of tryptophan hydroxylase 2, the enzyme responsible 
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for 5-HT synthesis in the raphe nucleus of the hind- brain, maternal care was 
assessed (Alenina et al. 2009; Angoa-Perez et al. 2014). Null females 
demonstrated poor maternal care, feeding pups on the first day, but later 
neglecting pups, with evidence of cannibalization. Importantly, tryptophan 
hydroxylase 2 mutant pups were born smaller, weaker, with slowed growth 
and softer skin, thus, although neglect was demonstrated in dams, the poor 
health of the pups may have also influenced the maternal response (Alenina 
et al. 2009).  
Pet-1, a transcription factor found only in 5-HT neurons, is responsible 
for 5-HT gene expression and synthesis (Lerch-Haner et al. 2008). None of 
the pups born to homozygous Pet-1 mice survived, except when cross-
fostered with wild-type females, suggesting a failure in maternal care 
associated with diminished 5-HT signalling. An assessment of maternal 
behaviour in the knockout dams demonstrated less time crouching and poor 
nesting behaviours, as well as poor pup grouping and retrieval. 
 
The maternal brain 
Behaviours, including maternal behaviours, are thought to arise due to 
changes in the neural networks within specific brain nuclei. These changes 
can occur due to neurogenesis, the establishment of new connections 
between neurons within a brain region or in multiple brain regions, the 
activation of established neurons, or the expression of new proteins such as a 
hormone receptor (Baez-Mendoza and Schultz 2013; Dragunow and Faull 
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1989; Galea et al. 2014). Both lesion and transcranial current brain stimulation 
studies have allowed scientists to establish causal relationships between 
specific brain regions and behaviours (Luft et al. 2014). With regard to 
maternal behaviours, the MPOA and ventral tegmental area (VTA) are 
considered two of the most relevant brain regions. Other important areas 
include the bed nucleus of the stria terminalis, nucleus accumbens, as well as 
limbic and hypothalamic structures (Lonstein et al. 2000; Numan and Insel 
2003). Neuronal plasticity in these brain regions, as well as others, occurs 
during pregnancy and lactation; there are severe adverse consequences for 
both the offspring and the mother if required changes do not occur normally 
(Hillerer et al. 2014). 
 
The MPOA 
 Numerous studies have uncovered many of the complex neural circuits 
involved in facilitating maternal behaviour, most notably, those in the MPOA 
(Figure 4). In rats, E2 signalling in the MPOA, mediated though ERα, is 
considered the primary mechanism responsible for the onset of maternal 
behaviour (Giordano et al. 1989; Numan et al. 1977).  Lesioning the MPOA 
with knife cuts or excitotoxins abolishes the onset of rat maternal behaviours 
and disrupts those that are established prior to lesion (Jacobson et al. 1980; 
Numan 1974; Numan et al. 1988; Numan 1990). Further evidence for 
estrogenic regulation of maternal behaviour in this region is demonstrated by 
the increase in c-Fos expression in the ERα-positive cells of the MPOA, as 
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well as other neural regions relevant for maternal behaviour in adult rats in 
response to pup-separation (Lonstein et al. 2000).   
Three of the hormones involved in the induction and maintenance of 
maternal behaviour, E2, OT and PRL, are elevated in rat maternal serum 
during late pregnancy and early postpartum and their associated receptors 
are expressed in the MPOA (Pedersen et al. 1994; X Pi and DR Grattan 1999; 
Shughrue et al. 1997). For example, expression of the long form of the PRL-
receptor changes during pregnancy and lactation, with an increase found 
during mid- pregnancy and two hours postpartum (Mann and Bridges 2002), 
and the infusion of a PRL-receptor antagonist into the MPOA delays the onset 
of maternal behaviours (Bridges et al. 2001). Within the MPOA, intracellular 
levels of DA also change during pregnancy and lactation, and are increased 
after the first week post-partum compared to late pregnancy or parturition 
(Lonstein et al. 2003). DA neural circuits also act on the MPOA in the 
regulation of maternal behaviour in rats and E2 and DA may interact to 
stimulate MPOA output during the onset of maternal behaviour (Shughrue et 
al. 1997).  
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Fig 1.4: ERα expression in the MPOA (arrow) of lactating female mice is 
robust. Representative image of immunohistochemical analyses of 40 µm 
transverse section of a CD-1 mouse dam on lactational day 20.  (Primary 
antibody, polyclonal anti-ERα, Millipore Cat# 06-935, secondary antibody, 
biotinylated goat anti-rabbit, Abcam Cat# AB642256, DAB chromagen.)  
 
 
 
 
 
  
		 38 
Dopaminergic signalling in the mesolimbic system comprises projections from 
the DA cell bodies in the VTA (Figure 5) to the ventral striatum, which includes 
the NAs, part of the dorsal striatum, and olfactory tubercule and to the limbic 
region (Hansen 1994; Numan and Numan 1996; Oades and Halliday 1987). 
The MPOA receives inputs from the periventricular hypothalamus and the 
VTA (Chiba and Murata 1985; Miller and Lonstein 2009; Simerly and 
Swanson 1986). Despite being low in number, broadly distributed 
dopaminergic neurons projecting to the MPOA play an integral role in driving 
rat maternal behaviour.  
 
The VTA 
In an elegant model for maternal behaviour based on neuroanatomical 
and behavioural studies, Numan et al., propose that projections from the 
MPOA to the DA neurons of the VTA which act upon the NAs, play an 
important role in “appetitive” or “motivational” aspects of maternal behaviour 
(Numan and Smith 1984; Numan and Stolzenberg 2009). In early studies, 
lesion of the VTA with knife cuts reduced responsiveness of rat dams to 
retrieve pups (Numan and Smith 1984). Infanticide occurred after 
radiofrequency lesion of the VTA in rats (Gaffori and Le Moal 1979); other 
disrupted maternal behaviours were also observed including the failure to 
build nests and the lack of nursing behaviours. Lesions to the VTA with 6-
Hydroxydopamine, which selectively destroys dopaminergic neurons, also 
diminish pup retrieval; these effects were specific to maternal responsiveness, 
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as there were no effects on proceptive or perceptive sexual behaviours 
(Hansen et al. 1991).  
 MPOA neurons expressing ER terminate in the VTA (Fahrbach et al. 
1986). Recent research has reported a convergence of E2, OT and DA in 
several brain regions responsible for the regulation of maternal behaviour, 
incuding both MPOA and VTA. In one study, investigators found that infusion 
of OT directly into the rat VTA enhanced the dopamine signal in the shell of 
the NAs during periods of pup licking and grooming (Shahrokh et al. 2010). 
Further, infusion of an OT-receptor antagonist into the VTA abolished 
behavioural differences in high and low licking dams. These findings indicate 
that oestrogen sensitive OT neurons from the MPOA projecting to the VTA 
may play a role in the increased level of DA in the NAs in mothers that provide 
high levels of care (Numan and Stolzenberg 2009; Shahrokh et al. 2010; 
Stolzenberg and Numan 2011). The authors note that neurons from the lateral 
preoptic area (Numan 1988) and the ventromedial hypothalamus also project 
to the VTA and so it remains possible that these neurons, alone or in 
combination with those from the MPOA are involved in this circuit (Shahrokh 
et al. 2010; Stolzenberg and Numan 2011). For more extensive review and 
discussion of neural circuits involved in maternal behaviour, readers are 
referred to Numan and Insel (Numan and Insel 2003). 
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Fig. 1.5: Dopaminergic neurons in the VTA. A) Sagittal view, anterior to the 
left; tyrosine hydroxylase, a marker of dopamine neurons, is expressed in the 
VTA (black arrow); the MPOA (red arrow) is rostral to the VTA.  Dopamingeric 
neurons in the VTA play an important role in maternal behaviour. B) Higher 
magnification transverse view of dopamine neurons in the VTA. 
Immunohistochemistry was performed with anti-tyrosine hydroxylase primary 
antibodies (Abcam, Cat# Ab112), biotinylated goat anti-rabbit, (Abcam Cat# 
AB642256), and DAB chromagen. 
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Maternal behaviour, a target of EDCs 
Compared to other endpoints that have received significantly more 
attention from the endocrine disruptor community, maternal behaviour has 
only been examined in a limited number of studies. In contrast, a large 
number of studies have examined the effects of EDCs on the pups, and many 
have revealed abnormal neurobehaviours in these offspring (Frye et al. 2012; 
Gore 2010; Walker and Gore 2011). It must be considered that effects of 
EDCs on pup behaviours could influence how the mother responds, as well as 
other factors (i.e. whether EDC exposures alter the timing of parturition, milk 
production, etc.) that could ultimately influence maternal-infant interactions. 
Unfortunately, these factors are rarely considered.  
 Maternal experience is also an important factor to consider, as 
maternal care typically improves with experience. We are not aware of any 
EDC studies using multi-parous females; many studies fail to include direct 
details about the parity of the dams used in their studies. Experimenters 
should give attention to these important details, and consider cross-fostering 
to separate the effects of EDCs on the mother versus the pups; this is 
discussed in some detail below.  
 Here, we review the studies that have examined one or more maternal 
behaviour endpoints in rodents exposed to EDCs, either during pregnancy 
and lactation, or during their own early development (gestation and neonatal 
life). The chemical structures of all compounds that may disrupt maternal 
behaviours are shown in Figure 6. 
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Ethinyl estradiol 
Ethinyl estradiol (EE2), a synthetic (or semi-synthetic) oestrogen with 
potency greater than 17β-estradiol for some biological endpoints, is a 
pharmacological agent widely used in contraceptive pills (Sitruk-Ware and 
Nath 2013). In two studies examining behavioural outcomes of gestational 
exposure to exogenous estrogens, EE2 was injected daily on days 9-14 of 
pregnancy in DA/HAN pigmented rats (Arabo et al. 2005; Dugard et al. 2001). 
The treatment dose, 15 µg/kg/day, was significantly higher than doses 
administered as contraceptives to women, and produced circulating 
concentrations 6-8x higher than typical serum levels of endogenous 
oestrogen at the end of pregnancy. The high EE2 dosage caused 50% of the 
dams to abort and death of more than 50% of neonates.  
In the first study, the authors reported limited pup retrievals (10 of 18 
surviving pups), in EE2-treated dams (Dugard et al. 2001). Early in the 
lactational period, pup retrieval latency was increased in EE2 treated dams 
relative to controls (indicating delayed retrieval), but latency to retrieve 
resembled controls at later lactational periods. When the EE2-exposed 
offspring were examined in adulthood, numerous behavioural deficits were 
noted in spontaneous motor activity, impaired cognitive processing, 
decreased exploration and increased anxiety. The authors proposed that 
these behavioural alterations may have been due to the poor maternal 
behaviour of the dams. 
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In the second study, the authors report lower latencies to retrieve pups 
in EE2-treated dams compared to controls, which the authors characterize as 
improved maternal behaviour (Arabo et al. 2005). In addition to more rapid 
pup retrieval, the EE2 treated dams demonstrated more directed pup retrieval. 
No real explanation for the differences in maternal behaviour induced by EE2 
in these two studies is supplied, although the authors propose that differences 
in lighting conditions, which may have influenced maternal stress, could have 
been responsible. Because of these conflicting results from two studies with 
very similar study designs, the same dosage, and conducted by the same 
group of researchers, as well as the obvious overt toxicity of ethinyl estradiol 
on the exposed pups, it is difficult to draw conclusions about the effects of 
exogenous oestrogens, or at least on this specific oestrogen, on maternal 
behaviours.  
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Fig. 1.6. Structures of EDCs with published effects or preliminary data showing effects on one or more aspect of 
maternal behaviour.
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Bisphenol A 
Bisphenol A (BPA) is used in a large number of consumer products 
including plastic food and beverage containers, can linings, some dental 
sealants, toys, thermal papers, and medical equipment (Geens et al. 2012; 
Vandenberg et al. 2007). Human exposures are widespread (Vandenberg et al. 
2010). For decades, it has been known that BPA has oestrogenic properties, but 
recent studies also indicate that it can activate other hormonal signalling 
pathways (Reif et al. 2010; Vandenberg et al. 2009). A number of studies 
suggest that BPA can disrupt maternal behaviours in rodents. One study 
examined these behaviours in female mice exposed during gestation, during 
pregnancy, or during both periods (Palanza et al. 2002a). Remarkably, 
exposures during either gestation or pregnancy decreased the time spent nursing 
and on the nest relative to controls, whereas females exposed both prenatally 
and in adulthood displayed no alterations in maternal behaviours. Another recent 
study examined maternal behaviours in two groups of female rats: one group 
was exposed to BPA during pregnancy and lactation, while the second group 
was exposed to BPA during gestation and throughout adulthood, but not during 
pregnancy (Boudalia et al. 2014). This study reported no effects of BPA when 
exposures were restricted to pregnancy and lactation; females exposed to BPA 
during development and adulthood spent less time on the nest and less time in 
the arched-back nursing posture. Together, these findings indicate that the timing 
of exposure might be critical to explain the differences reported between studies.  
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 Another experiment conducted in rats examined the effects of oral BPA 
exposures to dams from mating to the weaning of pups (Della Seta et al. 2005). 
BPA-exposed dams exhibited reduced licking and grooming of pups. Similar 
results were reported in a study of mice, where exposures to low levels of BPA 
during gestation decreased licking and grooming of pups and the display of 
arched-back nursing posture, with non-monotonic dose response relationships 
(Kundakovic et al. 2013). Importantly, none of these studies specifically 
examined behaviours of the pups, so it is not possible to conclude whether 
abnormal pup behaviour contributed to the deficits in maternal care that were 
observed; Because BPA is known to alter neurobehaviours in both mice and rats 
exposed during early development (Chapin et al. 2008; Richter et al. 2007; 
Vandenberg et al. 2013c), this possibility cannot be discounted. 
 The first study to evaluate BPA exposure in relation to behavioural 
development in non-human primates found that BPA affected maternal and infant 
behaviour in cynonolgus monkeys (Macaca fascicularis) (Nakagami et al. 2009); 
behavioural changes in “outward looking” measures in male infants and their 
mothers suggested BPA-induced alterations in the usual sexual dimorphism of 
this behaviour (Nakagami et al. 2009).  
 
PCBs 
 Polychlorinated biphenyls (PCBs) are industrial compounds that persist in 
the environment; although they were banned in the US more than three decades 
ago, they continue to be found in the environment, in fatty foods, and in human 
bodies (Cummings et al. 2008). Rat dams treated with PCB77 during gestation 
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spent more time on the nest and more time grooming their pups compared to 
untreated dams (Simmons et al. 2005). Although there were no differences in the 
total time spent nursing, PCB77-exposed females spent less time in the high 
crouch position, and the pups gained less weight during the first week of life, 
indicative of nursing deficits. When these results were followed-up with a 
subsequent study including a cross-fostering design, it was demonstrated that 
exposures of both the mother and the pup were required to observe effects of 
PCB77 on nesting and grooming behaviours, and exposures of the pups were 
required to induce effects on nursing (Cummings et al. 2005).   
 
Genistein 
 Genistein is a soy-derived phytoestrogen that has been shown to disrupt 
numerous endocrine-related endpoints in rodents, particularly when exposures 
occur during early development (Jefferson et al. 2007a; McLachlan et al. 2001; 
Patisaul 2013). One study, using a complex exposure design to separate out the 
effects of genistein treatment during gestation, lactation, or both periods, found 
that rat dams exposed to genistein during pregnancy spent more time nursing 
compared to unexposed dams or dams exposed only during lactation (Ball et al. 
2010). No effects were observed on pup licking or time spent away from the nest 
for any exposure group. A second study exposed female mice to genistein during 
early development and then examined their maternal behaviours in adulthood 
(Jefferson et al. 2007b). The genistein-exposed females displayed abnormal 
maternal behaviours including reduced nesting time and decreased time spent 
licking the pups. Females exposed to the lower dose (0.5 mg/kg) but not the 
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higher dose (5 mg/kg) spent increased time in the crouching nursing posture but 
failed to group their pups. 
 
Pesticides 
 A number of different pesticides have been evaluated for their effects on 
maternal behaviour. Methoxychlor, an estrogenic insecticide, produced non-
monotonic effects on maternal endpoints; mouse dams exposed to the lowest 
dose during pregnancy spent less time nursing and more time off the nest 
relative to controls, whereas higher doses did not disrupt these events (Palanza 
et al. 2002b). Sulentrazone, an herbicide with known reproductive toxicity, 
decreases overall maternal ‘scores’, a compiled measure that takes into account 
nesting, nursing and retrieval behaviours, after exposure of dams during 
gestation (de Castro et al. 2007). Meadow jumping mice exposed during 
pregnancy to carbaryl, an insecticide that can impair mammalian reproduction, 
are more likely to commit infanticide compared to controls; no effects were 
observed on pup grooming, the other maternal behaviour that was assessed 
(Punzo 2003).  
 Another study, examining rats exposed to 2,4-dichlorophenoxyacetic acid 
(2,4-D) during lactation revealed effects of this herbicide on latency to retrieve 
pups and total retrieval time; latency to achieve a crouching nursing posture; time 
spent off the nest; and overall grooming of pups (Sturtz et al. 2008). Perhaps the 
most stunning result observed was the elimination of all anogenital licking by 
treatment of all three doses of 2,4-D tested (15, 25 and 50 mg/kg/day). Another 
study examined the effects of fipronil, a phenylpyrazole insecticide used by 
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veterinarians and in agriculture, on rats exposed during pregnancy (Udo et al. 
2014). The highest dose tested (10 mg/kg) decreased grouping of pups and 
increased pup licking, while the lowest dose tested (0.1 mg/kg) decreased the 
quality of new nests and increased the latency to achieve nursing posture.  
 Two studies have addressed the effects of chlorpyrifos, a 
organophosphate insecticide with anti-androgenic properties. In one, mice 
exposed during pregnancy demonstrated increased pup grooming, but no effects 
on pup retrieval (Venerosi et al. 2009). In the second study, mice exposed during 
neonatal development were tested for maternal behaviours in adulthood 
(Venerosi et al. 2008). Chlorpyrifos-exposed females had longer latency to build 
nests but no difference in nest quality compared to controls; their latency to start 
licking pups was lower; they displayed lower frequency and duration of defence 
attacks against male intruders, and they had altered pup retrievals. Finally, in a 
two-generation rat guideline reproductive toxicity test, abnormal maternal 
behaviours were observed in the F1 generation exposed to lindane, an 
insecticide with estrogenic and anti-estrogenic properties (Matsuura et al. 2005). 
Effects were observed in non-guideline endpoints including absence of lactation 
and retrieving behaviours; this severely disrupted maternal behaviour was likely 
responsible for the death of the F2 generation pups.  
 
Other emerging EDCs 
 In our lab, we have examined maternal behaviours in female CD-1 mice 
exposed during pregnancy and lactation to one of several poorly studied EDCs 
including BDE-47, bisphenol S and tetrabromobisphenol A (TBBPA). [Note that 
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all compounds were administered from pregnancy day 8 – lactational day 20, at 
doses of 200 µg/kg/day or oil vehicle.] Although these data should be considered 
preliminary due to the relatively small sample sizes examined, our results do 
suggest the possibility that these compounds may disrupt maternal behaviours. 
For example, in control animals, we and others have found that the latency to 
retrieve pups is decreased over time (Figure 2A). In BDE-47 treated mouse 
dams, latency to retrieve was unchanged, or increased, in dams as the 
lactational period progressed (Figure 2B). We also examined pup retrieval in 
litters treated with TBBPA; dams exposed to TBBPA completed the retrieval of 
their litters faster than controls, even when accounting for differences in litter size 
(Figure 7). 
 Finally, we quantified numerous aspects of nest size in control animals 
and found fairly consistent nest dimensions and highly consistent nest qualities 
between mothers (Figure 8). Mothers that were treated with bisphenol S, a 
common replacement for BPA used in consumer products such as thermal 
papers, built larger nests that were given lower quality scores (Figure 8).  
 Although, again, these data should be considered preliminary because of 
the limited number of dams examined (n = 4-5 per treatment), overall these 
results provide suggestive data that these poorly studied EDCs may disrupt 
maternal behaviours, and suggest that they should be studied in more depth. 
Because maternal behaviours, like many behavioural endpoints, are quite 
variable, studies must be robust to show statistically significant results; some 
prior studies have examined similarly limited sample sizes, and these studies 
deserve additional attention from experimenters in the field. 
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Fig. 1.7: Pup retrieval was improved in dams exposed to 200 µg TBBPA/kg/day 
from pregnancy day 8 through lactational day 20 compared to vehicle-treated 
controls. A) TBBPA-exposed dams retrieved their entire litters faster compared to 
controls. However, TBBPA litters were somewhat smaller compared to litters 
from dams administered vehicle alone (TBBPA: 10.2 ± 4.3 pups; controls: 13 ± 
1.6 pups). B) To account for these differences, we calculated the average time to 
retrieve each pup. TBBPA-treated dams still retrieved quicker than control dams, 
although the differences were less striking. C) We also calculated the average 
time to retrieve 5 pups, the smallest litter size in this experiment. Again, TBBPA-
treated dams retrieved the first five pups faster than vehicle-treated dams. 
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Fig. 1.8. Exposure of CD-1 mice to bisphenol S (BPS) during pregnancy and 
lactation may alter nest size and nest quality. Dams were exposed to either oil 
(vehicle) or BPS (200 µg/kg/day) from pregnancy day 8 through lactational day 
20. The internal diameter (A) and cup volume (B) were larger in nests 
constructed by mothers exposed to bisphenol S compared to control dams. Cup 
volume was calculated from measures of internal diameter and nest depth. Nest 
quality was also more variable and included worse scores in bisphenol S-
exposed females compared to vehicle-exposed females (C). All measures 
presented here were collected on day 2 of lactation. Two quality scores per nest 
were assigned by independent researchers who were blind to treatment.  
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Deficient versus improved maternal behaviour outcomes: are EDCs making 
“better” or “worse” mothers? 
Our review of the maternal behaviour literature revealed several 
treatments that appeared to improve maternal behaviour endpoints, i.e. 
decreased latency to retrieve pups, increased time spent grooming and nursing, 
etc. Yet, hyper-maternal behaviour may have adverse consequences for 
offspring, just as deficient maternal behaviour does, and thus should not be 
considered improved. In some studies, increased time spent in contact with the 
pups (i.e. increased nursing) may be indicative of deficiencies in milk production; 
mothers may need to nurse for longer periods of time to ensure the survival of 
their pups. These actions are likely to have other costs to the mother, and 
possibly to the offspring. Importantly, elevated maternal care can be induced by 
increasing maternal anxiety, although this anxiety often manifests in protective 
behaviours such as increased maternal aggression (Bosch and Neumann 2008). 
In these cases, increased activity, including increased grooming of pups, may not 
confidently be assessed as improved maternal care. 
 The conflicting results observed in the two EE2 studies – one suggested 
improved maternal behaviour whereas the other concluded that EE2 exposures 
induced poor maternal behaviours – should also be viewed in light of the 
offspring; in both studies, the offspring displayed abnormal behaviours (Arabo et 
al. 2005; Dugard et al. 2001), suggesting that hyper-attentive mothering cannot 
‘cure’ the pups from a neurological perspective. Of course, cross-fostering 
studies are needed to separate the effects of these EDCs on the offspring 
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themselves from any indirect effects on the offspring due to altered maternal 
behaviours.  
 
Do EDCs disrupt the maternal brain? 
 Although the number of studies suggesting that EDCs disrupt maternal 
behaviours continues to grow, there is surprisingly little data examining the 
effects of these compounds on the maternal brain. A small number of studies 
have examined the effects of EDCs on brain regions that are implicated in 
maternal behaviour, e.g. the MPOA. Yet, these investigations have largely been 
limited to non-pregnant and non-lactating animals. For example, BPA and EE2 
exposures during gestation and postnatal development disrupted ER mRNA 
expression in the rat MPOA at postnatal day 90 (Rebuli et al. 2014). Another 
study by the same group examined the effects of BPA exposures that were 
limited to the first four days after birth, but found no effects of BPA on ERα 
expression in the rat MPOA (Adewale et al. 2011). These studies (Adewale et al. 
2011; Rebuli et al. 2014) and others (Fukushima et al. 2007) noted that the 
effects of BPA on gene or protein expression in the MPOA were distinct from the 
effects of E2 or other synthetic oestrogens.  
 In another study, the effects of long term BPA exposure on ERα 
expression was assessed in the MPOA, arcuate  nucleus, and ventromedial 
nucleus in cycling female adults and lactating  rats (Aloisi et al. 2001). Dams 
exposed to a very high dose of BPA (40 mg/kg/body weight/day) in pregnancy 
and lactation had decreased numbers of ERα-positive cells in the arcuate 
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nucleus during lactation; ERα expression was increased in the MPOA of cycling 
females in response to BPA as well.  
 Although these studies suggest that the MPOA may be sensitive to EDC 
exposures, particularly those that include critical periods of development, it 
remains unknown whether animals that have displayed abnormal maternal 
behaviours have abnormalities in regions of the brain that are implicated in these 
behaviours. In the future, when abnormal maternal behaviours are observed 
following environmental chemical treatments, the dam’s brain should be collected 
and assessed. 
  
The mother is more than a means of exposure: Maternal behaviours impact 
offspring 
Analysis of PCB toxicity testing in animal experiments over the last 40 
years shows a gradual increase in the percentage of studies that use pre- and 
perinatal exposures versus adult exposures (Suvorov and Takser 2008). This 
observation likely reflects an increased appreciation of the fact that perturbations 
during sensitive windows of development may have much more profound and 
long-lasting health effects than similar perturbations at adulthood. Although this 
relatively new focus on developmental testing from testing of adult animals is a 
positive movement, the mother is still considered an exposure tool in most 
current developmental toxicological experiments; the mother is seen simply as a 
means of exposing the individuals of interest, i.e. her offspring.  
Because of this limited view of the mother, maternal behaviours are typically not 
considered a factor that affects health outcomes in offspring. Yet, numerous 
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studies from a range of scientific disciplines have repeatedly shown that the 
mother, and in particular the level of maternal care that she provides, can 
significantly affect the health and behavioural phenotype of her offspring. For 
example, female rats artificially reared from days 4 to 20 in “zero parenting” 
conditions became mothers that engaged in significantly fewer pup-retrievals and 
less pup-licking (Gonzalez et al. 2001). They also showed deficits in attentional 
set shifting tasks (Lovic and Fleming 2004) and increased impulsive actions 
(Lovic et al. 2011). These behavioural deficits could be reversed by providing 
them with artificial licking-like stimuli during the neonatal period, indicating the 
importance of maternal attention in both maternal and other types of behaviours 
(Gonzalez et al. 2001; Lovic and Fleming 2004; Lovic et al. 2011).  
Macaque females exposed to harsh and inconsistent maternal care in infancy 
tended to have higher cortisol responses to stress and to corticotropin-releasing 
hormone (CRH) than animals provided positive maternal interactions, as well as 
blunted adenocortiocotropic hormone secretion in response to CRH (Maestripieri 
2005a; Sanchez et al. 2010). Infant maltreatment in rhesus monkeys has a long-
term effect on brain white matter structural integrity, particularly in tracts involved 
in visual processing, emotional regulation, and somatosensory and motor 
integration (Howell et al. 2013). 
The multigenerational character of maternal behaviours has also been 
established, where daughters of artificially reared mothers also showed a pattern 
of behaviour that mimicked the pattern shown by their mothers (Gonzalez et al. 
2001). Rat mothers provide high levels of maternal care (substantial levels of 
anogenital licking, and arched-back nursing, abbreviated LG-ABN behaviour) to 
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their offspring if they themselves received high maternal care as a pup from 
either their own or foster mothers (D Francis et al. 1999). In these experiments, 
maternal behaviours and stress-response behaviours were shown to be 
transmitted across three generations of females. Inheritance of abusive maternal 
behaviour was also demonstrated in a longitudinal study of rhesus monkeys 
(Maestripieri 2005b). In a cross-fostering design, 9 of 16 females who were 
abused by their mothers, regardless of whether they were reared by their 
biological mothers or by foster mothers, exhibited abusive parenting with their 
firstborn offspring, whereas none of the females reared by non-abusive mothers 
expressed abusive tendencies. These results suggest the possibility that when 
maternal behaviours are altered by external environmental factors, including 
EDC exposures, the effects may continue to be reproduced in subsequent 
generations, including generations that were never exposed themselves, either 
directly or indirectly. Additional studies examining maternal behaviours in F3 and 
F4 generations are needed to determine whether these effects are truly trans-
generational. 
 Not only does poor maternal behaviour affect offspring health, but also, 
positive maternal interactions can support healthy outcomes. It has long been 
recognized from experiments with laboratory animals that increased maternal 
care early in life reduces stress reactivity in offspring (Denenberg et al. 1968; 
Rosenberg et al. 1970). In a series of experiments with rodents, the natural 
variability in levels of maternal care between individual dams was established 
(Champagne et al. 2003; Champagne et al. 2007). In Long-Evans rats, that 
variability is mostly restricted to LG-ABN behaviours (Champagne et al. 2003). 
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Remarkably, postnatal handling of pups increases the frequency of maternal LG-
ABN behaviours (Lee and Williams 1974), thus allowing for the experimental 
manipulation of the intensity of maternal care in laboratory experiments. The 
offspring of mothers that exhibited high levels of LG-ABN showed substantially 
reduced behavioural fearfulness in response to novelty compared with the 
offspring of low LG-ABN mothers, which is associated with hypothalamic-
pituitary-adrenal blunting and changes in forebrain glucocorticoid receptor (GR) 
expression levels that persist into adulthood (Caldji et al. 1998; Kaffman and 
Meaney 2007). Using a cross-fostering experimental design, studies of rats show 
that postnatal maternal care, rather than direct genetic inheritance, is the factor 
that programs GR expression levels in brain regions controlling the 
hypothalamic-pituitary-adrenal axis (Weaver et al. 2004). In pups exposed to high 
levels of LG-ABN behaviours, the number of excitatory synapses in CRH 
neurons was reduced and levels of a negative regulator of CRH gene expression 
(neuron-restrictive silencer factor) were markedly elevated (Korosi et al. 2010). 
Altered expression of GR was also associated with altered histone acetylation at 
the GR promoter (Weaver et al. 2004). Similar effects of parental care may occur 
in humans; postmortem brains obtained from suicide victims with a history of 
childhood abuse had decreased expression of neuron-specific glucocorticoid 
receptor (NR3C1) and increased cytosine methylation of an NR3C1 promoter 
(McGowan et al. 2009). Thus, maternal behaviour directly affects the epigenome 
of offspring and these established changes may persist through generations. 
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Conclusions 
 EDCs represent an emerging problem for public health – and have been 
described as a “global health concern” (Bergman et al. 2013b). Collaborations 
across scientific disciplines are needed to address this emerging problem and 
better understand how EDCs and other environmental factors are contributing to 
the increased incidence of a large number of non-communicable diseases 
(Barouki et al. 2012). Work that crosses the fields of toxicology and 
endocrinology will also help to improve the methods used to classify compounds 
as EDCs, to prioritize these chemicals for scientific studies and regulation, and to 
understand the mechanisms by which these chemicals contribute to emerging 
diseases (Birnbaum et al. 2012; Birnbaum 2013; Gee 2006; Rice et al. 2003). 
What is clear is that new approaches are needed to accomplish these tasks.  
 From the perspective of hazard assessment, it has become very clear that 
test guidelines and the endpoints they include are not sufficient to address 
endocrine disrupting properties of environmental chemicals. Although test 
guidelines provide helpful tools for assessing general toxicity, as well as the 
induction of certain types of birth defects, EDCs can produce more subtle defects 
that take time to manifest and require state-of-the-art techniques to detect. 
Studies have successfully added non-guideline endpoints to test guidelines and 
have uncovered interesting effects of EDCs on health outcomes that would 
otherwise not be observed by relying on validated methods alone. Significant 
evidence has accumulated that maternal behaviours comprise complex, 
integrated endpoints that can be disrupted by EDCs. These behaviours can thus 
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provide important and compelling information about the hazardous properties of 
compounds that the general public encounters. 
 Most studies examining maternal behaviour have not investigated the 
underpinning neurological mechanisms. Although regions of the brain implicated 
in maternal behaviour have been examined in EDC studies, the link between the 
brain and neurobehaviours is not typically examined; it is this data that is most 
likely to shed light on the mechanisms by which these compounds disrupt 
maternal-pup interactions.  
 There is also a need for more complex experimental designs to determine 
whether the adverse outcomes observed in exposed pups are due to direct 
effects of an EDC on the offspring, or indirect effects via the dam. When maternal 
behaviour is disrupted, cross-fostering designs can help to discern whether the 
dam is responding to something ‘abnormal’ about her pups, or whether the 
environmental chemical is directly affecting the mother. A number of EDC studies 
have successfully used cross-fostering designs to determine whether the effects 
of exposure directly affects exposed pups, or whether the effects observed in 
pups are due to effects on the mother (see for example (Cox et al. 2010; Crofton 
et al. 2000; Cummings et al. 2005; Della Seta et al. 2005; Lilienthal and Winneke 
1991)). Only some of these studies have measured maternal behavioural 
endpoints.  
 In toxicology experiments, the mom is often seen as a mechanism by 
which the pups can be exposed to compounds of interest. Although 
developmental exposures are essential for assessing the biological hazards of 
EDC exposures, the mother should not be viewed as a simple exposure route, 
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but rather an integral part in the health of the offspring. Adverse outcomes 
observed in pups may be traced to abnormal maternal interactions, which can be 
missed in traditional toxicology studies. 
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CHAPTER 2 
INTRODUCTION TO DISSERTATION 
 
 As described in Chapter 1, maternal care is critical for the survival and 
long-term success of offspring. Poor maternal care can have profound and long-
term effects on health as well as the psychological, emotional and cognitive 
development of offspring.  Classical studies investigating the hormonal basis 
underlying maternal behavior in the rat model have demonstrated the critical role 
that endogenous estrogen plays in the onset of maternal behavior.  Estrogen is 
understood to mediate maternal behavior through estrogen receptor (ER) alpha 
(α) signaling in the medial preoptic area (MPOA) of the forebrain. Despite our 
understanding of the role of endogenous estrogen in maternal behavior, the 
potential effects of exogenous estrogens (xenoestrogens) on maternal behavior 
and brain remain poorly understood.  
 Studies of xenoestrogens including ethinyl estradiol (EE2), bisphenol A 
(BPA), 3,3',4,4'-tetrachlorobiphenyl (PCB77) and genistein have produced 
conflicting results on maternal behavior (Arabo et al. 2005; Ball et al. 2010; Della 
Seta et al. 2005; Dugard et al. 2001; Palanza et al. 2002a; Simmons et al. 2005). 
Yet, scientists from a range of disciplines have hypothesized that endocrine 
disrupting chemicals (EDC) can disrupt maternal care (Gore et al. 2014; Walker 
and Gore 2011). Amongst studies that have reported effects on maternal 
behavior, none have concurrently examined effects on the regions of the brain 
important to maternal behavior, a gap in current knowledge. 
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This chapter provides an overview of the compounds that we selected for the 
remainder of the dissertation and a rationale for the selection of doses that were 
used. 
 
Ethinyl Estradiol 
Oral contraceptives are used by an estimated 100 million women 
worldwide and by over 10 million women in the United States (Daniels et al. 
2015; Petitti 2003; Pletzer and Kerschbaum 2014).  The active synthetic estrogen 
in female contraceptive pills, 17α-ethinyl estradiol (EE2), is widely used as a 
positive control for estrogenicity in studies from academic groups as well as the 
US FDA/NCTR (Hinteman et al. 2006; Kostich et al. 2013; Pletzer and 
Kerschbaum 2014). In spite of its acknowledged estrogenic properties, there are 
relatively limited studies examining the effects of EE2 at low doses; many studies 
that use it as a positive control examine high doses, including doses that induce 
overt signs of toxicity (vom Saal and Welshons 2006; vom Saal et al. 2010).  
Originally synthesized by Inhoffen and Hohlweg in 1938, EE2 is an orally 
active estrogen in which the 17α substitution of an ethinyl group leads to higher 
bioavailability and delayed elimination compared to 17β-estradiol (Goldzieher 
and Stanczyk 2008; Guengerich 1990; Sitruk-Ware and Nath 2013). In humans, 
orally administered EE2 undergoes metabolism via enterohepatic circulation and 
has greater bioavailability compared to estradiol after first-pass metabolism; 
there is significant inter-individual variability of bioavailable EE2, ranging between 
~25-65% of intake, with variability also found in the pharmacokinetics; elimination 
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half-lives ranging from 6-30 hours have been reported (Brody et al. 1989; 
Fotherby et al. 1981; Goldzieher 1990; Goldzieher and Stanczyk 2008; 
Guengerich 1990; Kuhl 1990; Newburger and Goldzieher 1985; Sitruk-Ware and 
Nath 2013). This variability is attributed to individual differences in the 
metabolism of EE2, which is catalyzed by hepatic cytochrome P-450 IIIA, an 
enzyme that varies amongst individuals (Goldzieher and Stanczyk 2008; 
Guengerich 1990). The relationship between the pharmacokinetics of EE2 and its 
biological activity remains under investigation, and the individual variability in 
metabolism and bioavailability suggests that there will most likely be variability in 
the individual response to EE2 (Goldzieher and Stanczyk 2008). Additionally, 
EE2 has shown to act similar to 17β-estradiol in receptor and gene expression 
studies, suggesting that EE2 may have similar effects to estradiol on estrogen 
responsive genes in many tissue types (Anstead et al. 1997; Blair et al. 2000; 
Hyder et al. 1999). 
Approximately 2 million women each year become pregnant while using 
oral contraceptives (Della Seta et al. 2005), with approximately 3% of pregnant 
women reporting that they took estrogenic pharmaceuticals during the first 
trimester of their pregnancies (Thorpe et al. 2013). The postpartum use of 
combined hormonal contraceptives (with both EE2 and progestin) is also of 
clinical concern; however, studies examining the effects of estrogens on milk 
production and infant health remain under scrutiny due to study limitations and 
inconsistencies (Lopez et al. 2015; Tepper et al. 2015). It is important to note that 
exposures to EE2 may occur during both pregnancy and lactation. 
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While oral contraceptives have been prescribed widely for the past fifty 
years, the effects of synthetic estrogens on the brain and behavior in women 
remain understudied, thus the effects of oral contraceptives in women is an area 
of great research interest (Petitti 2003; Pletzer and Kerschbaum 2014). Recent 
studies in humans have shown that regional gray matter volumes were larger in 
the cerebellum, hippocampus, parahippocampal and fusiform gyri of oral 
contraceptive users; these brain regions are generally larger in men than in 
women (De Bondt et al. 2013; Pletzer et al. 2010). Structural changes were 
influenced by the duration of contraceptive usage, age (e.g. naturally cycling non-
contraceptive users tend to be older, users of newer forms of the Pill tend to be 
younger), and for some newer contraceptives with progestin, there was an 
additional influence of anti-androgenic properties of progestin on the brain 
(Pletzer and Kerschbaum 2014).  There is some evidence that contraceptive 
users experience changes in cognition, however this question has not been 
studied systematically (Pletzer and Kerschbaum 2014).  However, cognitive 
studies have shown enhancements in verbal memory (Mordecai et al. 2008) as 
well as resistance to cortisol induced memory impairment (Kuhlmann and Wolf 
2005) suggesting that there may be task dependent effects of oral contraceptives 
on cognition. 
A number of studies have investigated the effects of EE2 on brain and 
behavior in rodents. Prenatal and early postnatal exposure to EE2 (5 μg/kg/day) 
induced masculinization of sexually dimorphic behaviors such as short-term 
spatial-memory and anxiety-like behavior in female mice tested in adulthood 
(Ryan and Vandenbergh 2006).  Pubertal rats treated orally with 0.4 μg/kg/day 
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EE2 from PND 23 to PND 30 revealed an increase in the number of ER-
immunoreactive neural cells in the MPOA and arcuate nucleus in males 
compared to females on PND 37 with more ER-immunoreactive cells in the 
MPOA in females compared to males on PND 90 (Ceccarelli et al. 2007).  
Studies examining adult exposures, or exposures during a critical period of 
adulthood such as pregnancy and lactation, remain limited. 
While endogenous estrogens are required for the establishment of 
maternal behaviors in the rat model, there is conflicting information on the effects 
of EE2 on maternal behavior in this species (Arabo et al. 2005; Dugard et al. 
2001; Ferguson et al. 2003).  Two studies performed in the same laboratory 
produced conflicting data, and the results were likely influenced by the highly 
toxic dose selected (Arabo et al. 2005; Dugard et al. 2001). In these studies, 15 
μg EE2/kg/day was injected into pregnant female rats, inducing significant 
reproductive and developmental toxicity; ~50% of dams aborted and ~50% of 
neonates did not survive. This dose is approximately 30-times higher than those 
administered in oral contraceptives, and the observed toxicity as well as the 
small sample sizes (3-8 dams/treatment) likely confounded the analysis of 
maternal responses.  In the first study, the authors reported limited pup retrievals 
in EE2-treated dams, indicative of disrupted maternal behavior (Dugard et al. 
2001). In contrast, in the second study, the authors report lower latencies to 
retrieve pups in EE2-treated dams compared to controls, which the authors 
characterize as improved maternal behavior (Arabo et al. 2005). Due to these 
conflicting results from two studies with very similar study designs, using the 
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same dosage, and conducted by the same group of researchers, it remains 
difficult to draw conclusions about the effects of exogenous estrogens on 
maternal behavior. 
The studies described in this dissertation specifically focus on low doses 
of EE2, selected because there is a gap in our understanding of the neural, 
behavioral and cognitive effects of the widespread use of this synthetic estrogen 
in adult women (pre-menopausal) and due to its use as a positive control in 
studies of estrogenic EDC.    We investigated the effects of low doses of EE2 on 
maternal behavior and in neural regions critical for maternal care in CD-1 mice 
exposed during pregnancy and lactation and in their offspring exposed in utero 
and during the perinatal period. By examining both the F0 and F1 generations, 
the results of our study will allow for a broader understanding of the sensitivity of 
the mother to exogenous estrogen and the impact of developmental exposure on 
the later maternal behavior of F1 offspring. 
 
Bisphenol S 
EDCs such as BPA have been shown to interfere with endogenous 
estrogen signaling through binding to classical nuclear ERs (ERα and ERβ) as 
well as rapid signal induction through membrane- associated receptors (Colborn 
et al. 1993; Vandenberg et al. 2009; vom Saal et al. 2007; Watson et al. 1995; 
Welshons et al. 2006b). BPA also interferes with a broad range of physiological 
processes including neural development and reproduction (Vandenberg et al. 
2007; vom Saal et al. 2007; Welshons et al. 2006b). Due to public health 
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concerns with BPA and pressure from advocacy groups, alternative substances 
have been developed for use in consumer products. One replacement, bisphenol 
S (BPS), is used in baby bottles, thermal receipts, consumer paper products, 
personal care products such as lotions, hair and body wash, and food and 
beverage can linings (Liao et al. 2012b; Liao and Kannan 2013, 2014; Simoneau 
et al. 2011). Human biomonitoring studies reveal that human exposures are likely 
to be widespread and in the range of ~1.48 ±4.51µg/kg/day in the United States 
(Liao et al. 2012a).   
Currently, the potential endocrine disrupting effects of BPS remain poorly 
understood, although there is growing evidence that this compound acts as an 
ER agonist. Several studies indicate that it displays estrogenic properties in both 
genomic and membrane associated signalling similar to BPA in cell-based 
assays (Eladak et al. 2015; Kuruto-Niwa et al. 2005; Molina-Molina et al. 2013b; 
Rosenmai et al. 2014; R Vinas and CS Watson 2013).  Further, BPS exposure 
induced apoptosis and caused DNA damage in vitro (Fic et al. 2013; Lee et al. 
2013; Rochester and Bolden 2015; R Vinas and CS Watson 2013). 
To date, only a small number of studies have examined in vivo exposures 
to BPS. One of the earliest studies showed that high doses of BPS (20-500 
mg/kg/day) induce uterotrophic responses in prepubertal rats (Yamasaki et al. 
2004). Two studies indicate that BPS interferes with reproductive and endocrine 
regulation in zebrafish (Ji et al. 2013; Naderi et al. 2014). With regard to brain 
and behavior, low doses of BPS increase embryonic hypothalamic neurogenesis 
in zebrafish; embryonic exposures induce hyperactivity at the larval stage (five 
days post fertilization) (Kinch et al. 2015).  
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There are very few studies investigating the effects of BPS exposure on 
behavior and brain in mammals.  Male CD-1 mice exposed to BPS in utero and 
in the perinatal period were found to have decreased body weight at 11 and 16 
weeks and disrupted social behaviors (Kim et al. 2015).  BPS was also shown to 
decrease 5α-reductase-3 gene and protein expression, influence the transcription 
of genes involved in the metabolism of serotonin and induce Cyp2d4 in prefrontal 
cortex of 21 day old females rats (Castro et al. 2015). These latter findings 
suggest potential cognitive effects of BPS on steroid metabolism and 
neurotransmitter systems; effects on serotonin metabolism have implications for 
cognitive functioning as depleted serotonin in the prefrontal cortex reduces 
cognitive flexibility (Castro et al. 2015; Clarke et al. 2004).   
A small number of studies suggest that BPA can alter maternal behavior 
(Boudalia et al. 2014; Cox et al. 2010; Della Seta et al. 2005; Johnson et al. 
2015; Kundakovic et al. 2013; Palanza et al. 2002a). In one study, female mice 
exposed to 10 µg BPA/kg/day during days 14-18 of pregnancy spent less time 
nursing and less time on the nest compared to unexposed females (Palanza et 
al. 2002a). Interestingly, the same effects were observed in the F1 offspring of 
these females (exposed on gestational days 14-18), but when females were 
exposed during both periods (prenatal plus adult exposure during pregnancy), no 
alterations in maternal behavior were observed (Palanza et al. 2002a). This 
evidence suggests that increased estrogenic signaling might serve to alter 
maternal behavior, and that the timing of exposure is likely to be critical.   
We chose to examine the effects of BPS exposure in adulthood (in F0 
adult females) or during early development (in F1 pups exposed during gestation 
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and perinatal life), using the same experimental paradigm as we used for EE2. 
We hypothesized that BPS would induce altered maternal behavior at low doses 
due to its estrogenic properties, with different outcomes for F0 and F1 females.  
Selection of doses 
In the experiments described in this dissertation, we worked to balance a 
desire to examine doses that are environmentally relevant with a desire to 
determine whether exogenous estrogens, at any dose, influence maternal 
behavior. Prior studies of EE2 examined doses that were very high – they 
induced overt reproductive toxicity including spontaneous abortion and perinatal 
mortality. For this reason, we have selected EE2 doses that are much lower: 0.01 
µg/kg/day, a dose that has previously been shown to disrupt estrogen-sensitive 
endpoints in exposed offspring (Wadia et al. 2013); and 1 µg/kg/day, a dose that 
induces uterotrophic responses in pubertal females and is about 2-times greater 
than the dose administered to women in oral contraceptives (Kanno et al. 2001). 
For BPS, the dose we examined in our preliminary studies, 200 µg/kg/day, 
appeared to alter some aspects of maternal behavior including nest building and 
pup retrieval. This dose is significantly higher than suspected human exposure 
levels (Liao et al. 2012a), thus we also examined a lower dose that approaches 
human exposures, 2 µg/kg/day. 
 
Objectives 
We proposed to investigate the effects of low dose xenoestrogens during 
pregnancy and lactation on maternal behavior and in neural regions critical for 
 	 71 
maternal care.  We specifically investigated the effects of developmental 
xenoestrogen exposures (those that occur during gestation and the perinatal 
period) on maternal behavior and the maternal brain in the F1 offspring. We 
hypothesized that low levels of two xenoestrogens, EE2 and BPS, would alter 
maternal behavior in F0 dams exposed during pregnancy and lactation and their 
F1 offspring exposed in utero and during the perinatal period, by disrupting 
estrogen signaling in the MPOA. We further hypothesized that altered 
neurogenesis may be involved in these effects and took initial steps towards 
testing this hypothesis by investigating cell division in the MPOA and VTA.  
 
Overview of Dissertation Chapters 
 Chapter 3 investigates the effects of EE2 on maternal behavior and brain 
in CD-1 mice exposed during pregnancy and lactation.  While many studies view 
the dam as a means by which to study effects of exposures on offspring, we 
propose that the period of pregnancy and lactation may be vulnerable to 
xenoestrogens. In this chapter, we do not report significant changes in traditional 
maternal behavior throughout the lactational period.  However, EE2 induced 
increases in tail retrieval, a novel endpoint, which appears to be an OCD-like 
behavior or stereotypy. We also observed a reduction of tyrosine hydroxylase 
(TH) immunoreactivity (ir) in the VTA of dams from the higher EE2 exposure 
group. 
 In Chapter 4, we examined the effects of exposure to EE2 during 
gestation and the perinatal period on later maternal behavior and brain.  We 
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found that developmental exposure to EE2 alters specific components of 
maternal behavior, and that effects were dependent on both dose and lactational 
day assessed. We also observed alterations to ERα expression in the central 
MPOA in the group exposed to the lower dose and both exposure groups had 
significantly reduced TH-ir in the VTA early in lactation. These findings 
demonstrate effects of exogenous estrogenic compounds during the critical 
period of gestational and perinatal development that manifest in adulthood.  
 In Chapter 5 we investigate, for the first time, the effects of exposure to 
BPS, a replacement for BPA, on maternal behavior and brain in female mice 
exposed during pregnancy and lactation (F0 generation) and in offspring 
exposed during gestation and perinatal development (F1 generation).  We 
observed alterations to maternal behavior in both generations, with different 
effects in F0 and F1 mothers for a number of behaviors. While BPS-treated 
females in the F0 generation showed changes to ERα expression in the caudal 
subregion of the central MPOA, there were no significant effects on the MPOA in 
F1 dams.  Our results indicate that BPS affects maternal behavior and brain and 
further suggest that the period of pregnancy and lactation can be considered 
critical periods for endocrine disruption. 
 In Chapter 6 we took initial steps towards examining the potential for 
neurogenesis in the MPOA and VTA, which to the best of our knowledge, has not 
been investigated in these regions in the context of parturition. We test our 
hypothesis that neurogenesis might be one of the mechanisms underlying 
estrogen regulated maternal behavior in the MPOA by investigating cytogenesis.  
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Using BrdU incorporation and detection methods, we found low levels of cell 
division in the MPOA of females on LD2, as well as an increase in the number of 
dividing cells in the MPOA in postpartum females compared to non-pregnant 
females. While there appear to be few dividing cells, we also found that BPS 
disrupts the pregnancy-induced increase in dividing cells. While preliminary, our 
findings indicate that cell division in the maternal brain may be sensitive to 
xenoestrogen exposures. 
 In the concluding chapter of this dissertation, we review our findings and 
discuss whether some of the alterations to brain and behavior we observed might 
be considered adverse effects.  We also discuss the relevance of our findings to 
the “Developmental Origins and Adult Disease” as well as the activational and 
organizational effects of hormones.  We propose two sensitive periods of 
vulnerability to xenoestrogens for maternal behavior and brain: 
pregnancy/lactation and gestation/perinatal development.  We conclude our 
discussion with proposed future studies and broader implications of this work. 
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CHAPTER 3 
LOW DOSES OF 17α- ETHINYL ESTRADIOL ALTER THE MATERNAL BRAIN 
AND INDUCE STEREOTYPIES IN CD-1 MICE EXPOSED DURING 
PREGNANCY AND LACTATION 
 
Abstract 
 Maternal care is critical for the survival, development and long-term 
success of offspring. Poor maternal care experienced during childhood can have 
profound and lasting consequences into adult life. Classical studies investigating 
the hormonal basis underlying maternal behavior in the rat model have 
demonstrated the critical role that endogenous estrogen (17β-estradiol, E2) plays 
in the onset of maternal behavior. E2 is understood to mediate maternal behavior 
through estrogen receptor (ER) alpha (α) in the medial preoptic area (MPOA) of 
the forebrain. Dopamine (DA) also acts in the MPOA and may interact with E2 in 
output circuits to the ventral tegmental area (VTA), a region important for 
maternal motivation.  Despite our understanding of the role of E2 in maternal 
behavior, the potential effects of exogenous estrogens on maternal behavior and 
brain remain poorly understood.  Here, pregnant CD-1 mice were exposed to low 
doses (0.01 and 1 µg/kg/day) of 17α-ethinyl estradiol (EE2) from day 9 of 
pregnancy until weaning. Using maternal behavior assays, we document no 
significant changes in maternal behavior throughout the lactational period. 
Specifically, EE2 treatment did not alter time to retrieve pups, time spent on the 
nest, time spent on self-care, time spent grooming pups, or quantitative 
measures of nest building at early, mid or late postparum. However, EE2 induced 
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increases in tail retrieval, a novel endpoint that has not been well documented, 
which appears to be an OCD-like behavior or stereotypy. We also observed a 
reduction in tyrosine hydroxylase (TH) immunoreactivity (ir) in the VTA of dams 
from the 1 µg/kg/day EE2 exposure group.  
 
Introduction 
Maternal responsiveness is critical to the development and long-term 
success of offspring, and represents a complex and multimodal integration of 
physiological, endocrine and neural systems (Barrett and Fleming 2011; Bowlby 
1951; Pereira and Ferreira 2015; Rosenblatt 1994). In rodents, maternal care 
produces lasting effects on offspring behaviors into adulthood, including 
multigenerational effects on maternal behavior itself (Champagne et al. 2001; 
Champagne and Curley 2008; DD Francis et al. 1999). In humans, mistreatment 
and neglect during childhood can have long-term neurobiological and behavioral 
consequences including increased susceptibility to depression, drug abuse, and 
schizophrenia (Batten et al. 2004; Bifulco et al. 2002; Gilbert et al. 2009; Gunnar 
et al. 2006). Childhood maltreatment is also associated with vulnerability to a 
number of diseases including heart disease and cancer (Felitti et al. 1998).  
Research investigating the hormonal underpinnings of maternal behavior 
has demonstrated that in the rat, the onset of maternal behavior at parturition is 
induced by withdrawal of progesterone and elevation of 17β-estradiol (E2) and is 
maintained by prolactin, oxytocin and thereafter through tactile interactions with 
offspring (Bridges et al. 1985; Lonstein 2007; Morishige et al. 1973; Numan 
2003; Rosenblatt et al. 1988; Shaikh 1971; Siegel and Rosenblatt 1978).  The 
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medial preoptic area (MPOA) of the forebrain is considered to be the region most 
salient for the onset of maternal behavior, demonstrated by lesion studies in 
which ablation of the MPOA eliminates the onset of maternal behavior and 
extinguishes those that are established during early postpartum (Jacobson et al. 
1980; Numan et al. 1977; Numan et al. 1990). E2, prolactin and oxytocin levels 
are increased in maternal serum during late pregnancy and during the early 
postpartum period, and their cognate receptors are expressed in the MPOA 
(Bakowska and Morrell 1997; Insel 1990; Pedersen et al. 1994; XJ Pi and DR 
Grattan 1999; Shughrue et al. 1998; Wagner and Morrell 1996).  In the rat model, 
the onset of maternal behavior is triggered by increases in estrogen levels in the 
MPOA (Fahrbach and Pfaff 1986; Numan et al. 1977; Rosenblatt et al. 1988). 
There is also an increase in ERα binding in the MPOA (Giordano et al. 1989; 
Giordano et al. 1990a; Giordano et al. 1991) early in pregnancy with later 
increases in estrogen receptor (ER) alpha (α) mRNA (Wagner and Morrell 1995), 
and number of ERα immunoreactive cells (Wagner and Morrell 1996). These 
increases in receptor binding and expression are sustained throughout the end of 
pregnancy and are considered critical for the sensitivity of the MPOA to estrogen 
for the onset of maternal behavior. By comparison, in the mouse, pregnant and 
lactating females have been shown to have increased ER immunoreactivity in the 
MPOA compared to nulliparous virgins (Koch and Ehret 1989), findings which 
highlight the importance of this neural region for maternal behavior as well as the 
specificity and plasticity of ER regulation in the MPOA in relation to pregnancy, 
parturition and the postpartum period.  
In the mouse, the role of estrogen in the establishment of maternal 
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behavior is less clear than in the rat.  Nulliparous female mice demonstrate 
maternal behavior spontaneously, after brief exposure to pups, in contrast to 
nulliparous rats, which require an exposure of six to eight days (C Leblond 1938, 
1940; Rosenblatt 1967; Stolzenberg and Rissman 2011; Wiesner 1933). Due to 
the spontaneous display of maternal care in the mouse, the onset of maternal 
behavior in this species has long been considered liberated from hormonal 
control. In fact, pup exposure induces pup retrieval and other maternally relevant 
behaviors in ovariectomized and aromatase knockout mice (Gandelman 1973a; 
Stolzenberg and Rissman 2011). However, in female mice ovariectomized prior 
to the onset of puberty, fewer will display maternal behavior in adulthood, 
suggesting a role for estrogen during development for the later display of 
maternal behavior (Gandelman 1973b). Furthermore, ERα knockout females 
display poor maternal behavior when tested with surrogate pups (Couse et al. 
2000; Ogawa et al. 1998). More recently, conditional silencing of ERα in MPOA 
neurons was shown to abolish maternal behavior in adult female Swiss-Webster 
mice (Ribeiro et al. 2012), suggesting an important role for ERα in mouse 
maternal behavior.  
There is also evidence that dopaminergic neural circuits act on the MPOA 
in the regulation of maternal behavior (Miller and Lonstein 2005, 2009) and it is 
proposed that E2 and dopamine may interact or act via similar intracellular 
mechanisms to mediate MPOA output for maternal behavior (Numan and 
Stolzenberg 2009; Stolzenberg et al. 2007). The ventral tegmental area (VTA) is 
also critical for maternal behavior; lesion of the VTA interferes with the display of 
maternal behavior including diminished pup retrieval (Gaffori and Le Moal 1979; 
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Hansen et al. 1991; Numan and Smith 1984) and infanticide (Gaffori and Le Moal 
1979). Numan et al. propose that MPOA projections to dopaminergic neurons in 
the VTA act upon the nucleus accumbens to regulate “motivational” aspects of 
maternal behavior (Numan and Smith 1984; Numan and Stolzenberg 2009). 
There is evidence that the neurons that project from the MPOA to the VTA are 
sensitive to estrogen (Fahrbach et al. 1986; Morrell et al. 1984).  
Despite our understanding of the role that endogenous estrogen plays in 
the onset maternal behavior, the potential effects of exogenous estrogens on 
maternal behavior and brain remain poorly understood. A number of studies have 
demonstrated that endocrine disrupting chemicals (EDCs) with estrogenic 
properties can disrupt maternal behaviors in mice and rats [reviewed in 
(Catanese 2015). 17α-ethinyl estradiol (EE2) is the active synthetic estrogen in 
female contraceptive pills, and it has been used as a positive control for 
estrogenicity in studies from academic groups as well as the US Food and Drug 
Administration (FDA) (Bhandari et al. 2015; Hinteman et al. 2006; Kostich et al. 
2013; Pletzer and Kerschbaum 2014). Only a few studies have examined the 
effects of EE2 on maternal behavior in the rat (Arabo et al. 2005; Dugard et al. 
2001; Ferguson et al. 2003).  In two of these studies, conducted by the same 
research group, female rats were exposed to 15 μg EE2/kg/day from pregnancy 
days 9-14, which induced significant reproductive toxicity.  In the first study, EE2-
treated dams retrieved fewer pups and the latency to retrieve was longer when 
compared to controls (Dugard et al. 2001). In the follow-up study, surprisingly, 
the authors observed a reduced latency to retrieve pups in EE2-treated dams 
relative to controls and increased pup directed behaviors, which the authors 
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characterized as improved maternal behavior (Arabo et al. 2005). The authors 
hypothesized that differences in lighting in the first study may have induced a 
stress response leading to maternal anxiety-like behavior that could explain the 
opposing effects they observed between their two studies (Arabo et al. 2005), 
however it is difficult to draw conclusions regarding the effects of EE2 on 
maternal behavior from these studies due to the conflicting nature of the results 
and without further behavioral tests on the dams to investigate anxiety-like 
behavior. Furthermore, neither of these studies examined potential effects of EE2 
on the maternal brain. 
 Here, we investigated the effects of low doses of EE2 on maternal 
behavior. We chose specific time points across the post partum period to test 
potential effects of exogenous estrogen that may emerge during the early, mid 
and late post-partum.  We also examined ERα expression in the MPOA, due to 
its critical importance for maternal behavior, and tyrosine hydroxylase (TH) 
immunoreactivity (TH-ir) in the VTA, given its importance for maternal motivation 
and its connectivity with the MPOA.  
 
Methods 
Animals 
Timed pregnant Female CD-1 mice (Charles River Laboratories, Raleigh, 
NC) were acclimated for at least two days and individually housed in polysulfone 
cages (until parturition) with food (Harlan Teklad 2018) and tap water (in glass 
bottles) provided ad libitum. The animals were maintained in temperature (23 ± 
2°C), humidity (45 ± 15%) and light controlled (12h light, 12h dark, lights on at 
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0800 h) conditions at the University of Massachusetts, Amherst Central Animal 
Facility. All experimental procedures were approved by the University of 
Massachusetts Institutional Animal Care and Use Committee.  
Beginning on pregnancy day eight female mice were weighed daily and 
randomly allocated to treatment groups using SPSS software designed to 
normally distribute mice in treatment group based on body weight. EE2 dosage 
was adjusted daily for body weight. From pregnancy day 9 – lactational day 20, 
dams were provided a small wafer (Nabisco, East Hanover, NJ) treated with EE2 
(Sigma Aldrich, St. Louis, MO; >98% purity) or vehicle alone (70% ethanol, 
allowed to dry prior to feeding) (Gauger et al. 2007).  Wafers were dosed with 
solutions designed to deliver 0.01 or 1 µg EE/kg/day (n=12-16 for each dose). 
Dams were allowed to deliver naturally (birth designated lactational day [LD] 0). 
Litters were culled to 10 pups on LD1.  
 
Maternal behavior assays 
Maternal behavior was assessed on LD 2, 7, and 14. First, spontaneous 
maternal behavior was observed for a period of 90-minutes at the beginning of 
the light phase. Without disturbing the dams or litters, observations were 
recorded every three minutes for the following measures: dam position on/off 
nest, nursing posture, pup licking and grooming, nest repair and non-pup 
directed behaviors designated “self-care” (self grooming, eating, and drinking).  
At the end of the observational period, nest size and quality were 
measured. Nest building is important for protection of pups and for their 
thermoregulation. The dam and pups were carefully removed from the cage and 
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the nest dimensions were measured. The internal volume of the nest was 
calculated from the average inner nest diameter (measured using the internal 
walls constructed from a single cotton nestlet) and nest depth. External volume of 
the nest was calculated from the average outer nest diameter (measured as the 
outer extremes of the walls constructed from a single cotton nestlet) and nest 
depth. Two independent observers scored the nest quality using a 5-point scale 
adapted from the Hess Scale [further described in (Catanese 2015)]. 
Finally, dams were assessed using a pup retrieval assay. The pups and 
dams were separated during nest assessment, after which pups were then 
scattered in the cage at a distance from the nest and the dam returned to the 
opposite end of the nest. The latency to touch the first pup and return pups to the 
nest was recorded for a period of ten minutes. Data reported for time to retrieve 
pups is only reported for dams that successfully retrieved at least one pup. 
 
Open Field Behavioral Assay 
Dams were tested on pregnancy day 16 and LD 10 or 11 using a standard 
open field apparatus 40 cm X 40 cm X 40 cm (Kim et al. 2015). Testing was 
recorded with a camera positioned above the arena, connected to a computer 
using EthoVision XT10 software (Noldus, Wageningen, Netherlands). The 
software quantified distance traveled, mean velocity, and time spent in the center 
5 cm X 5 cm. Additional measures were scored by independent observers blind 
to treatment group including rearing against the walls, rearing away from the 
walls, freeze/stops, and grooming events.  
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Immunohistochemistry 
On LD 21, brains were collected from dams and fixed in Neutral Buffered 
Formalin (10%) (Fisher Scientific, Pittsburgh, PA).  Brains were cut in 40 μm 
transverse sections and the MPOA and VTA were identified using a mouse brain 
atlas (Franklin 2012, 1997). Free-floating sections were processed for ERα or 
tyrosine hydroxylase (TH, a marker for catelcholamine biosynthesis, found in 
dopamine neurons) immunoreactivity (ir). Briefly, antigen retrieval was performed 
using 0.01 Citric Acid Buffer (pH 6.0) and endogenous peroxidases were 
quenched using 3% hydrogen peroxide in methanol. Sections were washed, 
blocked with normal goat serum in 1.5% milk, and incubated overnight at 4°C 
with rabbit anti-ERα antibody directed against the C-terminus of the rat ERα 
(Anti-ERalpha C1355, Fisher Scientific) or a polyclonal antibody for TH (Abcam). 
Sections were then washed and incubated with biotin labeled secondary antibody 
(goat anti-rabbit Ab 64256, Abcam, Cambridge, MA) followed by streptavidin 
peroxidase complex (Ab64269, Abcam). A colorometric detection method was 
performed using diaminobenzidene (DAB) chromogen and substrate (ab64238, 
Abcam). Sections were rinsed in tap water, stored in PBS until mounted on 
slides, dehydrated and coverslipped.   
One image per section was collected using a Zeiss AxioImager (200X 
magnification) and Zeiss high-resolution color camera. Using ImageJ software 
(National Institutes of Health), the image was converted from RGB color to 8 bit, 
background was subtracted, and automatic thresholding was used. Cells 
expressing ERα in the MPOA and TH- ir cells in the VTA were counted on 
anatomically matched sections. While we observed differences in staining 
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intensity across sections, due to theoretical limitations in the quantification of 
DAB signal we did not assess staining intensity.  While it is possible to measure 
relative expression, coloration is not linearly related to amount of protein 
(Rudbeck 2015; van der Loos 2008). For feasibility reasons, ERα positive cells 
were quantified in two MPOA sections per animal; one from the rostral MPOA, 
one from the caudal MPOA, by an observer blind to treatment. The central 
MPOA was identified using neuroanatomical landmarks as described in 
(Tsuneoka et al. 2013). The VTA was identified using neuroanatomical 
landmarks (Franklin 2012, 1997) and TH immunoreactivity as demonstrated in 
(Yamaguchi et al. 2015). TH-positive cells were counted on two anatomically 
matched sections. 
 
Statistical Analysis 
Both behavioral and immunohistochemical analyses were conducted by 
experimenters blind to treatment groups. Data were analyzed using SPSS 
Version 22. For assessments of maternal behavior, continuous variable data 
were analyzed using 2-way ANOVA General Linear Model analyses with 
lactational day and treatment groups as independent variables, followed by 
Bonferroni posthoc tests. Open field data were analyzed using 1-way ANOVA 
with treatment groups as the independent variable. Categorical data were 
analyzed using Chi Square. Data were considered statistically significant at 
p<0.05. Graphs illustrate means ± standard errors unless otherwise stated. 
Sample sizes for behavioral analyses and MPOA counts were: control (n=16), 
0.01 µg EE2/kg/day (n=16) and 1 µg EE2/kg/day (n=12). Samples sizes for VTA 
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counts were: control (n=5), 0.01 µg EE2/kg/day (n=7) and 1 µg EE2/kg/day 
(n=6).  
 
Results 
Low dose EE2 exposure does not induce developmental toxicity 
Pups were counted, sexed and weighed on postnatal day (PND1), prior to 
litter culling. There were no treatment-related effects on litter size, sex ratio, litter 
weight, or average pup weight (Table 1). Poorly cleaned pups were observed in 
one litter from a dam treated with 0.01 µg EE2/kg/day. Mortality was also very 
low in the F1 generation. Only two pups died after culling and prior to weaning; 
both were from litters treated with 0.01 µg EE2/kg/day. Furthermore, overt birth 
defects were not observed in any pups in any treatment group although one 
female treated with 1 µg EE2/kg/day developed severe hydroencephaly in 
adulthood and had to be euthanized.  
 
EE2 exposure does not alter time spent on the nest, grooming pups, or 
non-pup directed self-care  
To assess the effects of EE2 exposure on spontaneous maternal 
behavior, dams were observed in their home cage without any experimental 
interventions. On LD2, dams in both EE2 treatment groups as well as the control 
group spent >70% of their time on the nest, with no significant differences 
between groups (Figure 1A). Throughout the lactational period assessed, the 
time dams spent on the nest decreased (ANOVA p<0.001), but no effects of EE2  
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Table 3.1: Litter outcomes indicate no developmental toxicity in F1 pups associated with low dose EE2 treatment 
 
 Control 0.01 µg EE2/kg/day 1 µg EE2/kg/day 
Litter size (live pups on PND1)a 12.50 ± 0.78 12.63 ± 0.54 12.17 ± 0.55 
Total litter weight (g) on PND1 a 23.84 ± 1.35 24.32 ± 1.03 24.06 ± 1.13 
Average pup weight (g) on PND1 1.93 ± 0.038 1.94 ± 0.061 1.98 ± 0.040 
Sex ratio (% males) a 49.3 ± 4.2 50.2 ± 3.2 45.4 ± 2.9 
Mortality rate b 0 (0/200 pups) 1% (2/202 pups) 0 (0/146 pups) 
a No significant differences were noted using 1-way ANOVA. 
b No significant differences were noted using Chi Square. 
		 86 
were observed. On LD2, dams exposed to 0.01 µg EE2/kg/day spent 
approximately 30% more time grooming pups compared to controls, although this 
difference was not statistically significant (Figure 1B). Again, throughout the 
lactational period assessed, time spent grooming pups decreased (ANOVA 
p<0.001), with no differences observed between treatment groups. Finally, time 
spent on self-care was calculated from the time the dam spent eating, drinking, 
and self-grooming. No differences were observed based on treatment, although 
increases were observed in self-care as the lactational period progressed 
(ANOVA p=0.001, Figure 1C). 
 
EE2-treated dams spend more time retrieving their own tails to the nest 
during home cage observations 
During home cage observations, we quantified a relatively novel behavior 
that is not well understood in rodents, tail retrieval. In the display of this behavior, 
occurring usually while the dam was off the nest, a female would circle, grasp her 
own tail with her mouth, and retrieve it to the nest. This behavior was observed in 
all treatment groups at LD2 and LD7, but in only one dam exposed to 0.01 µg 
EE2/kg/day at LD14 (Table 2). When the observed time spent performing tail 
retrievals was quantified in those females that displayed this behavior, dams from 
both EE2 treatment groups spent significantly more time (ANOVA, p=0.021) 
engaged in this behavior compared to controls (Figure 2).  
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Figure 3.1: EE2 exposure does not alter time spent on the nest, grooming pups, 
or non-pup directed self-care. (A) On LD2, dams in both EE2 treatment groups 
as well as the control group spent >70% of observed time on the nest, with no 
significant differences between treatment groups. The time dams spent on the 
nest decreased significantly as the lactational period progressed, but no effects 
of EE2 were observed. (B) On LD2, dams exposed to 0.01 µg EE2/kg/day spent 
approximately 30% more observed time grooming their pups compared to 
controls, however, this difference was not statistically significant.  The observed 
time spent grooming pups decreased significantly across the lactational period, 
with no differences observed between treatment groups. (C) Although there were 
significant differences in non-pup directed behaviors in early and late lactation, 
there were no significant differences between treatment groups. In all panels, 
blue = vehicle control, red = 0.01 µg EE2/kg/day, green = 1 µg EE2/kg/day. * 
indicates significant effects of lactational age, 2-way ANOVA with Bonferroni 
posthoc tests. 
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Table 3.2: Frequency of tail retrieval in the home cage and during pup retrievals 
 
 LD 2 LD 7 LD 14 
 Control 0.01 µg EE2 
1 µg 
EE2 Control 
0.01 µg 
EE2 
1 µg 
EE2 Control 
0.01 µg 
EE2 1 µg EE2 
Home cage: 6/16 
38% 
10/16 
63% 
5/12 
42% 
6/16 
38% 
8/16 
50% 
5/12 
42% 
0/16 
0% 
1/16 
6% 
0/12 
0% 
Pup retrieval: 2/16 
13% 
4/16 
25% 
2/12 
17% 
1/16 
6% 
2/16 
13% 
2/12 
17% 
0/16 
0% 
1/16 
6% 
0/12 
0% 
Either assay: 7/16 
44% 
12/16 
75% 
6/12 
50% 
7/16 
44% 
10/16 
63% 
5/12 
42% 
0/16 
0% 
1/16 
6% 
0/12 
0% 
      
Repetitive tail retrieval was observed in all treatment groups at LD2 and LD7, and in only one dam exposed to 0.01 µg 
EE2/kg/day at LD14 
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Figure 3.2: EE2-treated dams spend more time retrieving their own tails to the 
nest in the home cage. Time spent on tail retrieval was quantified at all three 
periods of lactation. Dams from both EE2 treatment groups spent more observed 
time engaged in this behavior, which was not extinguished in one dam from the 
low EE2 group by LD14. In all panels, blue = vehicle control, red = 0.01 µg 
EE2/kg/day, green = 1 µg EE2/kg/day. * indicates p<0.05 compared to controls of 
the same lactational age, Bonferroni posthoc test, after significant 2-way ANOVA. 
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EE2 treatment does not influence nest size or quality 
To determine whether EE2 treatment altered nesting parameters, 
quantitative and qualitative measures were collected. Quantitative measures 
(internal and external nest diameters, nest depth) were used to calculate the 
internal and external nest volumes. Although lactational day affected inner nest 
diameter (ANOVA, p=0.001), EE2 treatment did not affect internal volume at 
LD2, LD7 or LD14 (data not shown). Neither lactation day nor EE2 treatment 
affected external nest volume (data not shown). Nest quality decreased across 
the lactational period (ANOVA, p<0.001), likely reflecting the growing mobility of 
the pups, but no effect of treatment on nest quality was observed (data not 
shown). 
 
EE2 treatment did not alter pup retrieval across the early to mid-lactational 
period  
To determine the influence of EE2 on mouse dams’ abilities to retrieve 
their pups to the nest, standard pup retrieval assays were conducted at LD2, 
LD7, and LD14 after the pups were randomly scattered at one end of the cage. 
The number of dams that successfully retrieved at least one pup is indicated in 
Table 3. At all stages, dams exposed to 1 µg EE2/kg/day demonstrated shorter 
latency to touch their pups compared to controls, but these differences were not 
statistically significant (Figure 3A). Although lactational stage affected time to 
retrieve (ANOVA, p<0.001), no significant differences were found based on EE2 
treatment in the time to retrieve the first pup, although notably, only treated dams 
retrieved pups on LD14 (Figure 3B); retrieval at this age was striking due to the 
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size and overall mobility of the pups. There were also no treatment related 
effects on the time to retrieve all pups at any lactational stage (data not shown).  
Tail retrieval was again observed during the pup retrieval assay (Table 2). 
At LD2, tail retrieval was observed in all treatment groups during pup retrieval, 
although it was more common in both of the EE2 treatments. By LD7, tail 
retrieval was only observed in the two EE2 groups, and by LD14, it was observed 
in a single dam exposed to 0.01 µg EE2/kg/day. Importantly, although there was 
some overlap, dams that retrieved their tails in the pup retrieval assay were not 
necessarily the same dams that retrieved their tails in the home cage. In total, tail 
retrieval in one or more assay was observed in 7 of 15 control dams, 12 of 16 
dams exposed to 0.01 µg EE2/kg/day, and 6 of 12 dams exposed to 1 µg 
EE2/kg/day.  
 
Results from open field assays are not consistent with EE2-induced 
anxiety-like behaviour or effects on locomotion 
 In order to evaluate potential effects of exposure on anxiety-like behaviors 
or locomotion, we conducted open field tests on dams at pregnancy day 16 and 
LD 10-11. Overall, no significant differences were noted for any of the automated 
measures (average velocity, total distance traveled, time spent in the center) 
although there was a non-significant increase in the % time spent in the  
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Table 3.3: Number of dams that retrieved at least one pup during pup retrieval 
assays 
 
 Control 0.01 µg EE2/kg/day 1 µg EE2/kg/day 
LD2 14/16 
88% 
14/16 
88% 
10/12 
83% 
LD7 12/16 
75% 
12/16 
75% 
10/12 
83% 
LD14 0/16 
0% 
2/16 
13% 
2/12 
17% 
 
Retrieval of at least one pup was observed in all treatment groups on LD2 and 
LD7, and declined sharply by LD14. 
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Figure 3.3: EE2 treatment has no effect on time to touch or retrieve pups. (A) 
Time to retrieve pups was affected by postpartum stage but not EE2 at any stage 
examined. (B) Time to retrieve pups was calculated only in dams with litter sizes 
of 9-10 pups who retrieved at least one pup. There were no significant 
differences in the time to retrieve the first pup based on EE2 treatment, although 
notably, only treated dams retrieved pups on LD14. In all panels, blue = vehicle 
control, red = 0.01 µg EE2/kg/day, green = 1 µg EE2/kg/day. * indicates 
significant effects of lactational age, 2-way ANOVA with Bonferroni posthoc tests. 
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center of the open field in the dams treated with 0.01 µg EE2/kg/day at 
pregnancy day 16 (Figure 4). Increased time spent in the center of the open field 
is typically associated with lower measures of anxiety (Archer 1973; Belzung and 
Griebel 2001; Hall 1934, 1936; Prut and Belzung 2003; Spruijt et al. 2014). No 
significant differences were observed for rears, grooming events, or number of 
freeze/stops (data not shown).  
 
ERα expression in the MPOA is not affected by EE2 exposures in dams 
To determine whether changes in the expression of ERα in neurons in the 
MPOA is altered by EE2 exposure, brains were collected from dams on LD21, 
approximately 20 hours after the last administered dose. Following 
immunohistochemical analyses, cells expressing ERα were quantified in two 
matched sections of the central MPOA, a specific sub-region in the MPOA found 
to be essential for pup retrieval in the mouse using excitotoxic lesion studies 
(Tsuneoka et al. 2013). One section was selected from the rostral central MPOA 
and the second was selected from the caudal central MPOA. No significant 
differences were observed in ERα expression in either region based on treatment 
(Figure 5).  
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Figure 3.4: Results from open field assays are not consistent with EE2-induced 
anxiety-like behavior or alterations to activity levels. Open field tests were 
conducted on gestational day 16 and lactational day 10 – 11. (A) No effect of 
treatment was observed for average velocity. (B) Total distance travelled was 
similarly not affected by EE2. (C) No significant differences were observed for 
any of the automated measures collected during open field tests (average 
velocity, total distance traveled, time spent in the center) although there was a 
non-significant increase in the % time spent in the center of the open field in 
dams treated with 0.01 µg EE2/kg/day at pregnancy day 16 (a indicates a trend, p 
< 0.1 compared to controls, ANOVA with Bonferroni posthoc test). In all panels, 
blue = vehicle control, red = 0.01 µg EE2/kg/day, green = 1 µg EE2/kg/day. 
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Figure 3.5: EE2 does not alter expression of ERα in the central MPOA at 
lactational day 21. ERα-immunoreactive cells were quantified in two matched 
sections, a rostral (A) and caudal (B) section of the central MPOA. C) No effects 
of EE2 were observed in ERα-positive neurons in either region of the MPOA. In 
panel C, blue = vehicle control, red = 0.01 µg EE2/kg/day, green = 1 µg 
EE2/kg/day. 
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TH-immunoreactivity in the VTA is reduced after EE2 exposure in dams 
 
Because the VTA is important for maternal behavior, and dopamine 
projections from the MPOA may interact with E2 in output circuits to this region, 
we quantified TH-immunoreactive cells in the VTA in anatomically matched 
sections. There was a statistically significant decrease in TH-immunoreactivity in 
the VTA  in the 1 µg EE2/kg/day group (Figure 6).  
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Figure 3.6: EE2 treatment reduced TH-ir in the VTA. (A) TH-positive cells were 
counted in two matched sections of the VTA. (B) Shown are examples of VTA 
samples from dams of all three treatment groups. (C) Quantification of TH-
immunoreactive cells revealed significant decreases in the VTA of dams exposed 
to 1 µg EE2/kg/day.  * indicates significant effects of treatment, 1-way ANOVA 
with Bonferroni posthoc tests. 
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Discussion 
Here, we have demonstrated that EE2 affects the maternal brain and may 
induce repetitive stereotypy or OCD-like behavior in mice exposed to low doses 
during pregnancy and lactation. Two prior studies examining the effects of EE2 
on pregnant females injected 15μg EE2/kg/day i.p., inducing significant 
reproductive and developmental toxicity; ~50% of dams aborted and ~50% of 
neonates did not survive (Arabo et al. 2005; Dugard et al. 2001; Ferguson et al. 
2003).  This high dose is approximately 30-times higher than is administered in 
contraceptive pills, and the observed toxicity as well as the small sample sizes 
(3-8 dams/treatment) likely confounded the analysis of maternal responses. We 
specifically examined low doses of EE2, which were selected to avoid 
reproductive and developmental toxicity. Our high dose (1µg EE2/g/day) is 
similar to those used to induce estrogenic effects in adult females [i.e. a 
uterotrophic response, see (Ohta et al. 2012)] and approximately twice as high 
as the dose found in typical oral contraceptives. The low dose (0.01 µg/kg/day) 
has been shown to induce effects on estrogen-sensitive endpoints in mice during 
prenatal development (Wadia et al. 2013). Not only did we anticipate that these 
low doses would avoid overt signs of toxicity, but also, we anticipate that these 
low levels are more appropriate to study how relatively minor alterations to 
estrogen levels could affect maternal outcomes.  
Counter to our prediction based on prior studies of maternal behavior, we 
did not observe any effects of EE2 on traditional measures of pup-retrieval, pup 
grooming, time spent on the nest or on maternal self-care. We also did not 
observe effects of EE2 on quantitative measures of nest size or nest quality, 
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considered sensitive to hormones during pregnancy (Catanese 2015).  
Interestingly, although not statistically significant, only EE2-treated dams 
retrieved pups on LD14, a period when pups are mobile and exploratory.  
We report significant increases in a repetitive behavior, tail retrieval, in 
EE2-exposed dams during lactation. Importantly, this behavior was observed in 
both the pup retrieval assay and in home cage observations when the dam was 
undisturbed, suggesting that this behavior can manifest during both stressful and 
relatively stress-free periods. Tail retrieval is not well documented in the 
literature, and its interpretation remains unresolved; one study posits that it may 
indicate preparation for maternal behavior in dams during late pregnancy but this 
hypothesis was not tested and the behavior was quantified as a measure for 
stress-induced anxiety (Zucchi et al. 2013).  In Arabo et al., the dam carrying its 
tail was pooled along with a number of additional behaviors, including digging 
and moving on the nest, characterized as indirect pup related activities, however, 
the tail carrying behavior was not described further, or reported separately from 
the other behaviors (Arabo et al. 2005). Without further description of the 
behavior, or quantification of its display from their study, it is not possible to 
compare inclusion of this measure with our results.  
It is possible that tail retrieval represents a form of perseverative or OCD-
like behavior or stereotypy that could be assessed using tests for repetitive 
behaviors, insistence on sameness modeling or a signal attenuation test 
(Crawley 2007; Garner and Mason 2002; Gross et al. 2012; Joel 2006; Low 
2003). We found that this behavior first manifests late in pregnancy or after 
parturition and appears to extinguish in most dams by the mid-lactational period 
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(LD14).  In humans, post-partum depression is a focus of major research efforts, 
and there is mounting evidence that post-partum OCD develops early in 
parenthood (Abramowitz et al. 2003; Fairbrother and Abramowitz 2007; Forray et 
al. 2010; Maina et al. 1999).  The late pregnancy and early post-partum period is 
thought to be associated with increased preoccupations in both mothers and 
fathers (Leckman et al. 1999). Elevated vigilance to protect a newborn from harm 
is thought to drive repeated behaviors such as constant, unnecessary checking 
on the baby; neural regions that respond to the cry of one’s own baby were 
shown to change across post-partum and may be similar to circuits involved in 
OCD involving the thalamo-cortical and basal ganglia circuits (Leckman et al. 
1999; Leckman et al. 2004; Swain 2008; Swain et al. 2014).  Initially considered 
relatively uncommon, a recent study demonstrated that about 11% of women 
who became new mothers presented with symptoms of OCD at two weeks post-
partum, and half of these women’s symptoms persisted 6 months post-partum 
(Miller et al. 2015).  
EE2 treatment did not influence ERα expression in the MPOA, which is 
critical for maternal behavior in both rats and mice (Giordano et al. 1989; 
Giordano et al. 1990a; Giordano et al. 1991; Ogawa et al. 1998; Ribeiro et al. 
2012). The MPOA changes its activational role across the postpartum period to 
an inhibitory role in late postpartum (Pereira and Morrell 2009).  Future studies in 
both rats and mice will need to examine the MPOA at earlier time points across 
the lactational period to address potential effects of exogenous estrogen on ERα 
in the MPOA. However, because no effects of EE2 were observed on maternal 
behaviors even in the early postpartum period, it is plausible that no effects on 
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the MPOA would be observed at these early time points. It is also possible that 
the MPOA is affected by EE2, but ERα immunoreactivity in these neurons is not 
the appropriate measure of this effect. Other relevant levels of analysis may 
include gene expression or epigenetic modifications, as ERα methylation status 
differs depending upon maternal quality in rodents (Champagne et al. 2006; 
Champagne and Curley 2008).  
We observed a reduction in TH-immunoreactivity in the VTA in the 1 µg 
EE2/kg/day group. Dopaminergic neurons in the VTA play a role in motivation 
and reward.  The VTA is involved in a number of neural circuits and 
dopaminergic neurons project to the prefrontal cortex in the mesocortical system, 
the anteromedial caudate-putamen, the nucleus accumbens, and other ventral 
striatal areas in the mesostriatal system, and amygdala, septum and nucleus 
accumbens and additional regions in the mesolimbic system (Bjorklund and 
Dunnett 2007; Dahlstroem and Fuxe 1964; Iversen and Iversen 2007; Oades and 
Halliday 1987; Swanson 1982). The observed reduction in TH-immunoreactivity 
may be due to decreased TH expression in cell bodies below the limits of 
antibody detection and future studies are necessary to test this possibility as well 
as potential cell loss (Johnson et al. 2010).  Although we do not have data that 
can demonstrate causal relationships, and we did not observed reduction of TH-
immunoreactivity in the group treated with 0.01 µg EE2/kg/day, the stereotypy we 
observed (tail retrieval) in the 1 µg EE2/kg/day treatment group may have arisen 
due to changes in TH-immunoreactivity in the VTA, as TH is the rate limiting 
enzyme for dopamine synthesis. These dams engaged in tail retrievals on both 
LD2 and LD7, whereas the lower treatment group ceased to display this behavior 
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by LD7. Stereoptypies can arise after loss of VTA dopaminergic neurons, as 
seen in Borna disease (Solbrig et al. 1995). Lesion of the VTA affects 
dopaminergic levels in the cortex and nucleus accumbens (Devoto and Flore 
2006; Tassin et al. 1978); furthermore, dopaminergic cells in the VTA project to 
the prefrontal cortex (PFC) and may involve modulation of inhibitory GABA-ergic 
interneurons or excitatory glutamatergic signaling in the PFC (Lapish et al. 2007; 
Lavin et al. 2005; Pirot et al. 1992; Sesack et al. 1995; Tseng et al. 2006). Thus, 
effects on either inhibition or excitation or altered fine-tuned modulation in the 
PFC may be posited to potentially underlie the observed repetitive or stereotyped 
behaviors. It is also possible that the change in TH-ir and repetitive tail retrieval 
are independent of one another. 
It is important to note that hormone and EDC exposures can alter pups 
behaviors, which in turn, can alter the dam’s maternal responsiveness (Cox et al. 
2010; Cummings et al. 2005). In prior studies, cross fostering of pups was used 
to separate the effects of EDC exposures on the mother’s behavior from potential 
effects on offspring (Cummings et al. 2005). However, it has been demonstrated 
that maternal behavior can be affected in both a positive and negative direction 
by cross-fostered pups (Cox et al. 2010; Cox et al. 2013; Curley et al. 2010; 
Maccari et al. 1995). In one study published while this present study was 
underway, maternal behavior in dams was tested after treatment using the 
synthetic estrogen diethylstilbesterol (DES) (Tomihara et al. 2015). DES was 
prescribed to pregnant women after its discovery in the 1940’s until 1971; it was 
used in order to prevent miscarriage and premature birth (Swan 2000; Veurink et 
al. 2005) and its use was halted after daughters of exposed mothers were found 
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to suffer from a number of devastating and unexpected reproductive issues, 
including rare clear cell adenocarcinoma and infertility (Herbst et al. 1972; Herbst 
and Anderson 2015; Swan 2000; Veurink et al. 2005). The DES treated dams in 
the aforementioned study spent less time in arched back nursing and showed 
increased resting in the home cage, however, there were no differences in pup 
retrieval or other measures after ten minute separation test. The authors used a 
cross fostering approach and further found that the effects of DES treatment on 
maternal behavior had effects on offspring behavior, assessed later in adulthood 
(Tomihara et al. 2015). These results of DES on rodent maternal behavior reflect 
one of the overarching lessons from DES - which have informed conceptual 
foundations in the field of endocrine disruption - that the effects of exposures to 
compounds that interfere with hormone signaling early in fetal life and during 
development may not become apparent until adulthood. Furthermore, in classic 
work examining the epigenetic, multi-generational transmission of maternal 
behavior, cross fostering approaches have demonstrated that the quality of 
maternal behavior in the parental generation can influence the quality of maternal 
behavior and gene expression in offspring later in life (Champagne and Curley 
2008; D Francis et al. 1999; Meaney 2001). Thus, further studies using a cross-
fostering design will be necessary in order to better understand the relative 
contribution of exposures and maternal behavior on offspring behavior both early 
in life and later in adulthood.  Given the sensitivity of maternal-offspring 
interactions to the impact of environmental and behavioral factors, their interplay 
will ultimately influence future outcomes for offspring.  
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Conclusions 
While we did not observe statistically significant differences in traditional 
measures of maternal behavior such as pup retrieval or pup-directed behaviors, 
we did observe an effect of EE2 on what may be a stereotypy or OCD-like 
behavior (e.g. tail retrieval).  We further observed a reduction in TH-
immunoreactivity in the VTA in EE2-treated dams.  It will be important to test 
whether induced loss of dopamine in the VTA can specifically invoke repetitive 
tail retrievals, and determine if dopamine replacement can suppress this 
behavior, to provide evidence of a potential causal link between effects on the 
dopaminergic system and OCD-like or displaced maternal behavior.   
Our study focused on the effects of EE2 on maternal behaviors in the 
parental generation, i.e. individuals exposed only in adulthood. Many studies of 
estrogenic EDCs have shown more potent effects after developmental exposures 
compared to the effects observed on exposed mothers (Gore et al. 2006a; 
Vandenberg et al. 2013a; vom Saal et al. 2007). Thus, future studies will 
examine estrogen-sensitive endpoints, including those relevant to maternal 
behaviors, in the F1 generation. While many studies focus on effects of maternal 
exposures on offspring outcomes, this current study and others highlight the 
importance of testing effects of treatment on the maternal behavior of the mother, 
as there may be significant effects of altered maternal behavior on offspring 
(Cummings et al. 2005; Cummings et al. 2010; Tomihara et al. 2015). 
Understanding the neuroendocrine basis for maternal behavior, as well as how it 
can be disrupted by hormonally active compounds, is an important area of 
scientific inquiry as deficient parental care has important implications for 
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physiological and psychological development of offspring, with lasting effects into 
adulthood (Bale et al. 2010; Batten et al. 2004; Bifulco et al. 2002; Gilbert et al. 
2009; Gunnar et al. 2006). Our experiments indicate that low doses of a synthetic 
estrogen can alter aspects of behavior and brain in exposed adult females, 
suggesting that adults are not immune to the disruptive effects of these types of 
compounds.  
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CHAPTER 4 
 
ALTERATIONS TO MATERNAL BEHAVIOR AND BRAIN IN CD-1 MICE 
EXPOSED TO LOW DOSES OF ETHINYL ESTRADIOL IN UTERO AND 
DURING THE PERINATAL PERIOD 
 
Abstract 
 
 Because of its structural similarity to the endogenous estrogen 17β-
estradiol, 17α-ethinyl estradiol (EE2) has been used to study the effect of 
estrogen on sensitive organs at multiple stages of development. Here, we 
investigated the effects of EE2 on maternal behavior and the maternal brain of 
females exposed during gestation and the perinatal period via their mothers.  In 
developmentally exposed females, we assessed maternal behavior, 
characterized expression of estrogen receptor (ER) α in the medial preoptic area 
(MPOA), a brain region critical for the activation of maternal behavior, and 
quantified tyrosine hydroxylase (TH) immunoreactive cells in the ventral 
tegmental (VTA), a brain region important for maternal motivation. We found that 
developmental exposure to EE2 alters maternal behavior in both a dose and time 
dependent manner: 1 µg EE2/kg/day increased time building the nest on 
lactational day (LD) 2, whereas 0.01 µg EE2/kg/day increased time building the 
nest on LD 14.  EE2 exposure also induced a significant increase in time spent 
engaged in maternal self-care. While pup retrieval overall was not affected by 
treatment, the time to touch the first pup was significantly longer in dams 
exposed to the lower dose of EE2 on LD 7; interestingly, ERα expression in the 
central MPOA was significantly decreased in this group on LD 2 and increased 
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on LD 21.  This subregion of the MPOA has been shown to be dedicated to pup 
retrieval.  Further, on LD2, EE2-treated females had significantly reduced TH-
immunoreactive cells in the VTA, a region also critical for maternal care. Our 
results demonstrate both dose- and time-related effects of developmental 
exposure to EE2 on behavior and brain that manifest later in adulthood, during 
the maternal period. These findings provide further evidence for effects of 
exposure of exogenous estrogenic compounds during the critical period of fetal 
and perinatal development.  
 
Introduction 
 
17α-ethinyl estradiol (EE2) is the active estrogenic component found in 
oral contraceptives, used by 100 million women worldwide (Petitti 2003; Pletzer 
and Kerschbaum 2014). Because of its affinity for estrogen receptor (ER)α 
(Anstead et al. 1997; Blair et al. 2000) and its structural similarity to the 
endogenous estrogen 17β-estradiol, EE2 has been used to study the effect of 
estrogen on sensitive organs at multiple stages of development. In fact, EE2 is a 
common positive control in studies of other putative endocrine disrupting 
chemicals (EDCs) with estrogenic properties (vom Saal et al. 2005).  In 
numerous rodent studies, gestational or neonatal exposure to EE2 induced 
alterations in reproductive tissues of males and females (Fisher et al. 1999; 
Naciff et al. 2002; Sawaki et al. 2003a, b). A multi-generational reproductive 
toxicity assay conducted by the US National Toxicology Program showed effects 
of EE2 on the timing of puberty in females, weights of male reproductive organs, 
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incidence of mammary ductal hyperplasias in males, testicular sperm count, and 
disturbances to the estrus cycle (National Toxicology Program 2010).  
Only a small number of studies have investigated the effects of exposure 
to EE2 on brain and behavior of rodents. In one study, prenatal and early 
postnatal exposure to EE2 abolished differences in behaviors that are typically 
sexually dimorphic such as short-term spatial-memory and anxiety-like 
behaviors, in females tested in adulthood (Ryan and Vandenbergh 2006). In 
another study, pubertal rodents treated orally with EE2 showed alterations in the 
number of ERα-positive neurons in two regions of the brain, the medial preoptic 
area (MPOA) and the ventromedial nucleus (VMN); ERα expression was 
increased in males on postnatal day (PND) 37 in the VMN and increased in 
females in the MPOA on PND 90 (Ceccarelli et al. 2007), providing evidence that 
ERα expression is sensitive to EE2 exposure. 
The effects of low doses of exogenous estrogen on maternal behavior 
remains poorly understood. Maternal behavior is important for the 
neurobiological, emotional and cognitive development of offspring. Childhood 
abuse or neglect are associated with increased vulnerability to several 
psychopathologies (Batten et al. 2004; Gilbert et al. 2009; Gunnar and Fisher 
2006; Heim and Nemeroff 2001) and other medical morbidities later in adulthood 
(Felitti et al. 1998). In the mouse, nulliparous females are spontaneously 
maternal, suggesting that the display of maternal behavior is independent of 
hormonal control; pup exposure induces pup retrieval and other maternally 
relevant behaviors in ovariectomized and aromatase knockout mice (Stolzenberg 
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and Rissman 2011). However, there is some evidence for a role of estrogen in 
the establishment and display of maternal behavior (Gandelman 1973a; Hauser 
and Gandelman 1985; Stolzenberg and Rissman 2011). ERα knockout females 
display poor maternal behavior (Couse et al. 2000; Ogawa et al. 1998) and 
conditional silencing of ERα in the MPOA abolishes maternal behavior (Ribeiro et 
al. 2012). Additionally, pregnant and lactating females have been shown to have 
increased ER immunoreactivity in the MPOA compared to virgins (Koch and 
Ehret 1989), findings which suggest that ERα is important for the display mouse 
maternal behavior.  
Two studies of EE2 have produced conflicting results on maternal 
behavior in female DA/HAN pigmented rats exposed during pregnancy (Arabo et 
al. 2005; Dugard et al. 2001). In these studies, 15 µg/kg/day EE2 was injected 
daily on days 9-14 of pregnancy.  In addition to the high reproductive toxicity 
induced by the dose utilized, these two studies produced conflicting data on 
maternal behavior, even though they were conducted by the same research 
group, using the same experimental design. A number of behavioral measures 
were examined in the F1 offspring of these EE2 treated dams; in the first study, 
F1 offspring were found to have behavioral changes including increased 
spontaneous motor activity, decreased exploration, increased anxiety-like 
behavior, as well as changes in cognitive processing in adulthood (Dugard et al. 
2001). The latter study found EE2 increased anxiety-like and depressive-like 
behaviors in F1 offspring (Arabo et al. 2005).  Neither of these studies examined 
maternal behavior in the F1 female offspring.  
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Two more recent studies investigated the effects of developmental 
exposure to EE2 on maternal behavior in the F1 generation. In the first, female 
California mice exposed to EE2 during the gestational and perinatal period spent 
less time nursing or grooming pups, and more time away from the nest compared 
to controls (Johnson et al. 2015).  In the second study, female Swiss mice were 
exposed to 0.1 and 1 μg EE2/kg body weight/day from gestational day 10 
through postnatal day 40. In addition to effects on reproductive and anxiety- like 
behaviors, maternal behavior was examined in nulliparous females, which 
spontaneously display maternal behaviors (Derouiche et al. 2015). Interestingly, 
mice exposed to the lower dose of EE2 had longer latencies to retrieve pups and 
both EE2 groups spent more time in non-pup directed activities (Derouiche et al. 
2015). However, these mice were nulliparous, making it difficult to adequately 
assess effects of developmental EE2 exposures on reproductively associated 
maternal behavior. 
Here, we examined effects of low doses of EE2 on maternal behavior in 
female CD-1 mice exposed in utero and during the perinatal period (the F1 
generation). Based on studies demonstrating that developmental exposures to 
estrogenic chemicals and other EDCs produce effects with long latency (Heindel 
and Vandenberg 2015; Zoeller et al. 2012), we hypothesized that exposure to 
EE2 during early life would induce deleterious effects that manifest later in 
adulthood. In addition to effects on maternal behavior, we examined effects on 
expression of ERα in the MPOA, a brain region critical for the display of maternal 
behavior, and TH-immunoreactivity (ir) in the ventral tegmental area (VTA), a 
brain region receiving functional input from the MPOA. The VTA is implicated in 
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maternal motivation (Numan 2007; Numan and Stolzenberg 2009) and there is 
evidence that estrogen responsive neurons project from the MPOA to the VTA 
(Morrell et al., 1984; Fahrbach et al., 1986), thus the VTA may be sensitive to 
endocrine disruption. To our knowledge, this is the first study to examine the 
effects of low dose estrogens on both the maternal brain and maternal behavior. 
 
Methods 
Animals 
Timed pregnant female CD-1 mice (Charles River Laboratories, Raleigh, 
NC), were acclimated for at least two days and individually housed in polysulfone 
cages (until parturition) with food (Harlan Teklad 2018) and tap water (in glass 
bottles) provided ad libitum. The animals were maintained in temperature (23 ± 
2°C), humidity (40 ± 10%) and light controlled (12h light, 12h dark, lights on at 
0800 h) conditions at the University of Massachusetts, Amherst Central Animal 
Facility. All experimental procedures were approved by the University of 
Massachusetts Institutional Animal Care and Use Committee.  
From pregnancy day 9 – lactational day 20, F0 dams were provided a 
small wafer (Nabisco, East Hanover, NJ) treated with EE2 (Sigma Aldrich, St. 
Louis, MO; >98% purity) or vehicle alone (70% ethanol, allowed to dry prior to 
feeding) (Gauger et al. 2007). Wafers were dosed with solutions designed to 
deliver 0.01 or 1 µg EE2/kg/day (n=12-16 for each dose). Dams were allowed to 
deliver naturally (birth designated lactational day [LD] 0) and litters were culled to 
10 pups on LD1. Pups exposed to EE2 during gestation and perinatal 
development were weaned on PND21.  
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F1 female pups from all treatment groups were housed with same-sex 
littermates until 9 weeks of age. At that time, two females per litter were mated 
with proven fertile males (untreated, purchased from Charles River Laboratories). 
One F1 female was killed on LD 2. The second F1 female was assessed for 
maternal behavior on LD 2, 7, and 14 and killed on LD 21. All animals were 
euthanized by carbon dioxide asphyxiation followed by decapitation.  
 
Maternal behavior assays 
Maternal behavior was assessed on LD 2, 7, and 14 using quantitative 
measures described previously (Catanese et al. 2015). First, maternal behaviors 
were observed for a period of 90-minutes without disturbing the dams. 
Observations began at the start of the light phase and dam behaviors were 
recorded every three minutes for the following measures: dam position on/off 
nest, pup licking and grooming, nest repair, and non-pup directed behaviors 
designated “self-care” (self grooming, eating, and drinking). The dam and pups 
were carefully removed from the cage and nest size and quality were then 
measured using the 5-point Hess scale (Catanese et al. 2015).  
Following nest measures, pup retrieval assays were conducted. Briefly, 
pups were scattered in the cage at the opposite end from the location of nest. 
Dams were returned to the cage opposite the pups and observed for 10 minutes. 
First active touching of the pups and retrieval of each pup was recorded. Pup-
initiated nursing, characterized by active pursuit of the dam by the pup in order to 
nurse, was also recorded. 
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Open Field Behavioral Assay 
On pregnancy day 16 and LD 10 or 11, dams were tested using a 
standard open field apparatus 40 cm X 40 cm X 40 cm. Behaviors in the open 
field were scored by independent observers blind to treatment group. Measures 
included rearing against the walls, rearing in the center of the open field, 
freeze/stops, and grooming events.  
 
Immunohistochemistry 
On LD 2 and 21, brains were collected from dams and fixed in neutral 
buffered formalin (10%) (Fisher Scientific, Pittsburgh, PA).  40 μm transverse 
brain sections were cut using a cryostat and sections spanning the MPOA and 
VTA were identified using a mouse brain atlas (Franklin 2012, 1997) and 
collected in phosphate buffered saline (PBS; Fisher Scientific). Antigen retrieval 
was performed using 0.01 Citric Acid Buffer (pH 6.0) followed by quenching of 
endogenous peroxidases using 3% hydrogen peroxide in methanol. Sections 
were incubated overnight at 4°C with rabbit anti-ERα antibody directed against 
the C-terminus of the rat ERα (Anti-ERalpha C1355, Fisher Scientific) or a 
polyclonal antibody for tyrosine hydroxylase (Abcam, ab112). The sections were 
then incubated with biotin labeled secondary antibody (goat anti-rabbit Ab 64256, 
Abcam, Cambridge, MA) followed by streptavidin peroxidase complex (Ab64269, 
Abcam).  Diaminobenzidine (DAB) chromogen and substrate (ab64238, Abcam) 
colorometric detection was used to detect the reaction. Sections were mounted 
on slides, dehydrated and coverslipped.   
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Brain sections were imaged using a Zeiss AxioImager (120X magnification 
for MPOA and 100X for VTA) and Zeiss high resolution color camera. ImageJ 
software (National Institutes of Health) was used to automatically threshold and 
count ERα immunoreactive cells in the MPOA and TH-ir  cells in the VTA in 
anatomically matched sections. Both brain regions were identified using a mouse 
brain atlas (Franklin 2012, 1997). Due to theoretical limitations involved in the 
quantification of DAB signal, we did not analyze staining intensity (Rudbeck 
2015; van der Loos 2008). ERα expression was quantified in the central MPOA 
from two sections per animal, one from the rostral MPOA and one from the 
caudal MPOA, by an observer blind to treatment using neuroanatomical 
landmarks as described in (Tsuneoka et al. 2013).  The VTA was identified using 
neuroanatomical landmarks (Franklin 2012, 1997) and TH immunoreactivity as 
demonstrated in (Yamaguchi et al. 2015).  TH-positive cells were counted on one 
anatomically matched section. 
 
Statistical Analysis 
Both behavioral and immunohistochemical analyses were conducted by 
experimenters blind to treatment groups. Data were analyzed using SPSS 
Version 22. For assessments of maternal behavior, continuous variable data 
were analyzed using 2-way ANOVA General Linear Model analyses with 
lactational day and treatment groups as independent variables, followed by 
Bonferroni posthoc tests. Open field data and cell counts from 
immunohistochemical assays were analyzed using 1-way ANOVA followed by 
Bonferroni posthoc tests with treatment group as the independent variable. 
		 118 
Categorical data were analyzed using Chi Square. Data were considered 
statistically significant at p<0.05. Graphs illustrate mean ± standard error unless 
otherwise stated. 
 
Results 
 
EE2 exposure does not affect litter size, litter weight, or sex ratios in F2 
litters 
To determine whether developmental EE2 exposure alters reproductive 
performance, F1 females exposed to vehicle or EE2 during gestation and 
perinatal development were mated with untreated males. There were no 
significant differences in the number of pups born to females based on treatment 
group (Table 1). There were also no differences in the total litter weight or the 
average pup weight on PND1, prior to litter culling (Table 1). The percentage of 
male pups was decreased in the litters born to EE2-treated dams, although these 
differences were not statistically significant (Figure 1).  
Abnormal litter outcomes were observed in 13 litters. Poorly cleaned pups, 
including pups that were stuck to each other, were observed in five litters (2 
control dams, 2 dams exposed to 0.01 µg EE/kg/day, and 1 dam exposed to 1 µg 
EE/kg/day). Dead pups were observed in five litters (1 control dam, 2 dams 
exposed to 0.01 µg EE/kg/day, 2 dams exposed to 1 µg EE/kg/day). Poorly 
developed pups were observed in three litters (2 dams exposed to 0.01 µg 
EE/kg/day, 1 dam exposed to 1 µg EE/kg/day). Finally, infanticide was observed 
in three litters (one from each treatment group). 
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Table 4.1: Effects of developmental EE2 treatment on litter outcomes 
 
 
 Control 0.01 µg EE2/kg/day 1 µg EE2/kg/day 
Litter size (live pups on PND1)a 12.41 ± 0.61 12.77 ± 0.49 11.95 ± 0.77 
Total litter weight (g) on PND1 a 23.81 ± 1.13 23.73 ± 0.97 22.83 ± 1.39 
Average pup weight (g) on PND1 1.96 ± 0.050 1.87 ± 0.038 1.96 ± 0.063 
Mortality rate b 3.5% 3.2% 4.8% 
 
There were no effects of EE2 exposure on reproductive performance. There were no significant differences in the 
number of pups born to females based on treatment group, no differences in the total litter weight or the average 
pup weight on PND1 in F2 litters 
 
a No significant differences were noted using 1-way ANOVA. 
b No significant differences were noted using Chi Square. 
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Figure 4.1. Sex ratios in F2-generation litters suggest possible effects of EE2 
treatment. The percentage of male pups was decreased in the litters born to 
EE2-treated dams, but these differences were not statistically significant. 
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EE2 exposure increases time spent on maternal self-care and time spent on 
nest building  
To assess the effects of developmental EE2 exposure on maternal 
behavior, F1 females were first observed undisturbed in their home cage.  As 
expected, the time dams spent on the nest decreased across the post-partum 
lactational period (e.g. as their pups became more mobile), but no effects of 
developmental EE2 exposure were found (data not shown). On LD2, dams in the 
1 µg EE2/kg/day exposure group spent significantly more time on self–care, 
measured by the time the dam spent eating, drinking, and self-grooming, when 
compared to dams exposed to 0.01 µg EE/kg/day and controls (Figure 2A). 
Effects of EE2 were also observed for the percentage of time spent building the 
nest; on LD2, dams exposed to 1 µg EE2/kg/day spent more time nest building 
compared to controls and the 0.01 µg EE/kg/day treatment group. On LD14, 
dams exposed to 0.01 µg EE2/kg/day spent more time nest building compared to 
both controls and dams exposed to 1 µg EE2/kg/day (Figure 2B). Across the 
lactational period, time spent grooming pups decreased, but there were no 
differences observed between treatment groups (Figure 2C). 
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Figure 4.2: EE2 exposure alters time spent on maternal self-care and time spent 
building the nest in the home cage. A) On LD2, dams in the 1 µg EE2/kg/day 
group spent significantly more time on self–care (e.g. eating, drinking, and self-
grooming) compared to controls. B) These same females spent more time nest 
building on LD2, whereas on LD14, dams exposed to the lower dose of EE2 
spent more time nest building compared to controls. C) Developmental EE2 
treatment did not alter time spent grooming pups at any postpartum timepoint 
evaluated. However these activities decreased over time. In all panels, blue = 
vehicle control, red = 0.01 µg EE2/kg/day, green = 1 µg EE2/kg/day. δ indicates 
significant effects of treatment compared to untreated controls of the same age, 
2-way ANOVA with Bonferroni posthoc tests.
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Additional repetitive or OCD-like behaviors are observed in F1 females at  
 
LD2 and LD7 
 
We have previously reported that dams exposed to EE2 during pregnancy 
and lactation engage in what may be a stereotypy, or OCD-like behavior, we 
term tail retrieval. In this behavioral display, while away from the nest, a dam will 
circle, grasp her own tail with her mouth, and retrieve it to the nest (Catanese, 
Dissertation Chapter 3). In F0 females, we noted that this behavior was typically 
observed during the late stages of pregnancy and extinguishes by LD14.   
In the F1 generation, tail retrieval was observed in all treatment groups at 
LD2 and LD7. It was never observed at LD14. Approximately twice as many F1 
females in the 0.01 µg EE/kg/day treatment group displayed this behavior on LD2 
compared to controls, although this increase was not statistically significant 
(Figure 3A). There were no significant differences between treatment groups for 
time spent engaged in this behavior (Figure 3B).   
 
EE2 exposure does not induce anxiety-like behaviors in the open field 
Because F1 females demonstrated exposure related effects on a number 
of components of maternal behavior we assessed whether EE2 treatment 
induced anxiety-like behaviors in the open field test. F1 females were evaluated 
in late pregnancy (pregnancy day 16) or mid-lactation (LD10 or LD11). At both 
time periods, there were no effects of treatment on number of center rears 
(associated with lower anxiety-like behavior) or grooming events (associated with 
increased anxiety-like behavior). 
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Figure 4.3: Tail retrieval behavior in EE2-treated females in the F1 generation. A) 
Tail retrieval was observed in all treatment groups at LD2 and LD7 and was 
extinguished by LD14. There was no difference between treatment groups for 
observed time spent engaged in this behavior, although it appeared to be more 
common in EE2-treated females. B) There were no significant differences in the 
observed time spent conducting tail retrieval behaviors in the home nest by 
treatment group. In all panels, blue = vehicle control, red = 0.01 µg EE2/kg/day, 
green = 1 µg EE2/kg/day.  
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Figure 4.4: Results from open field assays are not consistent with EE2-induced 
anxiety-like behaviors. F1 females were evaluated late in pregnancy (pregnancy 
day 16) or mid-lactation (LD10 or LD11). A) EE2 treatment did not affect the 
number of center rears or B) the number of self-grooming events at either 
timepoint. (Figure 4A, 4B), suggesting that EE2 exposure does not induce 
anxiety-like behavior. 
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EE2 exposure did not alter nest size or quality in F1 females 
Following the evaluation of maternal behavior in the home cage, we next 
asked whether developmental EE2 treatment would affect nest size or quality in 
F1 females. At all stages examined, we observed no effects of EE2 on internal 
nest volume, external nest volume, or nest quality (data not shown). 
 
EE2 exposure alters time to touch first pup  
 The final behavioral evaluation we conducted was a pup retrieval assay, 
which includes measures for the latency to first touch one or more pups, the 
latency to retrieve the first pup, and the latency to retrieve the entire litter. To 
control for differences in litter size, we limited our analyses only to litters with 9-
10 pups. After scattering the pups at the end of the cage opposite the dam, upon 
return to the cage, dams exposed to 0.01 µg EE/kg/day showed significantly 
longer latency to touch the first pup on LD7 (Figure 5A). The number of dams 
that successfully retrieved at least one pup to the nest is reported in Table 2. On 
LD2, the latency to retrieve the first pup was increased in dams exposed to 1 µg 
EE/kg/day, whereas the latency to retrieve the first pup was decreased in this 
group at LD7, although these differences were not statistically significant (Figure 
5B). We also noted qualitative differences in retrieval strategy by treatment group 
(Supplemental Figure 1). There were no significant differences in the time to 
retrieve the full litter based on treatment (data not shown).  
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Figure 4.5: EE2 exposure alters latency to touch, retrieve pups. A) On LD7, dams 
developmentally exposed to 0.01 µg EE/kg/day demonstrated significantly longer 
latency to touch the first pup. B) There were no treatment related effects on the 
time to retrieve the first pup at any time-point across the postpartum period). In 
all panels, blue = vehicle control, red = 0.01 µg EE2/kg/day, green = 1 µg 
EE2/kg/day.* indicates a significant effect of age, 2-way ANOVA. δ indicates 
significant effects of treatment compared to untreated controls of the same age, 
2-way ANOVA with Bonferroni posthoc tests. 
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Table 4.2: The number of damsa that successfully retrieved at least one pup to 
the nest.  
 LD2 LD7 LD14 
Control 14/16 (88%) 7/16 (44%) 1/15 (7%) 
0.01 μg EE2/kg/day 9/16 (56%) 10/16 (67%) 0/16 (0%) 
1 μg EE2/kg/day 9/9 (100%) 5/9 (56%) 0/9 (0%) 
 
a Note that only dams with 9-10 pups were evaluated for retrieval, so the overall 
sample size is lower than for other behavioral endpoints evaluated 
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 EE2 exposure attenuates pup induced nursing in mid-lactation 
 
During the pup retrieval assay, pup induced nursing (PIN), in which the 
pup initiates nursing by pursuing the dam, rooting and latching onto the dam’s 
ventrum and actively nursing, was examined. PIN was not observed in any litters 
on LD2. On LD7, 31% of control litters displayed PIN behavior, whereas this 
behavior was seen less frequently (6-8%) in litters born to either EE2 dose 
(Figure 6A). On LD14, PIN behavior was observed at a high rate in controls (81% 
of litters) but in significantly fewer dams from both EE2 treatment groups (31-
33%, Figure 6B).   
 
ERα expression in the central MPOA is altered in EE2-exposed dams 
To evaluate the effect of developmental EE2 exposure on maternally 
relevant brain regions, neural cells expressing ERα were quantified in the central 
MPOA (cMPOA) of dams on LD2 and on LD21 using a DAB chromogen; two 
matched sections were selected, one from the rostral subregion of the cMPOA 
and another from the caudal subregion of the cMPOA (Figure 7A,B).  On LD2, a 
significant reduction in ERα positive cells was observed in the rostral subregion 
of the cMPOA in the 0.01 µg EE/kg/day exposure group compared to controls 
(Figure 7C). Surprisingly, at LD21, evaluation of the same rostral subregion of 
the cMPOA revealed a significant increase in ERα expression in the 0.01 µg 
EE/kg/day group (Figure 7D). 
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Supplemental Figure 1: Individual pup retrieval curves reveal qualitative 
differences in retrieval strategy on LD2 and LD7 by treatment group. The retrieval 
times of individual dams on LD2 (solid lines) and LD7 (dashed lines) is shown. 
Blue = vehicle control, red = 0.01 µg EE2/kg/day, green = 1 µg EE2/kg/day. 
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Figure 4.6: EE2 exposure attenuates pup induced nursing. A) On LD7, about 
one-third of control litters displayed PIN behavior, but this behavior was observed 
less frequently in litters born to either EE2 dose. B) On LD14, PIN behavior was 
observed in the vast majority of control dams but was less frequently observed in 
females from the two EE2 treatment groups.  * p<0.01, Chi Square relative to 
controls. 
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While we observed differences in staining intensity between some sections, due 
to theoretical limitations involved in the quantification of DAB signal, such that 
coloration does not linearly correspond to amount of protein, we did not assess 
staining intensity (Rudbeck 2015; van der Loos 2008).  
 
TH immunoreactivity is altered in EE2-exposed dams 
TH immunoreactive cells were quantified in dams on LD2 and LD21 
(Figure 8A). On LD2, TH expression in the VTA was reduced in females in both 
groups developmentally exposed to EE2 (Figure 8B). Yet, on LD21, there were 
no treatment related differences in TH expression in this brain region (Figure 8C). 
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Figure 4.7: ERα expression in the central MPOA is affected by EE2 exposures in 
dams. Using ERα immunoreactivity to characterize expression in the central 
MPOA (cMPOA), we assessed one section from the rostral subregion of the 
cMPOA and a second section the second from the caudal subregion of the 
cMPOA,(representative images from LD2 are shown). (Figure 7A,B). On LD2, 
there was a significant reduction in ERα expression in the lower EE2 group in the 
rostral subregion of the cMPOA (Figure 7C). On LD21, there was a significant 
increase in ERα expression in the lower EE2 treatment group in the rostral 
subregion of the cMPOA. There were no significant effects of exposure on ERα 
expression in the caudal subregion of the cMPOA on LD2 or LD21 (Figure 7D).  * 
indicates significant difference from control, p<0.05, Bonferroni posthoc after 
significant 1-way ANOVA. 
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Figure 4.8: TH-immunoreactivity is altered in EE2-exposed dams. A) TH-ir cells 
in the VTA, were quantified on transverse sections in dams on LD2 and LD21. 
Representative photomicrographs from dams on LD2. B) On LD2, females 
exposed to both the lower and higher dose of EE2 had significantly fewer TH-ir 
cells in the VTA. C) On LD21, there were no treatment related differences in TH-
ir in this region. * p<0.01, Bonferroni posthoc after significant 1-way ANOVA. 
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Discussion 
Maternal behavior is a sensitive and integrated endpoint involving the 
interaction of numerous endogenous and environmental factors (Bale et al. 2010; 
Barrett and Fleming 2011; Bridges 2015), including estrogen signaling (Pfaff et 
al. 2011). Here, we investigated the effects of gestational and perinatal exposure 
to EE2 on maternal behavior and brain. Several components of maternal 
behavior were altered by developmental exposure to EE2, including longer 
latency to touch the first pup, time spent nest building, and time on maternal self-
care. Increased time spent nest building and self-care behaviors including self-
grooming may indicate OCD-like behaviors (Albelda and Joel 2012; Greene-
Schloesser et al. 2011; Korff and Harvey 2006) that may interfere with maternal 
behavior (Stern and Protomastro 2000).  Further, these OCD-like behaviors may 
be related to the repetitive tail retrieving behavior we also observed previously in 
F0 dams, the mothers of the current F1 generation, which were exposed to EE2 
during pregnancy and lactation (Catanese, Dissertation Chapter 3). Repetitive tail 
retrieval appears to be specific to late pregnancy and the postpartum period as it 
extinguishes by LD14, and it does not appear to be a ‘learned’ behavior, as the 
F1 females that performed this behavior did not necessarily have mothers that 
also engaged in repetitive tail retrieval (data not shown).  
The behavioral effects observed in the current study were dependent on 
postpartum day as well as exposure dosage. After developmental exposure to 1 
µg EE2/kg/day, dams spent more time building the nest on LD2, whereas 
exposure to 0.01 µg EE2/kg/day led to increased time building the nest on LD14 
(Figure 2). Dams from the 0.01 µg EE/kg/day treatment group took longer to 
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interact with their pups during the pup retrieval assay on LD7, but there were no 
differences earlier (LD2) or later (LD14) in the postpartum period (Figure 5). In 
mice, the active display of maternal behavior declines across the postpartum 
period (Shoji and Kato 2006). Our behavioral findings in this and a prior study 
(Catanese, Dissertation Chapter 3) are consistent with these data.  Estrogen 
levels are moderate soon after parturition and anticipated to be low across the 
lactational period (Atkinson and Leathem 1946). In relation to the maternal brain,  
during pregnancy, when estrogen levels are at their highest, female mice have 
increased numbers of ER-immunoreactive cells in the MPOA, and these 
numbers remain increased during early lactation, suggesting changes to the 
regulation of ER in the MPOA that may occur during pregnancy  (Koch and Ehret 
1989).  
The effects we observed were also dependent on EE2 dose. In contrast to 
many other studies examining the effects of EE2 (Arabo et al. 2005; Dugard et al. 
2001; Howdeshell et al. 2008; Ryan et al. 2010), we examined low doses of EE2, 
which did not induce reproductive toxicity in F1 offspring at birth (Catanese, 
Dissertation Chapter 3). Some adverse outcomes were observed in F1 dams/F2 
litters (Table 1), but these did not appear to be related to EE2 exposure. Another 
issue relevant to dose is an expectation that higher doses might induce greater 
deficits in behavior or other outcomes. Non-linear and non-monotonic dose 
responses are common for hormones and EDCs (Vandenberg et al. 2012); thus, 
effects observed at the lower EE2 dose may not manifest in dams exposed to the 
higher dose of EE2 (Vandenberg 2014). We observed both behavioral and neural 
alterations in dams exposed to 0.01 µg EE2/kg/day that were not observed in 
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females exposed to 1 µg EE2/kg/day. For example, dams developmentally 
exposed to 0.01 µg EE2/kg/day displayed a significantly longer latency to touch 
the first pup whereas dams exposed to 1 µg EE2/kg/day were unaffected (Figure 
5). Females exposed developmentally to 0.01 µg EE2/kg/day also demonstrated 
changes in ERα expression in the rostral cMPOA at both LD2 and LD21, 
whereas the group exposed to the higher dose did not (Figure 7).  These 
differences may be an example of a non-monotonic dose response, but 
additional dose groups are needed to better characterize the dose response 
relationships for these endpoints. 
A small number of studies have examined the effects of EE2 and other 
EDCs on maternal behavior in F1 females exposed during gestation (or gestation 
and the perinatal period) (Derouiche et al. 2015; Jefferson et al. 2007b; Johnson 
et al. 2015; Palanza et al. 2002a; Venerosi et al. 2008). In one study examining 
effects of EE2 on California mice, F1 dams spent less time nursing, less time 
grooming pups and less time on the nest (Johnson et al. 2015). In contrast to 
these findings, we did not observe changes in time spent grooming pups or time 
on the nest; however, we did observe increased maternal self-care in the 1 µg 
EE2/kg/day group on LD2 and increased time spent building the nest in both 
groups on different days during the lactational periods (Figure 2). These 
behaviors are similar between studies in that they are directed away from pup 
care. The different outcomes resulting from these studies may be due to 
variations in the method and timing of dosage; in the study in California Mice, the 
parental generation was fed a diet supplemented with 0.1 part per billion EE2, 
which began two weeks prior to breeding, and lasted through pregnancy and 
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lactation, producing exposures that were longer than in the current study. 
Additionally, the California mouse is a bi-parental mouse, thus the paternal 
contribution to pup care may have influenced the maternal results in that study.  
Despite modest differences in specific behavioral outcomes, the results of 
this study support other behavioral investigations, which suggest that the 
gestational period is sensitive to disruption by xenoestrogens (Ball et al. 2010; 
Della Seta et al. 2005; Palanza et al. 2002a; Simmons et al. 2005). In fact, there 
is significant interest in identifying the most vulnerable periods for EDC 
exposures (Grandjean et al. 2015). In a study of CD-1 mice, exposures to BPA 
during either pregnancy (in F0 females) or gestation (in F1 females) altered 
maternal behavior, suggesting that both periods are sensitive to xenoestrogens 
(Palanza et al. 2002a). Yet, females exposed during both periods did not appear 
to have disruptions in maternal behavior. The authors postulated that there may 
have been permanent changes to homeostatic mechanisms due to the early 
gestational exposure that may have changed the response to adult exposure 
(Palanza et al. 2002a). They also suggest there may be differences of effects 
between acute and long-term exposures, which seems likely, and mention that 
further studies are necessary to test physiological and behavioral responses to 
different exposure durations across life stages (Palanza et al. 2002a). While the 
initial hypothesis seems plausible, it remains unclear which homeostatic 
mechanisms may be involved. Interestingly, the authors had also hypothesized 
that decreases in maternal behavior that were found after in utero exposure only, 
may have been due to organizational effects on the developing neuroendocrine 
systems important for later maternal behavior. Thus, it is plausible that in dams 
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treated both in utero and in adulthood, an organizational change that may have 
occurred developmentally could have altered the activational status of the 
neuroendocrine underpinnings governing maternal behavior later in adulthood. It 
is also possible that BPA-induced alterations to maternal care in the parental 
generation led to changes in their own display of maternal care in adulthood (D 
Francis et al. 1999; Meaney 2001). 
In our previous study of maternal behavior in the F0 generation, we found 
no changes in traditional measures of maternal behavior (Catanese, Dissertation 
Chapter 3). However, we did observe an increase in an infrequently quantified 
stereotypy or OCD-like behavior, tail retrieval, in the parental dams exposed to 
EE2.  It is important to note that these EE2-induced effects on the F0 dams may 
have affected the behavior of the offspring; the quality of maternal behavior in the 
parental generation can influence the quality of maternal behavior in offspring 
(Champagne and Curley 2008; D Francis et al. 1999; Meaney 2001). Further, 
many factors including EDC exposures can potentially alter offspring in some 
manner, including changes in physiology or behavior, which could in turn alter 
the dam’s maternal responsiveness; cross fostering of pups has been used to 
separate the effects of exposures to environmental chemicals on the mother’s 
behavior from potential indirect effects on offspring (Cummings et al. 2005). For 
example, the decreased initiation of PIN behavior in EE2-treated F2 generation 
pups could be an effect of developmental exposure on the pups themselves, an 
effect on the F1 mothers, or an interaction between both factors. Cross fostering 
studies would help to address these issues, although such studies face 
limitations; for example, fostering of pups can modify maternal behavior (D 
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Francis et al. 1999; Maccari et al. 1995). PIN may also be affected by time from 
last nursing; in this study pups were separated from dams for a brief (5) minute 
period before the pup retrieval assay begins. 
To our knowledge, this study is the first to examine the effects of EE2 on 
both maternal behavior and the maternal brain in the F1 generation. We found 
that ERα expression in the MPOA was significantly decreased on LD2 and 
significantly increased on LD21 in dams developmentally exposed to 0.01 µg 
EE2/kg/day (Figure 7).  The subregion of the MPOA in which ERα was quantified 
has been shown to be dedicated to pup retrieval (Tsuneoka et al. 2013). 
Although quantitative deficits in pup retrieval were not observed at LD2, we did 
find that on LD7, the dams in this same exposure group demonstrated a longer 
latency to make initial contact with pups (Figure 5), as well as alternative pup 
retrieval strategies in the EE2-treated females (Supplemental Figure 1); 
additional experiments are needed to determine whether these behaviors are 
mediated via ERα. 
A number of studies have demonstrated the importance of the MPOA in 
the onset of maternal behavior and as a site of hormone response to pup stimuli 
(Bridges et al. 1990; Fahrbach and Pfaff 1986; Giordano et al. 1989; Giordano et 
al. 1990a; Moltz et al. 1970; Numan et al. 1977; Numan 2006; Rosenblatt et al. 
1988; Rosenblatt et al. 1994). Studies have also demonstrated that the MPOA is 
involved in motivational aspects of maternal behavior, using approaches such as 
operant responding and modified conditioned place preference paradigms (Lee 
et al. 2000; Numan 2007; Numan and Stolzenberg 2009; Olazabal et al. 2013; 
Pereira and Morrell 2011). Developmental exposures to xenoestrogens can 
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affect ERα expression in the MPOA (Ceccarelli et al. 2007) and our results 
suggest that developmental alterations to ERα expression can manifest during 
the lactational period. It is possible that the low level of EE2 exposure 
experienced during development altered the response of the MPOA to estrogen 
mediated expression of its receptor early in the postpartum period (Borras et al. 
1994; Liu and Shi 2015; Wilson et al. 2008). Further, the alterations observed 
during early postpartum may have induced a compensatory increase in receptor 
expression later in postpartum, e.g. at weaning.  
The reduction in tyrosine hydroxylase immunoreactivity in the VTA as a 
result of developmental exposure to both doses of EE2 on LD2, but not LD21 
(Figure 8), suggest that the effects of developmental exposure to EE2 may be 
specific to the early postpartum period for this endpoint. It is tempting to 
speculate that the differential effects on the brain are tied to differences in 
behavior; while both treatment groups experienced this reduction in TH 
expression in the VTA at LD2, only the lower dose showed altered MPOA ERα 
expression at this time (Figure 7). The reduction in TH-ir in the VTA, along with 
manifestation of repetitive or potentially OCD-like behaviors, in this study in 
addition to a prior study (Catanese, Dissertation Chapter 3), does provide some 
support for the possibility that these phenomena may be linked. Stereoptypies 
arise after loss of VTA dopaminergic neurons as seen in Borna disease (Solbrig 
et al. 1995). However, further studies are necessary to test whether conditional 
loss of TH expression or dopaminergic cells in the VTA might also induce OCD 
like behaviors. In humans, post-partum OCD has been found to develop early in 
parenthood (Abramowitz et al. 2003; Fairbrother and Abramowitz 2007; Leckman 
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et al. 1999; Maina et al. 1999). Approximately 11% of women manifest symptoms 
of OCD at two weeks post-partum, and as many as half of these women’s 
symptoms can persist 6 months post-partum (Miller et al. 2015). It is important to 
note that the reduction in TH-ir may be due to decreased TH expression below 
the limits of antibody detection and future studies will be necessary to this, and to 
test possible cell loss (Johnson et al. 2010). 
The findings presented here demonstrate that gestational and perinatal 
exposure to low doses of EE2, the main estrogenic component of oral 
contraceptives, induce changes to regions of the maternal brain and alterations 
to maternal behavior, long after the period of exposure. Oral contraceptives are 
used by an estimated 100 million women worldwide and by over 10 million 
women in the United States (Petitti 2003; Pletzer and Kerschbaum 2014). 
Approximately 2 million women each year become pregnant while using oral 
contraceptives (Della Seta et al. 2005), with approximately 3% of pregnant 
women reporting that they took estrogenic pharmaceuticals during their first 
trimester (Thorpe et al. 2013). Although EE2 exposures are widespread in 
women, and it is an acknowledged positive control for estrogenicity in 
developmental toxicity studies, relatively little is known about the effects of this 
synthetic estrogen on neural and cognitive function in humans or rodents. Our 
experiments indicate that exposure to low doses of EE2 in utero and during the 
perinatal period can alter certain aspects of maternal behavior and brain in 
exposed females once they reach adulthood. These findings provide further 
evidence for the impact that xenoestrogens have on brain and behavior when 
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young are exposed during the critical periods of early fetal life and perinatal 
development. 
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CHAPTER 5 
BISPHENOL S (BPS) ALTERS MATERNAL BEHAVIOR AND BRAIN IN 
FEMALES EXPOSED DURING PREGNANCY AND LACTATION AND IN 
THEIR DAUGHTERS EXPOSED DURING PERINATAL DEVELOPMENT 
 
Abstract 
 Estrogenic endocrine disrupting chemicals (EDCs) have been shown to 
disrupt maternal behaviors in female rodents. We investigated the effects of an 
emerging xenoestrogen, bisphenol S (BPS), on maternal behavior and the 
maternal brain in CD-1 female mice exposed during pregnancy and lactation (F0 
generation) and in female offspring exposed during gestation and perinatal 
development (F1 generation). Here we report that maternal behavior is altered in 
females of both generations. In particular, we observed different effects in F0 and 
F1 dams for a variety of maternal behaviors, including time on the nest, time 
spent on nest-building, latency to retrieve pups, and latency to retrieve the entire 
litter. In the maternal brain, BPS-treated females in the F0 generation displayed a 
significant increase in ERα expression in the caudal subregion of the central 
medial preoptic area (cMPOA) in a dose dependent manner. In contrast, there 
were no significant effects of BPS on the MPOA in F1 dams.  These results 
indicate that BPS affects maternal behavior and brain in a time and dose 
dependent manner and that these endpoints are sensitive to endocrine 
disruption. 
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Introduction 
 
In the rat, estrogens play an important role in the regulation of maternal 
behaviors via estrogen receptor (ER)α signaling in the medial preoptic area 
(MPOA) of the forebrain (Fahrbach and Pfaff 1986; Giordano et al. 1989; 
Giordano et al. 1990a; Giordano et al. 1991; Numan et al. 1977; Wagner and 
Morrell 1995). The MPOA is critical for the onset of maternal behavior and 
lesions to this area abolish maternal care (Jacobson et al. 1980; Numan et al. 
1977; Numan 1990; Numan and Insel 2003). In the mouse, the onset of maternal 
behavior is not strictly dependent on the high levels of estrogen produced during 
late pregnancy as nulliparous females demonstrate spontaneous maternal 
behavior (C Leblond 1938, 1940; Rosenblatt 1967; Stolzenberg and Rissman 
2011; Wiesner 1933). However, there is evidence indicating a role for estrogen 
during specific critical periods (Gandelman 1973a; Hauser and Gandelman 1985; 
Stolzenberg and Rissman 2011) and an important role for ERα in the display of 
mouse maternal behavior (Ogawa et al. 1998; Ribeiro et al. 2012).   
Endocrine disrupting chemicals (EDCs) with ER agonist activities such as 
the xenoestrogen bisphenol A (BPA) can bind to classical nuclear ERs, ERα and 
ERβ, and induce rapid signal induction through membrane- associated receptors 
(Colborn et al. 1993; Vandenberg et al. 2009; Watson et al. 1995; Welshons et 
al. 2006a). BPA interferes with a broad range of physiological processes 
including neural development and reproduction and induces deleterious 
physiological effects in a number of tissues (Vandenberg et al. 2007; vom Saal et 
al. 2007; Welshons et al. 2006a) including structural changes in brain regions 
that are associated with changes in behavior (Wolstenholme et al. 2011).   
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A small number of studies suggest that BPA can alter maternal behaviors 
in rodents (Boudalia et al. 2014; Cox et al. 2010; Della Seta et al. 2005; Johnson 
et al. 2015; Kundakovic et al. 2013; Palanza et al. 2002a). In one study, female 
mice exposed to 10 µg BPA/kg/day during pregnancy days 14-18 spent less time 
nursing and less time on the nest compared to unexposed females (Palanza et 
al. 2002a). Interestingly, the same effects were observed in the F1 offspring 
(exposed on gestational days 14-18). Yet, when females exposed prenatally 
were exposed again during pregnancy, no alterations in maternal behaviors were 
observed (Palanza et al. 2002a). This evidence suggests that xenoestrogen 
exposures can alter maternal behavior, and that the timing of exposure might be 
critical; pregnancy as well as the developmental period may be sensitive to 
endocrine disruption. Surprisingly, in studies examining the effects of BPA and 
other EDCs on maternal behavior, the potential underlying neural mechanisms 
have not yet been investigated.  
Due to public health concerns with BPA, alternative chemicals have been 
developed for use in consumer products. One replacement, bisphenol S (BPS), 
is currently used in baby bottles, thermal receipts, consumer paper products, 
personal care products, and has been found to be present in foodstuffs and 
canned foods (Liao et al. 2012b; Liao and Kannan 2013, 2014; Simoneau et al. 
2011).  Human biomonitoring studies reveal that human exposures to BPS are 
likely to be widespread (Liao et al. 2012a) and have increased over the last 
decade (Ye et al. 2015).  Although BPS has not been examined extensively, 
several studies indicate that it displays estrogenic properties in both genomic and 
membrane associated estrogen signaling similar to those of BPA (Kuruto-Niwa et 
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al. 2005; Molina-Molina et al. 2013a; P Vinas and CS Watson 2013). To date, 
studies of BPS in mammals are limited, and there are no studies examining 
whether this compound disrupts maternal behavior or brain in rodents.  
 We postulated that low dose exposures to BPS would affect maternal 
behavior and related neural structures in both dams and their offspring in 
adulthood. Given that one mechanism of endocrine disruption is altered hormone 
receptor expression, we examined the effects of BPS on ERα expression in the 
MPOA.  Additionally, we investigated tyrosine hydroxylase expression, a marker 
for dopaminergic cells, in the ventral tegmental area (VTA), a brain region 
receiving functional input from the MPOA. Dopaminergic neural circuits in the 
MPOA are involved in the regulation of the onset and maintenance of maternal 
behavior in rats and Numan and et al. propose that estradiol and dopamine may 
act through the same signaling cascades during the onset of maternal behavior 
(Numan and Stolzenberg 2009). Further evidence indicates that estrogen 
sensitive oxytocin neurons project from the MPOA to the VTA (Fahrbach et al. 
1986; Morrell et al. 1984; Shahrokh et al. 2010). The MPOA output to the VTA is 
also important for maternal motivation (Numan and Stolzenberg 2009; Pereira 
and Morrell 2011).   
Here, we investigated potential effects of BPS exposures on maternal 
behavior and in neural regions important for maternal behavior. We tested the 
hypothesis that exposures to BPS affect the F0 generation exposed during 
pregnancy and lactation, and the F1 generation exposed in utero and during the 
perinatal period, as EDCs have been shown to cause long-term effects, including 
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some that may not manifest until adulthood, and others that may only be 
apparent under specific conditions (i.e. maternal behavior after parturition). 
 
Methods 
 
Animals 
Timed pregnant female CD-1 mice (Charles River Laboratories, Raleigh, 
NC) were individually housed (until parturition) in polysulfone cages with food 
and water (in glass bottles) provided ad libitum. The animals were maintained in 
temperature and light controlled (12h light, 12h dark, lights on at 0800 h) 
conditions at the University of Massachusetts, Amherst Central Animal Facility. 
All experimental procedures were approved by the University of Massachusetts 
Institutional Animal Care and Use Committee.  
Beginning on pregnancy day eight, pregnant females were weighed daily 
and BPS dosage was adjusted for body weight. On day 8, dams were randomly 
allocated to treatment groups using SPSS software that allowed normal 
distribution in each treatment group based on body weight.  
From pregnancy day 9 to lactational day 20, dams ingested a small wafer 
(Nabisco) treated with BPS or vehicle alone (70% ethanol, allowed to dry prior to 
feeding) (Gauger et al. 2007). Wafers were dosed with solutions designed to 
deliver 2 or 200 µg/kg/day BPS (Santa Cruz Biotechnology) (n=15-17 for each 
dose). The 200 µg/kg/day dose was used in a pilot study and appeared to alter 
some aspects of maternal behavior. This dose is higher than suspected human 
exposure levels (Liao et al. 2012a), thus we also selected a lower dose of 2 
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µg/kg/day, which approaches human exposures. Dams delivered naturally (birth 
designated lactational day [LD] 0). Litters were culled to 10 pups on LD1.  
 Two F1 female offspring from each F0 dam were raised to adulthood, 
mated with unexposed CD-1 males (Charles River Laboratories, Raleigh, NC) 
and tested for maternal behavior using the same assays at the same timepoints 
across lactation as used to test their mothers. A schematic illustrating the 
exposure paradigm and timing of behavioral evaluations is shown in Figure 1. 
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Figure 5.1: Schematic illustrating the experimental design. Red bar indicates the 
period of exposure (pregnancy day 9 through lactational day 21). Exposures 
were directly to the F0 mother; F1 pups were exposed via the mother (placental 
transfer in utero and milk during the perinatal period). Blue arrows indicate the 
timing of open field behavioral assessments. Green arrows indicate the timing of 
maternal behavior assays. 
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Maternal behavior assays 
 
For both the F0 and F1 generations, maternal behavior was assessed on 
LD2, 7, and 14. First, dams were observed without intervention for a period of 90-
minutes at the beginning of the light phase. Observations were recorded every 
three minutes for the following measures: dam position on/off nest, nursing 
posture, self-care (self grooming, eating, drinking), sleeping/resting, nest repair, 
and pup licking/grooming. 
At the end of the observational period, nest size and quality was 
measured. The dam and pups were removed from the cage, weighed, and the 
dimensions of the nest were measured. Two independent observers scored the 
nest quality using a 5-point scale (Catanese et al. 2015).  
Finally, dams were assessed for pup retrieval. Following nest 
measurement, the pups were scattered in the cage at a distance from the nest 
and the dams were returned to the cage opposite the pups. The latency to first 
touch and retrieve pups to the nest was recorded for a period of ten minutes.  
 
Open Field Behavioral Assay 
Dams were tested on pregnancy day 16 and LD10/11 using an open field 
apparatus 40 cm X 40 cm X 40 cm (Kim et al. 2015). Measures were scored by 
two independent observers blind to treatment group including rearing against the 
walls, rearing (without contact with walls), freeze/stops, and grooming events.  
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Immunohistochemistry 
Brains were collected from F0 dams on LD21 and from F1 dams on LD2 
or LD21 and fixed in Neutral Buffered Formalin (10%) (Fisher 
Scientific,Pittsburgh, PA).  Brains were sectioned in the transverse plane at 40 
μm, and the MPOA and VTA were identified using a mouse brain atlas (Franklin 
2012, 1997). Free-floating sections were processed for immunoreactivity to ERα 
or tyrosine hydroxylase (TH, the rate limiting enzyme in catecholamine synthesis, 
used as a marker for dopaminergic cells).  Antigen retrieval was performed using 
0.01 Citric Acid Buffer (pH 6.0), followed by quenching of endogenous 
peroxidases using 3% hydrogen peroxide in methanol. Sections were washed, 
blocked with normal goat serum in 1.5% milk, and incubated overnight at 4°C 
with rabbit anti-ERα antibody directed against the C-terminus of the rat ERα 
(Anti-ERalpha C1355, Fisher Scientific) or a polyclonal antibody for TH (Abcam, 
ab112). Sections were then washed and incubated with biotin labeled secondary 
antibody (goat anti-rabbit, Ab64256, Abcam, Cambridge, MA) followed by 
streptavidin peroxidase complex (Ab64269, Abcam). Colorimetric detection using 
diaminobenzidene chromogen and substrate (ab64238, Abcam) was followed by 
a wash in tap water. Sections were stored in PBS with 0.1% Tween-20 until 
mounted on slides, dehydrated and coverslipped.   
One image per section was collected using a Zeiss AxioImager (120X 
magnification) and Zeiss high-resolution color camera. ImageJ software (National 
Institutes of Health) was used to convert the image from RGB color to 8 bit, 
subtract background, and for automatic thresholding. Cells expressing ERα in the 
MPOA and TH in the VTA were counted on anatomically matched sections.  Due 
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to limitations in the quantification of DAB coloration, we did not measure staining 
intensity (Rudbeck 2015; van der Loos 2008). For feasibility reasons, ERα 
expression was quantified in two MPOA sections per animal; one from the rostral 
central MPOA (cMPOA), one from the caudal cMPOA, by an observer blind to 
treatment. The cMPOA was identified using neuroanatomical landmarks as 
described in (Tsuneoka et al. 2013). The VTA was identified using 
neuroanatomical landmarks (Franklin 2012, 1997) and TH immunoreactivity as 
demonstrated in (Yamaguchi et al. 2015). TH-positive cells were counted on one 
anatomically matched section. 
 
Statistical Analysis 
Behavioral and immunohistochemical analyses were conducted by 
observers blind to treatment groups. Data were analyzed using SPSS Version 
22. For assessments of maternal behavior, continuous variable data were 
analyzed using 2-way ANOVA General Linear Model analyses with lactational 
day and treatment as independent variables, followed by Bonferroni post hoc 
tests. Open field data were analyzed using 1-way ANOVA with treatment as the 
independent variable. Categorical data were analyzed using Chi Square. Data 
were considered statistically significant at p<0.05. Graphs illustrate means ± 
standard errors unless otherwise stated. Sample sizes for individual endpoints 
are provided in Table 1. 
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Table 5.1: Sample sizes used for evaluation of different endpoints 
 
 Control 2 μg BPS/kg/day 200 μg 
BPS/kg/day 
F0 maternal 
behavior 
N=15 N=17 N=15 
F0 MPOA 
evaluation (ERα 
expression) 
N=10 N=13 N=11 
F0 VTA evaluation 
(TH expression) 
N=10 N=13 N=10 
F1 maternal 
behavior 
N=14 N=15 N=15 
F1 MPOA 
evaluation on LD2 
(ERα expression) 
N=10 N=15 N=15 
F1 VTA evaluation 
on LD 2 (TH 
expression) 
N=10 N=15 N=15 
F1 MPOA 
evaluation on 
LD21 (ERα 
expression) 
N=14 N=15 N=15 
F1 VTA evaluation 
on LD 21 (TH 
expression) 
N=13 N=14 N=14 
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Results 
Infanticide and maternal neglect was observed in F1 but not F0 dams 
exposed to BPS  
 BPS treatment did not affect litter size, litter weight, average pup weight, 
or the sex ratio (% male pups) in either the F0 or the F1 generation (Table 2). No 
examples of infanticide or severe neglect were observed in the F0 generation, for 
any treatment. However, moderate neglect, including poor cleaning of the pups 
and pups retaining their umbilical cords, was observed in 18% of F0 dams 
exposed to 2 μg BPS/kg/day (Chi Square, p=0.08 compared to controls). 
In the F1 generation, examples of infanticide, or severe neglect requiring 
euthanasia of some pups or the entire litter, was observed in 13% of females 
exposed to 2 μg BPS/kg/day (Table 2). Other more moderate examples of poor 
care were observed in the F1 generation including pups that were stuck together, 
improperly cleaned, or severely bruised on postnatal day (PND) 1 (Table 2).  
 
BPS exposure alters time spent on the nest and nest building in the home 
cage 
To assess the effects of BPS exposure on maternal behavior, dams were 
observed in their home cage without any experimental interventions. F0 dams 
exposed to 200 µg BPS/kg/day spent significantly more time on the nest on 
LD14, with no significant differences between treatment groups at any other time  
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Table 5.2: Litter outcomes from F0 and F1 dams (in F1 and F2 litters) 
 
da
m
 
 Litter size Litter weight 
on LD1 (g) 
Average 
pup weight 
(g) 
% males in 
litter 
% litters with 
infanticide or 
severe 
neglect 
% litters with 
moderate 
neglect 
F0 
Control 9.9 ± 1.04 19.5 ± 1.77 2.04 ± 
0.070 
50.2 ± 5.0 0% 0% 
2 μg BPS/kg/day 10.5 ± 0.85 19.7 ± 1.42 1.94 ± 
0.056 
46.0 ± 3.4 0% 18% a 
200 μg BPS/kg/day 10.1 ± 0.97 20.0 ± 1.53 2.06 ± 
0.073 
46.9 ± 4.4 0% 7% 
        
F1 
Control 11.1 ± 0.74 21.7 ± 1.29 2.01 ± 
0.058 
51.6 ± 2.7 0% 4% 
2 μg BPS/kg/day 12.2 ± 0.52 23.1 ± 1.12 1.94 ± 
0.048 
50.2 ± 2.4 13% a 9% 
200 μg BPS/kg/day 11.2 ± 0.61 22.0 ± 1.04 2.05 ± 
0.064 
48.3 ± 2.4 0% 17% a 
 
a p<0.1, Chi Square comparison with controls in the same generation  
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evaluated (Figure 2A).  Strikingly, F1 dams exposed to both 2 and 200 µg 
BPS/kg/day spent significantly less time on the nest on both LD2 and LD7 
compared to controls. BPS did not alter the time dams spent grooming pups in 
either the F0 or F1 generation (Figure 2B).   
The time that dams spent building and repairing the nest was also 
evaluated. Prior studies have suggested that this might represent OCD-like 
behavior (Catanese Dissertation Chapter 4). In F0 dams, BPS treatment did not 
affect time spent nest building. However, in the F1 generation, dams that were 
developmentally exposed to 200 µg BPS/kg/day spent more time nest building on 
LD14 compared to controls (Figure 2C). 
 
BPS affects nest size in the F0 but not F1 generation 
The internal volume of the nest was calculated using the average internal 
diameter of the nest, measured using the internal walls constructed from a single 
cotton nestlet, and the average nest depth.  In the F0 generation, dams treated 
with 2 µg BPS/kg/day were found to have smaller nests on LD2 compared to 
controls. There were no significant differences in nest size between treatments in 
F1 females at any point across the lactational period examined (Figure 3). Nest 
quality was not affected in either the F0 or the F1 dams (data not shown). 
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Figure 5.2: BPS exposure alters time spent on nest and time spent nest building 
in the home cage. A) On LD14, F0 dams exposed to 200 µg BPS/kg/day spent 
significantly more of the observed time on the nest.  F1 dams developmentally 
exposed to both 2 and 200 µg BPS/kg/day spent significantly less of the 
observed time on the nest on both LD2 and LD7 compared to controls. B) Adult 
or developmental BPS exposure did not alter observed time spent grooming 
pups at any point in the postpartum period, but these activities decreased over 
time. C) There were no significant changes in observed time spent nest building 
in F0 dams, whereas F1 dams exposed to 200 µg BPS/kg/day spent significantly 
more observed time nest building on LD14. Red graphs indicate F0 dams and 
blue graphs indicate F1 dams. *p<0.05, Bonferroni posthoc after significant 2-
way ANOVA for treatment. 
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Figure 5.3: BPS exposure induces minor changes in nest size in the F0 
generation at LD2.  On LD2, F0 dams exposed to 2 µg BPS /kg/day built 
significantly smaller nests compared to controls.  F0 dams exposed to 200 µg 
BPS /kg/day also built smaller nests, but this was not significant.  There were no 
treatment related effects on nest size in F1 dams at any time point across the 
postpartum period. *p<0.05, Bonferroni posthoc after significant 2-way ANOVA 
for treatment. 
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BPS treatment alters pup retrieval 
  
Pup retrieval assays were conducted on LD2, LD7 and LD14, and include 
measures for the latency to first touch one or more pups, the latency to retrieve 
the first pup, and the latency to retrieve the entire litter. To control for differences 
in litter size, we included only those litters with 9-10 pups in our analysis. F0 
dams exposed to 200 µg BPS/kg/day showed significantly longer latency to touch 
the first pup on LD14. In contrast, there were no significant differences in time to 
first touch pups between treatment groups for F1 females at any timepoint 
(Figure 4A).  
Effects of BPS were observed for the time to retrieve the first pup in dams 
from both the F0 and F1 generation. On LD2, F0 dams exposed to 2 µg 
BPS/kg/day displayed a significantly longer latency to retrieve the first pup 
(Figure 4B). In contrast, F1 dams developmentally exposed to 2 µg BPS/kg/day 
demonstrated significantly shorter latency to retrieve their first pup on LD7 
(Figure 4B). 
Finally, there were no effects of BPS on the time to retrieve the entire litter 
in the F0 generation. However, F1 females developmentally exposed to 2 µg 
BPS/kg/day had significantly shorter latency to retrieve their entire litter on LD7 
(Figure 4C). 
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Figure 5.4: BPS alters pup retrieval parameters in both F0 and F1 dams. A) On 
LD14, F0 dams exposed to 200 µg BPS/kg/day displayed a significantly longer 
latency to touch the first pup.  There were no treatment related changes to this 
parameter in F1 dams. B) On LD2, F0 dams exposed to 2 µg BPS /kg/day 
displayed longer latency to retrieve the first pup compared to controls and dams 
exposed to 200 µg BPS/kg/day. On LD7, F1 dams exposed to 2 µg BPS/kg/day 
displayed significantly shorter latency to retrieve the first pup. C) There were no 
treatment related effects in the time to retrieve the entire litter in F0 dams, On 
LD7, F1 dams developmentally exposed to 2 µg BPS/kg/day demonstrated 
significantly shorter latency to retrieve the full litter. Red graphs indicate F0 dams 
and blue graphs indicate F1 dams. *p<0.05, Bonferroni posthoc after significant 
2-way ANOVA for treatment. 
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BPS does not affect behavior of F0 or F1 dams in open field assays  
The open field test is used to assess anxiety-like behavior and locomotor 
activity levels. Increased time spent in the center of the open field is associated 
with lower anxiety-like behavior (Archer 1973; Belzung and Griebel 2001; Hall 
1934, 1936; Prut and Belzung 2003; Spruijt et al. 2014). In evaluations 
conducted on pregnancy day 16 and LD10/11, BPS exposure was not associated 
with any changes in behavior in the open field including the number of rears in 
the center of the field or in the number of grooming events (Figure 5). No 
significant effects of BPS were observed for the number of freeze/stops, number 
of fecal pellets, or the number of rears on the walls of the open field apparatus 
(data not shown). Collectively, these data suggest that BPS does not induce 
anxiety-like behaviors in females exposed during pregnancy and lactation (F0 
females) or in females exposed during development upon reaching adulthood 
(and pregnancy/lactation in particular). 
 
ERα expression in the cMPOA is affected by BPS exposures in the F0, but 
not the F1, generation 
To determine the effect of BPS on brain regions that are considered 
relevant for maternal behavior, neural cells expressing ERα were quantified in 
two matched sections of the cMPOA in F0 dams (on LD21) and F1 dams (on 
LD2 and LD21).  The first subregion of interest was selected from the rostral  
cMPOA (Figure 6A)  whereas  the  second was selected  from  the  
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Figure 5.5: BPS exposure does not affect behaviors in the open field test in either 
the F0 or F1 generations. A) BPS exposure did not affect the number of center 
rears on pregnancy day 16 in F0 or F1 dams. B) BPS exposure did not affect the 
number of grooming events in F0 or F1 dams on pregnancy day 16. C) BPS 
exposure did not affect the number of center rears on LD 10/11 in either F0 or F1 
dams. D) BPS exposure did not affect the number of grooming events on LD 
10/11. Red graphs indicate F0 dams and blue graphs indicate F1 dams. 
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Figure 5.6: BPS treatment increases ERα expression in the cMPOA of F0, but 
not F1, dams. A) Photomicrograph illustrating representative examples of the 
rostral cMPOA from control and BPS-treated F0 females. B) Photomicrograph 
illustrating representative examples of the caudal cMPOA from control and BPS-
treated F0 females. C) There were no treatment related effects on ERα 
expression in the rostral cMPOA of F0 females on LD21 or F1 females on LD2 
and LD21. D) On LD21, F0 dams exposed to 200 µg BPS /kg/day had increased 
ERα expression in the caudal cMPOA. There were no exposure related effects in 
F1 females on either LD2 or LD21 in the caudal cMPOA. *p<0.01 Bonferroni 
posthoc statistic after significant ANOVA.  
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caudal cMPOA (Figure 6B). ERα immunoreactive neural cells were quantified in 
both regions (Figure 6C,D).  
We observed a significant increase in ERα expression in the caudal 
subregion of the central MPOA in F0 dams exposed to 200 μg BPS/kg/day 
relative to the control dams (Figure 6D). BPS treatment also appeared to 
increase ERα expression in the rostral subregion of the central MPOA in F0 
dams, but these differences were not statistically significant (Figure 6C). In 
contrast to the effects observed on the F0 dams, there were no significant 
differences observed in ERα expression in either subregion of the MPOA for F1 
dams at LD2 or LD21 (Figure 6C,D).  
 
TH immunoreactivity is not affected by BPS exposure in either the F0 or the 
F1 generation 
We quantified TH-immunoreactive cells in the VTA in anatomically 
matched sections in F0 dams on LD21 and F1 dams on LD2 or LD21 (Figure 
7A).  There were no significant effects of BPS treatment on TH immunoreactivity 
in the VTA for any of the groups examined (Figure 7B) 
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Figure 5.7: TH-immunoreactivity in the VTA is not affected by BPS treatment. A) 
Photomicrograph illustrating the region of the VTA that was evaluated in F0 
females (at LD21) and in F1 females (at LD2 and LD21). Shown here are 
examples of F0 females. B) There were no treatment related effects on TH-
immunoreactivity in the VTA in either F0 or F1 dams at any time-point examined. 
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Discussion 
 
For the first time, we have evaluated the effects of exposure to BPS, a 
common BPA replacement chemical, on maternal behavior and brain. We 
specifically characterized the effects of BPS on F0 generation dams, exposed 
during pregnancy and lactation, and F1 generation females, exposed in utero 
and during the perinatal period. We found that maternal behavior is sensitive to 
BPS exposure and observed different outcomes depending on generation, 
postpartum period and dose. In contrast to our behavioral findings, only ERα 
expression in the MPOA of F0 generation females was significantly affected by 
BPS exposure. 
With regard to maternal behavior, F0 dams exposed to the higher dose of 
BPS (200 µg/kg/day) spent significantly more time on the nest on LD14, with no 
significant differences between treatment groups at other time points across the 
lactational period. Dams spend less time on the nest as the postpartum period 
progresses (Shoji and Kato 2006), thus these results suggest that BPS exposure 
in the F0 dams induces an extension of a behavior that is generally diminished 
by this later stage of the postpartum period; this may indicate a lack of 
adjustment in the dam to the changing need of her pups (Pereira and Ferreira 
2015). In contrast, dams of the F1 generation developmentally exposed to either 
2 or 200 µg BPS/kg/day spent significantly more time off the nest on LD2 and 
LD7 compared to controls. During these early postpartum periods (LD2 and 
LD7), the pups require constant care including attention to thermoregulation and 
feeding (Lonstein 2007; Pereira and Ferreira 2015) and thus the BPS-treated 
dams are providing quantitatively diminished care.  
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Observations suggesting an inability to attend to the changing 
development and needs of the pups may also be extended to measures of nest 
building. In F1 dams, BPS treatment increased the observed time spent nest 
building on LD14. These dams spent more than twice the amount of time nest 
building compared to the other treatment groups, which may indicate a repetitive 
or OCD-like behavior (Albelda and Joel 2012; Alonso et al. 2015; Greene-
Schloesser et al. 2011; Korff and Harvey 2006). Actual effects on the physical 
nest themselves were only observed in the F0 generation on LD2, where the 
internal diameter of the nests was smaller in dams exposed to 2 µg BPS/kg/day 
compared to controls.  Nest building is dependent on hormone levels during 
pregnancy and is important for thermoregulation and protection of pups 
(Catanese et al. 2015). Thus, a smaller nest may indicate a heightened response 
to the young, or an alternative nest building strategy and may be affected by pup 
and/or litter size.  
The final components of maternal behavior we have evaluated include 
time to first touch and retrieve pups to the nest. On LD14, F0 dams exposed to 
200 µg BPS/kg/day showed significantly longer latency to touch the first pup. A 
longer latency to touch the pups was also seen for F0 females exposed to 2 µg 
BPS/kg/day on LD2 although these results were not statistically significant; these 
females displayed significantly longer latency to retrieve the first pup on LD2.  
These changes suggest alterations to approaching and retrieving pups to the 
safety of the nest, which could have serious repercussions for litter survival in the 
wild.  
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A striking pattern for pup retrieval was observed in the F1 generation; 
dams exposed to 2 µg BPS/kg/day showed significantly shorter latency to 
retrieve their first pup and significantly shorter latency to retrieve their entire litter 
on LD7. It is tempting to interpret this rapid response to pup retrieval as 
“improved” maternal behavior, but it remains in question whether more rapid 
retrieval should be considered an improvement in care, as it may indicate 
hyperactivity, compulsivity-like behavior, heightened stress response to scattered 
pups, or a displaced form of retrieval.  Results from open field tests are not 
consistent with increased anxiety-like behaviors in BPS-treated females in either 
generation. However, preliminary data from our lab suggests that BPS may 
induce hyperactivity in F1 females prior to the onset of puberty (Catanese & 
Vandenberg, unpublished observations), which is consistent with the effects 
observed in F1 dams’ pup retrievals.  
 The ability of BPS-exposed females to build a maternal nest and groom 
their young indicates that the effects we observed in a number of components of 
maternal behavior are not due to wholesale changes in maternal care. 
Considering this, we next evaluated whether BPS treatment altered two brain 
regions considered important for maternal behavior, the MPOA and VTA. We 
observed a significant increase in ERα expression in the caudal subregion of the 
central MPOA in F0 dams exposed to 200 µg BPS/kg/day on LD21 and a non-
significant increase in the rostral subregion of the central MPOA in the same 
animals. There were no significant differences observed in ERα expression in 
either subregion of the MPOA for F1 dams at either LD2 or LD21. While this 
study did not investigate mechanisms underlying this increase in receptor 
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expression, the regulation of ERα expression in the MPOA remains under 
investigation. It is understood that E2 is able to down regulate ERα gene 
expression in the MPOA of cycling adult female rats (Shughrue et al. 1992) and 
that protein levels fluctuate across the estrus cycle in response to estrogen (Zhou 
et al. 1995), indicating that endocrine state is key in assessing ER regulation in 
this region. Studies demonstrate that high levels of ER binding are required in the 
rat during early pregnancy for the display of maternal care, even though serum 
estradiol levels are low, indicating that low estrogen levels at that time may be 
adequate to increase levels of receptor (Giordano et al. 1989; Giordano et al. 
1990b; Giordano et al. 1991; Rosenblatt et al. 1994).  Increased mRNA and 
protein expression occur later in pregnancy, and appear to be regulated by 
transcriptional mechanisms such as transcription rate (Rosenblatt et al. 1994; 
Wagner and Morrell 1995, 1996); receptor turnover and receptor phosphorylation 
may also account for increases in ER expression (Rosenblatt et al. 1994). In the 
mouse, ERα expression in the MPOA is thought to be positively correlated with 
estradiol levels, however the relationship between estradiol and ERα expression 
is not fully understood (Koch and Ehret 1989). A recent study found that 
letrozole, the aromatase inhibitor, interfered with pup retrieval and latency to 
build a nest in ovariectomized virgin females and induced increased mRNA 
levels of ERα, indicating a role for brain derived estrogen in the regulation of ERα 
gene expression in the MPOA (Murakami 2016).   
The effects of overexpression of ERα are considered to be tissue 
dependent (Tomic et al. 2007). In the brain, for example, induced overexpression 
of ERα in the hippocampus of aging female rats has been shown to enhance 
 	 171 
memory (Dubal et al. 2001; Witty et al. 2012). ERα expression is upregulated in 
response to neuronal injury and is considered neuroprotective (Dubal et al. 
2001). Determining the mechanism underlying the increase in ERα in the MPOA 
in the F0 generation as well as potential downstream neural and/or genomic 
effects will be important to investigate in the future.   
To date, there are relatively few data to predict the effects of 
xenoestrogens on ER expression in the MPOA. A study of non-pregnant or 
lactating Sprague-Dawley rat dams examined the effects of high doses of BPA 
(40 mg/kg/day) on ERα immunoreactive cells in the MPOA, ventromedial 
hypothalamus and arcuate nucleus. Although lactating females had fewer ERα 
expressing cells in the MPOA compared to non-lactating females, there was a 
slight increase in ERα expression, but no significant effects of BPA in the 
lactating group (Aloisi et al. 2001). There are many differences between our 
study and this study of BPA, including the compounds examined, the magnitude 
of the dose, the species, the length of the exposure period, the exposure 
administration protocol, etc.  Additionally, maternal behavior was not assessed in 
the BPA experiment.  
 Our results are consistent with altered expression of ERα in response to 
BPS treatment after an activational exposure (Arnold and Gorski 1984; Phoenix 
et al. 1959; Richter et al. 2007). We were surprised to find that ERα expression in 
the cMPOA was not altered by developmental BPS exposure in F1 dams. 
Developmental exposures to BPA, for example, have been shown to affect ERα 
expression. Neonatal exposure to 0.05 mg/kg and 20 mg/kg BPA demonstrated 
dose dependent effects; there was increased ERα expression on postnatal day 
		 172 
(PND) 8 and PND21 in response to the lower 0.05 mg/kg dose and decreased 
expression on PND8 and PND21 in response to the higher 20 mg/kg dose 
(Monje et al. 2007).  In an additional study, maternal exposure to 2, 20 or 200 µg 
BPA/kg/day in BALB/c mice during pregnancy (gestational day 0-19) led to dose- 
and sex-specific changes in the expression of genes encoding of ERα, ERβ, and 
ERRγ in the hypothalamus of offspring (Kundakovic et al. 2013). Effects of 20 µg 
BPA/kg/day on ERα expression in the hypothalamus of female offspring was 
correlated with reduced methylation of the gene coding for ERα. Maternal 
behavior was altered in the dams in these experiments, however, these 
alterations were reported to not have mediated effects on gene expression 
(Kundakovic et al. 2013).  
At first glance, the results of our studies might suggest that the in utero 
and perinatal periods are not sensitive to BPS for this measure.  We did 
however, observe striking effects in the maternal behavior of the F1 generation, 
specifically, in increased time spent away from the nest as well as reduced 
latency to retrieve pups.  It is possible that BPS affects ERα expression at a 
different level of analysis than we conducted such as gene expression or 
promoter methylation, or that the effects of BPS are only apparent at other 
stages in development. It is also possible that developmental exposures to BPS 
had an early effect on ERα expression but that these effects were transient or 
stage dependent; further experiments are necessary to uncover any potential 
change to expression earlier in life. However, there appears to have been a 
developmental or “organizational” effect of BPS exposure on the later adult 
behavior in the F1 generation.  
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Studies of estrogenic EDCs often show robust effects after developmental 
exposures when compared to the effects observed in adults, consistent with the 
organizational role of hormones (Arnold and Gorski 1984; Gore et al. 2006a; 
Phoenix et al. 1959; Vandenberg et al. 2013a; vom Saal et al. 2007). Yet, in 
many studies examining developmental effects of EDCs, the dam is considered a 
vessel through which offspring are exposed, and thus is rarely examined herself 
(Catanese et al. 2015; Cummings et al. 2010). Work from Angel Nadal’s group 
and others is challenging this paradigm (Alonso-Magdalena et al. 2010; Alonso-
Magdalena et al. 2015), and strong evidence suggests that pregnancy may be 
considered a ‘vulnerable period of development’ for the mother. Here we 
demonstrate that adult exposures can induce both neural and behavioral 
changes in exposed dams including changes to maternal behavior, thus 
suggesting that pregnancy and the lactational period are sensitive to endocrine 
disruption. These effects on the mother may then impact her offspring’s 
behavioral and neural development (Walker and Gore 2011). One major 
challenge is to distinguish the direct effects of EDC exposures on the pups from 
indirect effects observed in pups due to altered maternal behaviors (Cox et al. 
2010; Cummings et al. 2005). In a small number of studies, cross fostering has 
been utilized to isolate the effects of EDC exposures on the mother’s behavior 
from potential effects on offspring (Cox et al. 2010; Cummings et al. 2005). 
However, care must be taken in study design as maternal behavior can be 
affected in both a positive and negative direction by cross -fostered pups (Cox et 
al. 2010; Cox et al. 2013; Curley et al. 2010; Maccari et al. 1995).   
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To the best of our knowledge, ours is the first study to examine whether 
exposure to one of the current BPA replacement chemicals, BPS, affects 
maternal behavior as well as maternally relevant neural correlates. A growing 
body of evidence indicates that exposure to environmental chemicals can alter 
maternal behavior (Catanese et al. 2015; Cummings et al. 2010) and disruptions 
to maternal care can profoundly influence the development of subsequent 
generations, which are also sensitive to developmental and environmental 
impacts (Bale et al. 2010; Barrett and Fleming 2011; Heim and Nemeroff 2001; 
Nemeroff 2004; Walker and Gore 2011). A combination of neural, endocrine, 
behavioral and cognitive processes drive proper maternal care, allowing mothers 
to adjust to the needs of the young over the course of their early development 
(Bridges 2015; Pereira and Ferreira 2015; Reisbick et al. 1975; Uriarte et al. 
2008).  Our results suggest that these processes become impaired after BPS 
exposures with differing effects based on dose, postpartum period and 
generational timing of exposure. The results from our study highlight the need to 
understand the effects of low doses of exogenous estrogens on maternal 
behavior and to better understand the neural mechanisms underlying these 
behavioral changes. Overall, our results provide further evidence for the impact 
that EDCs have on brain and behavior in both the adult and developing 
individual.  
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CHAPTER 6 
BISPHENOL S (BPS) EXPOSURE DURING PREGNANCY AND LACTATION 
ALTERS CELL DIVISION IN TWO MATERNALLY RELEVANT BRAIN 
REGIONS IN FEMALE MICE 
 
Abstract 
 
 Adult neurogenesis has been well studied in the sub-ventricular zone 
(SVZ) of the lateral ventricles and sub-granular zone (SGZ) of the dentate gyrus 
of the hippocampus but there is emerging evidence that this phenomenon occurs 
in additional neural regions. The plasticity of maternal behavior and the dynamic 
neuroendocrine events of pregnancy and parturition suggest the potential for 
neurogenesis in the medial preoptic area (MPOA), the brain region most critical 
for the onset of maternal behavior. There are studies that have examined cell 
proliferation and neurogenesis in rodents during pregnancy and lactation in 
traditional neurogenic zones. Yet, to the best of our knowledge, neurogenesis in 
the MPOA or other brain regions that receive input from the MPOA, such as the 
ventral tegmental area (VTA), has not been studied with respect to the onset of 
maternal behavior. We hypothesize that neurogenesis might be one of the 
mechanisms underlying estrogen regulated maternal behavior in the MPOA. We 
also postulate that exposure to bisphenol S (BPS), a xenoestrogen that we have 
shown to disrupt maternal behavior and the brain, might also disrupt 
neurogenesis in the MPOA or VTA. Taking steps towards the investigation of 
neurogenesis, we used BrdU incorporation to assess cell division in these 
regions. We found an increase in the number of dividing cells in the MPOA in 
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postpartum females on lactational day (LD)2 compared to non-pregnant females. 
Furthermore, exposure to 2 or 200 µg BPS/kg/day decreased the number of 
dividing cells in the VTA of females on LD2 compared to postpartum controls. 
Although lactating females exposed to 200 µg BPS/kg/day had similar numbers 
of dividing cells in the caudal MPOA compared to postpartum controls, females 
exposed to 2 µg BPS/kg/day did not show a pregnancy-induced increase in 
dividing cells. These findings indicate that cell division in neural regions important 
for maternal care may be sensitive to xenoestrogen exposure.  
 
Introduction 
 Neurogenesis, the process by which new neurons are created, was initially 
considered to be limited to embryonic development, as reflected in Ramon y 
Cajal’s famous assertion: “Once the development was ended, the founts of 
growth and regeneration of the axons and dendrites dried up irrevocably.  In the 
adult centers, the nerve paths are something fixed, ended and immutable.  
Everything may die, nothing may be regenerated. It is for the science of the 
future to change, if possible, this harsh decree” (Gross 2000; Ramón y Cajal 
(Trans. Day, R. M., from the 1913 Spanish edn) (Oxford Univ. Press, London, 
1928)). Cajal’s pronouncement, while prescient in its view towards the future, 
gave rise to dogma regarding the static nature of the adult brain; this dogma has 
since been overturned, but not without controversy in the field (Gould 2007; 
Gross 2000; Ma et al. 2009).   
 Neurogenesis is sustained throughout life in the mammalian brain through 
the proliferation and differentiation of adult neural stem cells (Ming and Song 
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2011; Zhao et al. 2008). Currently, there are two accepted neurogenic brain 
regions, the sub-ventricular zone (SVZ) of the lateral ventricles and the sub-
granular zone (SGZ) in the dentate gyrus of the hippocampus (Lim and Alvarez-
Buylla 2014; Migaud et al. 2010; Ming and Song 2011; Zhao et al. 2008).  Neural 
stem cells in the SVZ give rise to neuroblasts, which migrate through the rostral 
migratory stream to become granule and periglomerular interneurons in the 
olfactory bulb, while new neurons from the SGZ migrate into the granule cell 
layer of the dentate gyrus and become granule cells (Lim and Alvarez-Buylla 
2016; Ma et al. 2009; Migaud et al. 2010; Ming and Song 2011; Zhao et al. 
2008).  There is evidence from studies in rodents that olfactory experience and 
olfactory related learning can regulate neurogenesis in the SVZ and that 
increased neurogenesis in the SGZ involves learning through hippocampal 
dependent tasks, yet the functional significance of neurogenesis in both regions 
remains under investigation (Zhao et al. 2008).    
The dynamic neuroendocrine changes associated with pregnancy and 
lactation, along with evidence for neurogenesis in the hypothalamus (Kokoeva et 
al. 2005, 2007; Pencea et al. 2001), suggest the potential for neurogenesis in the 
medial preoptic area (MPOA), the brain region most critical for the onset of 
maternal behavior. In the rat, increased ERα expression in the MPOA 
established during the later stages of pregnancy is required for estrogenic 
regulation of the onset of maternal behavior (Bridges 1984; Giordano et al. 1989, 
1991). While mice are considered to display maternal behavior independent of 
estrogen, there is some evidence indicating a role for the hormone (Gandelman 
1973a; Hauser and Gandelman 1985; Stolzenberg and Rissman 2011). ERα 
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knockout mice are not responsive to estrogen and are poor mothers (Ogawa et 
al. 1998) and conditional knockout of ERα in the MPOA abolishes the display of 
maternal behaviors (Ribeiro et al. 2012), evidence indicating the importance of 
estrogen signaling in this brain region. Further, during pregnancy and lactation, 
there is enhanced ER-immunoreactive cell number, suggesting changes to the 
regulation in the MPOA that may occur during these sensitive periods (Koch and 
Ehret 1989). 
 More broadly, neural structure and function for many brain regions are 
dependent upon estrogen (McEwen and Alves 1999). In relation to neurogenesis, 
estrogen induces an increase in cell proliferation in cells identified as immature 
granule neurons in the adult female rat dentate gyrus, a short-term effect that is 
not as pronounced in males (Galea 2008). Studies have examined cell 
proliferation and neurogenesis in rodents during pregnancy and lactation in 
traditional neurogenic zones. For example, in maternal rats, hippocampal cell 
proliferation and neurogenesis are down regulated during late pregnancy and 
parturition (Galea 2008; Galea et al. 2013; Galea et al. 2014).   
There is emerging evidence that EDCs can interfere with neurogenesis.  
Both estrogen and BPA affect cortical and hippocampal neurogenesis and 
several studies suggest that BPA disrupts neurogenesis, for example, 
prepubertal BPA exposure alters neurogenesis and spatial learning in the 
hippocampus (Kim et al. 2011). Maternal exposure to BPA disrupts neurogenesis 
in neural stem/ progenitor cells in the fetal mouse neocortex (Komada et al. 
2012).  The effects of BPA on neurogenesis have profound implications for 
developmental exposures to environmental chemicals and further suggest that 
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neural effects of EDCs may be deleterious. A recent study has found that 
exposure to very low doses of both BPA and BPS increased neurogenesis in the 
developing zebrafish hypothalamus and induced hyperactivity when tested at the 
later larval stage (Kinch et al. 2015).  
To the best of our knowledge, neurogenesis in the MPOA and other brain 
regions that receive input from the MPOA, including the ventral tegmental area 
(VTA), has not been studied with respect to maternal behavior. We hypothesize 
that neurogenesis might be one of the critical mechanisms underlying estrogen 
regulated maternal behavior and that alterations to neurogenesis due to 
xenoestrogen exposure during pregnancy may influence maternal care.  Taking 
initial steps to address this question, we assessed whether cells in the MPOA 
actively divide using BrdU proliferation assays in pregnant females.  We further 
investigated proliferation in BPS-treated dams to determine whether exposure to 
BPS alters cell division in the MPOA and the VTA. 
 
Methods 
 
Animals 
Pregnant female CD-1 mice (Charles River Laboratories, Raleigh, NC) 
were acclimated for at least two days and individually housed in polysulfone 
cages with food (Harlan Teklad 2018) and tap water (in glass bottles) provided 
ad libitum. The animals were maintained in temperature (23 ± 2°C), humidity (45 
± 15%) and light controlled (12h light, 12h dark, lights on at 0700 h) conditions at 
the University of Massachusetts, Amherst. All experimental procedures were 
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approved by the University of Massachusetts Institutional Animal Care and Use 
Committee.  
Beginning on pregnancy day 8, female mice were weighed daily to allow 
chemical dosage to be adjusted for body weight. Females were randomly 
allocated to treatment groups using software which distributed the mice into 
groups based on body weight. From pregnancy day 9 – lactational day (LD) 1, 
dams were provided a small wafer (Nabisco, East Hanover, NJ) treated with BPS 
(99% purity, Santa Cruz Biotechnology) or vehicle alone (70% ethanol, allowed 
to dry prior to feeding) (Gauger et al. 2007). Wafers were dosed with solutions 
designed to deliver 2 or 200 µg BPS/kg/day. Dams were allowed to deliver 
naturally (birth designated LD0).  
Non-pregnant females were fed wafers dosed with vehicle (70% ethanol, 
allowed to dry prior to feeding) for a period of thirteen days to match the length of 
treatment for pregnant dams. All other housing conditions were the same. 
 
BrdU incorporation 
BrdU (Sigma Aldrich, B5002) was administered via interperitoneal (ip) 
injection on LD0, at a concentration of 70 ug/kg body weight. The dams were 
sacrificed 48 hours (± 3) after BrdU injection on LD2. Non-pregnant females were 
injected with BrdU on the 12th day of treatment and sacrificed 48 hours (± 3) 
later. 
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Maternal behavior assays 
Maternal behavior was assessed on LD2 in the experimental group; dams 
were observed for a period of 90-minutes at the beginning of the light phase and 
behavior was recorded every three minutes for the following components of 
behavior: dam position on/off nest, nursing posture, pup licking and grooming, 
nest repair and dam “self-care” (self grooming, eating, and drinking).  
 
Immunohistochemistry 
After sacrifice, brains were collected and fixed in Neutral Buffered 
Formalin (10%) (Fisher Scientific, Pittsburgh, PA), washed, and stored in 70% 
ethanol at 4°C.  Brains were sectioned at 40 μm, in the transverse plane and the 
MPOA and VTA were identified using a mouse brain atlas (Franklin 2012, 1997). 
Sections including the SVN, a known neurogenic region, were included as a 
positive control. 
Free-floating sections were processed for BrdU immunoreactivity using a 
DAB chromogenic reaction.  Briefly, endogenous peroxidases were quenched 
using 3% hydrogen peroxide in methanol. Sections were washed, and DNA was 
denatured in 2N HCl for 2 hours followed by neutralization of acid with 0.1M 
sodium borate buffer, pH 8.5 (Alfa Aesar) for 25 minutes.  Sections were washed, 
then blocked with normal goat serum in 1.5% milk, and incubated overnight at 
4°C with polyclonal rabbit anti-BrdU. (ThermoFisher Scientific, PA5-32256). 
Sections were washed and incubated with biotin labeled secondary antibody 
(goat anti-rabbit Ab 64256, Abcam, Cambridge, MA) followed by streptavidin 
peroxidase complex (Ab64269, Abcam). Diaminobenzidene chromogen and 
		 182 
substrate (ab64238, Abcam) were used to develop the reaction. Sections were 
briefly washed in tap water, stored in 0.1% PBS-Tween 20 until mounted on 
slides, dehydrated and coverslipped.   
Cells expressing BrdU in the MPOA were counted on anatomically 
matched sections using a Zeiss AxioImager (120X magnification) and Zeiss high-
resolution color camera. BrdU immunoreactivity was counted in two MPOA 
sections per animal; one section from the rostral MPOA, one from the caudal 
MPOA, by an observer blind to treatment. The central MPOA was identified using 
neuroanatomical landmarks as described in (Tsuneoka et al. 2013).  The VTA 
was identified using neuroanatomical landmarks and BrdU incorporation was 
counted on 2 anatomically matched sections at 100X magnification.  
 
Statistical Analysis 
Both behavioral and immunohistochemical analyses were conducted by 
an experimenter blind to treatment groups. Data were analyzed using SPSS 
Version 22. For assessments of maternal behavior and BrdU-positive cell 
numbers, data were analyzed using 1-way ANOVA with treatment group as an 
independent variable, followed by Bonferroni posthoc tests. Data were 
considered significant when p<0.05. Categorical data (% females retrieving tails) 
were analyzed with Chi Square. Graphs illustrate means ± standard errors unless 
otherwise stated. Sample sizes for behavioral analyses were: control (n=5), 2 µg 
BPS/kg/day (n=8), and 200 µg BPS/kg/day (n=9). Sample sizes for MPOA and 
VTA counts were: non-pregnant control (n=3), control on LD2 (n=5), 2 µg 
BPS/kg/day on LD2 (n=7) and 200 µg BPS/kg/day on LD2 (n=9). 
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Results 
BPS exposure increases nest building and tail retrieval behaviors 
 To determine the effect of BPS on maternal behavior, we first observed 
dams with their litters in the home cage on LD2. Similar to what we saw in 
previous experiments examining F0 dams exposed to BPS during pregnancy and 
lactation (Catanese, Dissertation Chapter 5), we observed few effects of BPS on 
maternal behavior at LD2. The fraction of time the dam spent on the nest (Figure 
1A) or nursing (data not shown) was not affected by BPS treatment. Time spent 
on self-care (self-grooming, eating or drinking) (Figure 1B) and the time spent 
grooming pups (Figure 1C) was also not affected. There was an increase in the 
time spent nest-building in females exposed to 200 μg BPS/kg/day (Figure 1D; 
ANOVA p<0.1, Bonferroni posthoc p<0.05), consistent with increased display of 
repetitive or OCD-like behavior (Albelda and Joel 2012; Alonso et al. 2015; 
Greene-Schloesser et al. 2011; Korff and Harvey 2006).  
 We also evaluated the frequency of tail self-retrieval to the nest, an 
example of a stereotypy or OCD-like behavior that we have observed previously 
(Catanese Dissertation Chapter 3). BPS induced tail retrieval behavior in more 
dams compared to the controls (Figure 1E), although these differences were not 
statistically significant. BPS-exposed dams also spent more time retrieving their 
tails to the nest compared to controls (Figure 1F); in the group exposed to 2 μg 
BPS/kg/day, the time spent on these behaviors more than doubled that observed 
in controls. Collectively, these results are consistent with BPS-induced 
stereotypies in lactating dams. 
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Figure 6.1: BPS induced modest effects on maternal behavior in dams at LD2. A) 
No treatment related effects of BPS exposure were observed in fraction of time 
spent on the nest. B) BPS exposure did not alter the fraction of time the dam 
spent on self-care. C) BPS did not alter the fraction of time dams spent grooming 
pups. D) Dams exposed to 200 µg BPS /kg/day spent increased fraction of time 
nest building compared to controls. E) BPS treated dams were more likely to 
display tail retrieval behaviors compared to controls, but these differences were 
not statistically significant. F) Dams exposed to 2 μg BPS/kg/day spent more 
than double the fraction of time engaged in tail retrieval compared to controls. 
These differences were not statistically significant, likely due to the small sample 
sizes. (*), p<0.1, ANOVA, with significant Bonferroni posthoc test compared to 
controls. 
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Validation of the BrdU procedure 
To determine whether the BrdU protocol included sufficient time (2 days) 
and an appropriate administered dose to label cells in the brain, we first 
examined BrdU in the SVN, a known neurogenic region, in lactating females 
(Figure 2). Robust BrdU immunoreactivity was observed in this brain region, 
consistent with what has been reported previously in the literature. From this 
analysis, we concluded that our BrdU incorporation and detection protocols were 
appropriate for use in the brain. 
 
Cell division increases in the MPOA of lactating females 
We next evaluated BrdU immunoreactivity in the MPOA to determine 
whether cell division takes place in this brain region. We specifically focused on 
the central MPOA (cMPOA) ; a sub-region in the MPOA essential for pup 
retrieval (Tsuneoka et al. 2013). In the rostral cMPOA, rates of cell division were 
very low but a small number of BrdU-labelled cells were observed in most 
females (Figure 3A). There was no effect of lactation or BPS exposure on BrdU 
incorporation in this region. In contrast, within the caudal cMPOA, lactation 
induced a significant  increase in  the  number  of  BrdU labeled cells compared 
to non-pregnant females, suggesting that proliferation is increased between 
parturition and LD2 (Figure 3B). Lactating females exposed to BPS also showed 
increased numbers of BrdU-immunoreactive cells. Females exposed to 200 µg 
BPS/kg/day were indistinguishable from lactating controls and had significantly 
more positive cells compared to non-pregnant controls. Yet, females exposed to  
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Figure 6.2: BrdU incorporation is visible in the SVN, a known neurogenic region. 
BrdU labeling in the SVN was used as a positive internal control for BrdU 
incorporation and detection methods. A) Low magnification and B) high 
magnification view of the SVN. Positively-stained cell nuclei are indicated with 
red arrows in panel B. 
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Figure 6.3: BPS induces modest effects on cell division in the caudal MPOA. A) 
Photomicrographs illustrate BrdU incorporation in the rostral and caudal MPOA. 
B) Quantification of BrdU immunoreactivity in the rostral MPOA. The number of 
BrdU-positive cells in non-pregnant and lactating controls was statistically 
indistinguishable. BPS also did not affect cell division in this brain region. C) 
Lactating controls had significantly more BrdU-positive cells than non-pregnant 
control females. Lactating females dosed with 200 μg BPS/kg/day also displayed 
an increase with a similar magnitude. Females exposed to 2 μg BPS/kg/day 
displayed an intermediate phenotype that was statistically indistinguishable from 
either the non-pregnant or the lactating controls. The use of the term pregnant is 
intended to highlight that these groups had gone through pregnancy, compared 
to non-pregnant controls, while data was collected at LD2. In panel C, different 
letters indicate significant differences (p<0.05, Bonferroni posthoc analysis after 
significant ANOVA test.)  
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2 µg BPS/kg/day appeared to have a more intermediate phenotype, with BrdU-
labelled cell numbers that were not different from either non-pregnant or lactating 
controls. 
 
Cell division in the VTA is induced on LD2 and disrupted in BPS-treated 
dams 
The VTA is important for maternal motivation and receives input from the 
MPOA. We observed low numbers of BrdU labeled cells and quantified dividing 
cells in two anatomically matched sections of the VTA. While it appears that few 
cells are dividing at this time, in pregnant/lactating control females, there was an 
increase in the number of dividing cells compared to non-pregnant controls 
(Figure 4A), suggesting that cell division in this brain region is responsive to 
pregnancy and or the lactational period. In contrast, LD2 females exposed to 
either dose of BPS did not display a pregnancy/lactation-induced increase in 
BrdU incorporation; there were significantly fewer numbers of dividing cells in the 
VTA of both BPS treatment groups compared to controls (Figure 4B).  
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Figure 6.4: BPS treatment attenuates the effects of lactation on cell division in 
the VTA. A) A photomicrograph illustrating BrdU incorporation in the VTA. The 
outline of the VTA is provided, as this region is not readily apparent without 
additional landmarks. Positive cells are indicated with red arrows. B) Lactation 
induced a significant increase in BrdU immunoreactive cells in control females 
compared to non-pregnant controls. In contrast, BPS-treated females did not 
display an increase in BrdU-positive neurons in the VTA on LD2. The use of the 
term pregnant is intended to highlight that these groups had gone through 
pregnancy, compared to non-pregnant controls, while data was collected at LD2. 
In panel B, different letters indicate significant differences (p<0.05, Bonferroni 
posthoc analysis after significant ANOVA test.) 
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Discussion 
 
 Neurogenesis was first demonstrated in a number of structures including 
the cerebral cortex, hippocampus and olfactory bulb in the adult mammalian 
brain in the early 1960’s by Altman and Das and has been well documented in 
the SVZ of the lateral ventricles and SGZ of the dentate gyrus of the 
hippocampus (Altman 1962; Altman and Das 1965, 1966; Gould and Gross 
2002; Gould 2007; Ming and Song 2011; Taupin and Gage 2002; Zhao et al. 
2008). While neurogenesis in the SVZ and SGZ is currently accepted, other 
studies that failed to observe neurogenesis in the brain of adult nonhuman 
primates (Rakic 1985) stalled the field. The halted study of neurogenesis reached 
a turning point after Nottebohm and colleagues demonstrated that new neurons 
are produced seasonally in the ventricular zone of songbirds; these neurons 
migrate to the hyperstriatum ventral, pars caudalis (HVc), or the high vocal 
center, which is a structure important for the production of birdsong (Alvarez-
Buylla and Kirn 1997; Goldman and Nottebohm 1983).  These neurons were 
found to incorporate into functional circuits (Paton and Nottebohm 1984), thus 
providing strong evidence for functional integration of new neurons.  In the early 
1990’s, Gould revisited Altman and Das’ earlier work and found that there are 
thousands of new hippocampal neurons generated in the adult rat hippocampus 
(Gould et al. 1999a). Additional studies demonstrated adult neurogenesis in the 
hippocampus of Old World Primates (Gould et al. 1999b) as well as evidence 
that estrogen plays a role in the regulation of hippocampal neurogenesis in 
female rats (Tanapat et al. 1999). The rediscovery of neurogenesis in the 
mammalian brain culminated in evidence for neurogenesis in the human dentate 
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gyrus using post-mortem tissue from cancer patients (Eriksson et al. 1998). 
These studies provided the first confirmation of neural plasticity in the adult 
human brain, which reinvigorated the field (Eriksson et al. 1998).  
Evidence for adult neurogenesis has recently been demonstrated in 
additional brain regions with comparatively lower germinative levels compared to 
the SVZ and SGZ such as the cortex, striatum, amygdala, substantia nigra and 
hypothalamus (Gould 2007; Migaud et al. 2010).  While the MPOA is located in 
the forebrain, its many functional connections with the hypothalamus (Simerly 
and Swanson 1986) and its location adjacent to the third ventricle supported a 
rationale for examining proliferation (Kokoeva et al. 2005, 2007; Migaud et al. 
2010; Pencea et al. 2001).  Further, cells derived from 7 week old rat 
hypothalamus are capable of producing neuronal and glial cells, as well as 
neuropeptide positive cells in culture (Markakis et al. 2004).  An in vivo study 
showed that neuronal progenitors are produced from ependymal cells in the 3rd 
ventricle in the 8wk old rat hypothalamus and a number of dividing cells identified 
as orexin neurons (Xu et al. 2005). Finally, recent work from human patients has 
demonstrated support for neurogenesis in additional brain regions; striatal 
interneurons undergo neurogenesis; this forebrain structure is important for 
motor behavior (Ernst et al. 2014). However, questions regarding the functional 
integration of new neurons in the adult as well as questions regarding the origin 
of these cells and whether neural stem cells in the adult behave more like 
progenitors or stem cells remain to be resolved (Ming and Song 2011).  
Here, our results demonstrate that, while at very low levels, there are 
dividing cells in the MPOA and VTA in the maternal mouse on LD2.  To the best 
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of our knowledge, cell proliferation has not been assessed in these regions in 
relation to maternal behavior.  We further found that BPS affects this 
phenomenon in both regions, with more striking effects observed in the VTA.  
Adult neurogenesis is well established in two regions, the SVZ and SGZ of the 
dentate gyrus in the hippocampus, and there is evidence to suggest that EDCs 
can interfere with this process (Kim et al. 2011; Komada et al. 2012). Our study 
provides preliminary evidence that the adult female brain is sensitive to 
environmental chemicals early in the postpartum period, and one mechanism of 
disruption in the maternal brain may be due to altered cell proliferation. We 
observed modest effects on maternal behavior, with an increase in the observed 
time spent nest-building in females exposed to 200 μg BPS/kg/day, and BPS 
related increases in time spent engaged in tail retrieval, consistent with increased 
display of stereotypy or OCD-like behavior (Albelda and Joel 2012; Alonso et al. 
2015; Greene-Schloesser et al. 2011; Korff and Harvey 2006), suggesting that 
BPS exposure in adulthood may affect behavior. 
A small number of studies have considered neurogenesis in relation to the 
onset of maternal behavior. In rats, there is decreased cell proliferation in the 
hippocampus soon after parturition (Galea 2008; Galea et al. 2013; Galea et al. 
2014) associated with increased glucocorticoid levels during lactation 
(Darnaudery et al. 2007; Leuner et al. 2007). This effect was shown to last until 
weaning (Leuner et al. 2007). Maternal experience also leads to decreases in 
hippocampal proliferation (Pawluski and Galea 2007). In contrast, cell 
proliferation increases in the SVZ during pregnancy and lactation (Furuta and 
Bridges 2005). In CD-1 mice, pregnancy leads to increased proliferation in the 
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SVZ on gestational day (GD) 7, with a return to levels similar to virgin females on 
GD14 and a subsequent increase on LD7 with LD14 and LD21 levels similar to 
virgin levels (Shingo et al. 2003).  
The plasticity of maternal behavior and its dynamic neuroendocrine basis 
during pregnancy and lactation suggests the potential for neurogenesis in the 
adult maternal brain. Interestingly, women with multiple sclerosis (MS) 
experience remission in symptoms during pregnancy, which then return during 
the postpartum period (Voskuhl 2003), suggestive of a link between endocrine 
state and neuroplasticity. One study recently showed that new oligodendrocytes 
and increased myelination were found in maternal female mice, an effect 
regulated by prolactin (Gregg et al. 2007).   
  In fact, multiple evaluations of neurogenesis have specifically focused on 
the role of hormones in this process. Estrogen receptors (ERs) are expressed in 
neural stem cells in embryonic and adult rats (Brannvall et al. 2002) and estradiol 
increases cell division in the dentate gyrus in females in an estrus cycle 
dependent manner (Tanapat et al. 1999). In female prairie and meadow voles, 
estradiol differentially regulates proliferation and ER expression in the adult 
hypothalamus (Fowler et al. 2005; Fowler et al. 2008) and influences 
neurogenesis following a social exposure test (Fowler et al. 2002).  These 
studies provide evidence for a role for estrogens in neurogenesis during 
embryonic development and in adulthood. Other studies have focused on a role 
for prolactin in neurogenesis. Due to the increase in circulating prolactin in mice 
between GD6 and 7, it was postulated that an increase in neurogenesis was 
mediated by prolactin; infusion of prolactin and prolactin releasing peptide in 
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ovariectomized females as well as adult males induced increases in SVZ 
proliferation (Shingo et al. 2003).  Interestingly, a similar effect was also found in 
females that mated with sterile males, suggesting that hormone changes 
associated with mating as well as increases of hormones during 
pseudopregnancy, which are similar to those of early gestation, may induce this 
effect (Shingo et al. 2003). Low levels of prolactin reduced neurogenesis in the 
SVZ on LD7 and gave rise to increased anxiety-like behavior in dams that 
displayed normal maternal behavior in the home cage but deficits in maternal 
behavior in a novel environment (Larsen and Grattan 2010, 2012).  
Neurogenesis in the MPOA has not been examined in relation to maternal 
behavior. We took first steps towards examining neurogenesis by investigating 
cell division and provide preliminary evidence for a low number of dividing cells in 
this region soon after parturition; future studies are needed to determine whether 
cell division and further, if neurogenesis, in either the MPOA or VTA is necessary 
and/or sufficient for the onset or maintenance of maternal behaviors. Other 
studies have found that ablation of neural progenitors in the SVZ led to a chronic 
reduction of neurogenesis in this region (Feierstein et al. 2010) and changes to 
maternal behavior (e.g. dams receiving irradiation spent more time on the nest 
and more time nursing) (Feierstein et al. 2010). In additional studies, genetic 
ablation of new neurons in the SVZ induced poor retrieval and disrupted feeding 
behaviors, leading to death in the pups at 24h-3 days, which suggests that 
continuous neurogenesis is important for reproductive success as well as 
maternal behavior (Sakamoto et al. 2011).  Taken together, these findings 
indicate that prolactin, as well as maternal experience can induce neurogenesis 
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in the SVZ, and suggest the importance of timing in relation to hormone levels 
during pregnancy and lactation for cell proliferation and neurogenesis in this 
germinative zone. Estradiol actively regulates pituitary prolactin (Freeman et al. 
2000) and thus may play a role in prolactin-induced neurogenesis during the 
maternal period. 
Our use of BrdU indicates that cell division is occurring in specific brain 
regions during the peripartum period, but cannot demonstrate that neurogenesis 
is occurring. We will need to investigate whether treatment related reductions in 
dividing cells are due to apoptosis or interference with cell cycle progression. 
Future studies are also needed to determine the phenotype of  dividing cells 
detected in the MPOA and VTA, if they are neurons or glia using markers for 
radial glia (RC2, GFAP), progenitor phenotype [Ki-67, doublecortin (DKX)] 
immature neurons (Tuj1) and mature neurons (Neu-N).  It will be important to 
also examine if new cells survive and become functionally integrated into circuits.  
BrdU is a thymidine analogue that incorporates into DNA during the synthesis (S) 
phase of the cell cycle.  In this present work, we detected cells born during a two- 
day time window. A long- term pulse of one to two weeks would allow an 
investigation of migrating cells as well as potentially uncovering differentiated 
neurons or glia. Future studies will also need to address whether there are 
effects of exposure on differentiation, for example, if there are discrepancies 
between differentiated immature or mature neurons, or between mitotic and 
differentiated cells due to lactation or treatment. This future work will contribute to 
our knowledge of neural plasticity and cell renewal in brain regions important for 
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the regulation of maternal behavior, which are not generally considered regions 
undergoing neurogenesis. 
We uncovered low levels of cell division in two brain regions important for 
maternal behavior, the MPOA and the VTA, in response to parturition and 
lactation. These regions were also affected by BPS exposure, with effects that 
are more striking in the VTA. BPS is an understudied replacement for BPA, and 
is currently used in a wide number of consumer products (Liao et al. 2012b; Liao 
and Kannan 2013, 2014; Simoneau et al. 2011). Thus, human exposures to BPS 
are widespread (Liao et al. 2012a; Ye et al. 2015), and found to have increased 
in the last decade (Ye et al. 2015). These current studies suggest that exposure 
to BPS may interfere with cell division in the adult female brain with effects on 
behaviour, which could impact health outcomes in offspring. 
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CHAPTER 7 
DISCUSSION 
 
 This dissertation examines the effects of exposure to low dose 
xenoestrogens on maternal behavior and neural regions critical for maternal 
care. Two periods of development were examined: pregnancy/lactation (in F0 
mothers) and gestation/the perinatal period (in F1 females). We hypothesized 
that low levels of two xenoestrogens, EE2 and BPS, would alter maternal 
behaviors in F0 dams and their F1 offspring by altering estrogen receptor (ER) 
expression in the MPOA.  We further proposed that exposures would affect 
tyrosine hydroxylase (TH) immunoreactivity (ir) in the VTA. Finally, we postulated 
that altered neurogenesis might be involved in these effects. This chapter 
summarizes our findings, proposes potential mechanisms that may underlie 
alterations to maternal brain and behavior after xenoestrogen exposure, and 
discusses future directions for further research.   
 
Overview of findings 
Ethinyl Estradiol 
We examined the effects of exposure to low doses of EE2 on maternal 
behavior and in neural regions critical for maternal care in CD-1 mice. First, we 
examined females exposed to EE2 (0.01 and 1 µg/kg/day) from day 9 of 
pregnancy until weaning (LD21). EE2 did not induce significant changes in 
maternal behaviors including time to retrieve pups, time spent on the nest, time 
spent on self-care, time spent grooming pups, or quantitative measures of nest 
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building at early, mid or late postpartum. However, EE2 induced increases in 
repetitive tail retrieval, a novel endpoint that has not been well documented, 
which appears to be an OCD-like behavior or stereotypy. We also observed a 
reduction TH-immunoreactivity in the VTA of dams from both EE2 treatment 
groups at the end of the lactational period on LD21. 
We next examined the same endpoints in offspring exposed to EE2 during 
early development. Here, we found that developmental exposure to EE2 alters 
components of maternal behavior in both a dose and time dependent manner: 1 
µg EE2/kg/day increased time building the nest and time spent engaged in 
maternal self-care on LD2, whereas 0.01 µg EE2/kg/day increased time building 
the nest on LD14, with no changes in time spent engaged in maternal self care.  
While pup retrieval overall was not affected by treatment, dams exposed to the 
lower dose had a significantly longer latency to touch the first pup in in the mid-
postpartum period (LD7). Interestingly, ERα expression in the MPOA was 
significantly decreased in females developmentally exposed to 0.01 µg 
EE2/kg/day on LD2, but significantly increased on LD21.  Both exposure groups 
were observed to have decreased TH-immunoreactivity on LD2, but there were 
no treatment related differences in TH expression in the VTA on LD21. 
Together, these studies reveal two interesting points: 1) an adult exposure 
to EE2 is sufficient to induce a striking stereotypy of OCD-like behavior and 
reduces TH-immunoreactivity in the VTA.  2) developmental EE2 exposures 
produce effects on both the brain and behavior, including disruptions observed 
after exposure to a dose that is 1500-times lower than some previous studies 
(Arabo et al. 2005; Dugard et al. 2001).  
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Bisphenol-S 
To date, there are very few studies investigating the effects of BPS 
exposure on behavior or brain in mammals (Castro et al. 2015; Kim et al. 2015) 
although effects of BPA, a related compound, have been extensively 
documented (Frye et al. 2012; Richter et al. 2007; Wolstenholme et al. 2011). We 
examined the effects of BPS exposure on maternal brain and behavior using the 
same experimental paradigm as our EE2 studies.  
In the F0 generation, dams exposed to 200 µg BPS/kg/day spent 
significantly more time on the nest and displayed longer latency to touch the first 
pup on LD14. In the brain, we observed a significant increase in ERα expression 
in the caudal but not the rostral subregion of the central MPOA on LD21.  Dams 
exposed to 2 µg BPS/kg/day retrieved the first pup with significantly longer 
latency and built smaller nests on LD2. In contrast to F0 dams exposed to EE2, 
there were no significant effects of BPS on TH-immunoreactivity in the VTA on 
LD21. 
The most surprising finding was the increased incidence of infanticide in 
F1 females exposed to the lower dose of BPS. Although these same effects were 
not seen at the higher dose, more than 10% of females exposed to 2 μg 
BPS/kg/day either killed their pups or provided such poor maternal care that their 
pups needed to be euthanized.  
F1 dams exposed to both doses of BPS spent significantly less time on 
the nest on LD2 and LD7 compared to controls. This effect is striking because 
during this early postpartum stage, the pups are young and in need of constant 
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care including nursing and thermoregulation. Additionally, F1 females exposed to 
200 µg BPS/kg/day spent more time nest building on LD14.  Dams treated with 2 
µg BPS/kg/day had significantly shorter latency to retrieve their first pup and 
significantly shorter latency to retrieve their entire litter on LD7. Because of these 
effects on the behaviors of F1 females, we were surprised to find no BPS-
dependent effects on ERα expression in the MPOA (at either LD2 or LD21) and 
no significant differences in TH -immunoreactivity in the VTA (also on LD2 or 
LD21).   
In a follow-up study, we asked whether cell division was altered in 
maternally relevant brain regions by the physiological changes associated with 
parturition, and whether BPS would disrupt this process. While very low levels of 
cell division were observed, we found increased numbers of dividing cells in the 
caudal MPOA and the VTA in postpartum females compared to non-pregnant 
controls. BPS-induced alterations to cell division were also observed in the 
MPOA and the VTA, with effects that were more striking in the VTA; there were 
fewer dividing cells in the VTA of both BPS treatment groups compared to 
postpartum controls.  
Taken together, these results indicate that BPS affects maternal behavior 
and brain in a time and dose dependent manner and induces different effects in 
the F0 and F1 generations.  For most of the alterations to maternal behavior and 
brain that we observed, the effects were unique to compound, dose, critical 
period (F0 versus F1) and postpartum age.  To the best of our knowledge, the 
results of this study are the first to demonstrate that there are low levels of 
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dividing cells in the MPOA and VTA whose number appear to be influenced by 
parturition and BPS exposure.   
 
Are the observed alterations adverse effects? 
EDCs challenge traditional toxicological assessments because the effects 
of exposure rarely involve gross anatomical defects; rather, EDCs induce more 
subtle alterations to gene/protein expression, tissue organization, behavioral 
responses, or endpoints that are more indicative of disease than toxicity (Gore et 
al. 2006b; Vandenberg et al. 2013a; Zoeller et al. 2012). The Endocrine Society 
proposes that disruptions to hormone action are themselves adverse, especially 
if such alterations occur during critical periods of development (Vandenberg et al. 
2013a; Zoeller et al. 2012).   
To a risk assessor, repetitive behaviors or increased time away from the 
nest early in the postpartum period may not be considered an adverse effect if 
they do not directly affect the survival of pups. However, the increased incidence 
of infanticide and severe neglect observed in F1 females (toward F2 litters) 
following BPS exposure should be considered evidence of an adverse effect, 
even though the number of females that committed these acts was not 
significantly different from controls (Chi Square, p=0.07). Even in circumstances 
where pup survival itself is not affected by xenoestrogen treatments, some 
changes to maternal behavior that we have observed could have outcomes that 
impinge on future measures of health for offspring; in humans, there are lasting 
effects of poor maternal behavior on a number of neurobiological, psychological 
and behavioral outcomes, even when deficient maternal behaviors would not be 
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characterized as abuse (Bale et al. 2010; Batten et al. 2004; Bifulco et al. 2002; 
Gilbert et al. 2009; Gunnar et al. 2006; Heim and Nemeroff 2001). 
As discussed in the first chapter of this dissertation, standard protocols for 
evaluating the toxicity of chemicals examine limited endpoints. Even 
standardized neurotoxicity evaluations might fail to detect the effects we 
observed here on infanticide and deficient maternal care in the F1 generation. 
Thus, even if the effects we observed were acknowledged to be adverse, it is 
unlikely that a standardized guideline assay would ever have noted these same 
effects. 
 
Reimagining “development” in the context of the Developmental Origins of 
Health and Disease (DOHaD) hypothesis 
 
 The presence of EDCs in maternal blood, milk and placental tissue suggest 
that fetuses, infants and neonates are likely exposed to these compounds during 
vulnerable periods of development (Massart et al. 2005; Schonfelder et al. 2002; 
Woodruff et al. 2011). Additionally, the postpartum use of combined hormonal 
contraceptives, which contain EE2 and progestin, is of clinical concern for 
potential effects on infants (Lopez et al. 2015; Tepper et al. 2015; Thorpe et al. 
2013).  Gonadal steroids play a role in the organization of the brain during 
development, priming it for transient activational effects that occur in puberty and 
adulthood (Arnold and Gorski 1984; Bakker et al. 2003; McCarthy et al. 2009; 
Phoenix et al. 1959). Hormones thus influence the structure and function of the 
nervous system; this has become the fundamental basis underlying our 
 	 203 
understanding of structural and behavioral sex differences in the brain.   
 The “developmental origins of health and disease hypothesis” (DOHaD) 
grew out of the concept of the “fetal origins of adult disease” which emerged from 
landmark epidemiological studies of Barker, Osmond and colleagues (Barker and 
Osmond 1986; Barker 2007; Barouki et al. 2012).  Barker was credited with 
identifying a link between poor maternal health and nutrition in lower income 
families and diseases of metabolism (stroke, diabetes, etc.) in children from 
these families upon reaching adulthood. Further epidemiological investigation 
found connections between poor nutrition across the gestational period and the 
effects of maternal and placental hormones on fetal physiological and metabolic 
regulation, which in turn was suggested might lead to increased risk of cardiac 
disease later in life (Barker 2007; Wadhwa et al. 2009).  Critics of these studies 
focused on the inference of fetal nutrition without sufficient records of food intake, 
the use of correlational data, as well failure to consider confounding factors such 
as social class (Paneth and Susser 1995).  However, studies of the Dutch 
Hunger Winter, a period during WWII when the western region of the 
Netherlands suffered famine, provided additional insight into the effects of 
nutritional deficit on heart disease and metabolic health (Roseboom et al. 2001). 
Individuals in early gestation during the famine experienced higher incidence of 
obesity in adulthood compared to adults that experienced the same nutritional 
deficits in mid-to late gestation (Roseboom et al. 2006).  
The DOHaD hypothesis is further evidenced by the lessons from women 
prescribed diethylstilbestrol (DES) to prevent miscarriage (Swan 2000; Veurink et 
al. 2005). DES is a synthetic estrogen first developed by Dodds, Goldberg, 
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Lawson and Robinson in 1938 (Dodds 1938).  In 1947, DES was approved by 
the FDA for use in preventing spontaneous miscarriage due to its biological 
similarity to estrogen (Swan 2000; Veurink et al. 2005). DES was eventually 
found to be ineffective in the prevention of miscarriage. Furthermore, between 
1966 and 1969, a rare vaginal cancer, clear cell adenocarcinoma (CCAC), which 
had until then only been seen in women over fifty, was diagnosed in a number of 
young women who had been exposed to DES in utero (Herbst et al. 1971). 
Young women exposed to DES, also called DES daughters, were also found to 
suffer from a number of additional issues including morphological changes to the 
reproductive tract, infertility, and increased risk of breast cancer (Herbst et al. 
1972; Soto et al. 2008; Swan 2000; Veurink et al. 2005).  The lessons from DES 
have informed the understanding that the effects of exposures to estrogenic 
compounds during development may not manifest until adulthood.  Animal 
studies have been both predictive and confirmatory for many human health 
outcomes of DES exposures (Reed and Fenton 2013).   
In the field of Endocrinology, hormones (and EDCs) are often considered 
to have organizational and activational effects depending on when exposures 
occur (Gore et al. 2006b). The concept that there are critical periods of 
development when the brain and reproductive organs are organized by 
hormones, and that these organs are then activated by these same hormones 
later in puberty/adulthood, was first demonstrated in seminal work by Phoenix 
and colleagues (Phoenix et al. 1959). The notion of the organizational effect of 
hormones and EDCs fits within the DOHaD paradigm because it acknowledges 
critical windows of development when organs and systems are vulnerable to 
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environmental influences including hormones (Gore et al. 2006a; Gore and 
Patisaul 2010; Vandenberg et al. 2013a; Vandenberg et al. 2013c; Vandenberg 
2014; Zoeller et al. 2012).   
  The ability of organisms to adapt to the environment confers evolutionary 
advantages. For this reason, the effects of EDCs are often interpreted to be 
‘adaptive’ rather than adverse (Vandenberg et al. 2013b). In light of hormone 
activity, however, developmental organizing effects of hormones (or EDCs) in the 
brain and other organs during development are often permanent and irreversible, 
even when changes are not evident until adult life (Barker 2007; Barouki et al. 
2012; Diamanti-Kandarakis et al. 2009; Gore et al. 2006b; Heindel and 
Vandenberg 2015).  
 
Two critical periods for maternal behavior & brain 
 
  Here we demonstrate that the maternal brain and behavior are sensitive to 
EE2 and BPS. The experiments conducted for this dissertation indicate that the 
periods of pregnancy and lactation are sensitive to endocrine disruption, as is the 
period of gestation and perinatal development.   
The response to BPS in the MPOA observed in the F0 generation suggests 
that there may be an activational response to BPS, supporting the idea that 
pregnancy/lactation represents a critical period. Counter to our prediction that 
both EE2 and BPS exposure would lead to decreased expression of ERα in the 
MPOA, we found increased ERα in the MPOA in the F0 BPS treated females and 
no treatment related effect in the F0 EE2 treated dams.  It is possible that BPS 
led to an up-regulation of the receptor, similar to what has been seen following 
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BPA exposure in some tissues (Aloisi et al. 2001; Ceccarelli et al. 2007).  Our 
results further suggest that the more caudal subregion of the MPOA is sensitive 
to endocrine disruption, which has implications for its connectivity with the VTA 
(Morrell et al. 1984).  
Intriguingly, in the F1 generation, also counter to our predictions, we did not 
observe changes in ERα expression in the MPOA of females developmentally 
exposed to BPS. F1 females exposed to the lower dose of EE2, however, 
displayed decreased ERα expression in the MPOA on LD2, suggesting potential 
alterations to the regulation of the receptor which may be due to organizational 
effects of developmental exposure (Arnold and Gorski 1984; Gore 2010; Gore 
and Patisaul 2010) or epigenetic mechanisms (Champagne and Curley 2008). 
The F1 females displayed increased expression of the receptor in late 
postpartum, which may result from compensation for low expression in the early 
postpartum period (De Vries 2004) or could reflect that developmental exposures 
to EE2 leads to misregulation of this receptor, which manifests during the 
postpartum period.  
Despite observing no effects in the brain of F1 females exposed to BPS, 
alterations to their maternal behavior was striking, with both treatment groups 
spending significantly more time off the nest on both LD2 and LD7 and the lower 
dose of BPS displaying shorter latency to retrieve the first pup and to retrieve the 
entire litter on LD7.  Furthermore, while the BPS F1 generation did not 
demonstrate any differences in ERα expression in the MPOA, we cannot rule out 
the possibility of other neural endpoints we did not examine.  
One possible explanation for our difference in results between the F0 and F1 
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generation in the MPOA is that the F1 may have been affected by BPS exposure, 
but ERα immunoreactivity in these cells is not the appropriate measure of this 
effect. Other relevant levels of analysis may include gene expression or 
epigenetic modifications, as ERα methylation status differs depending upon 
maternal quality in rodents (Champagne et al. 2006; Champagne and Curley 
2008). It is also possible that BPS affects ERα expression at a different level of 
analysis than we conducted such as gene expression or promoter methylation, or 
that developmental exposures to BPS had early transient or stage dependent 
effects; further experiments are necessary to uncover any potential change to 
expression earlier in life.  
 
Are all xenoestrogens created equally? 
 
In comparing our results of EE2 and BPS, we did not find the same 
responses to these chemicals in either the F0 or F1 generation. For example, 
reductions in TH-immunoreactive cells in the VTA were observed in both the F0 
and F1 females after EE2 exposure, yet this effect was not observed in either the 
F0 or F1 dams exposed to BPS.  It is possible that the differences we observed 
were due to the doses selected for these two chemicals.  Questions of dose may 
be resolved by a establishing a more complete dose response relationship for 
behavioral and neural endpoints for both compounds. More likely is the possibility 
that these two compounds act in distinct ways. For example, BPA has been 
shown to have different effects on ER when compared to estradiol (Gould et al. 
1998), and does not completely reproduce the effects of EE2 on neural endpoints 
(Ceccarelli et al. 2007). Thus, it is important to consider that BPS may not be 
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acting via the ER, or it may act via the ER in a manner that is distinct from EE2.  
The differences in effects induced by EE2 and BPS may indicate the need to 
reconsider the use of EE2 as an estrogenic positive control in studies of other 
EDCs. The mechanisms underlying EDC effects on hormone receptors are 
complex, as are the actions of estrogen on its receptors (Heldring et al. 2007; 
Katzenellenbogen et al. 2000; Nilsson et al. 2001; Welshons et al. 2006b; Zoeller 
et al. 2012). There are a number of potential mechanisms, at different levels of 
the estrogen signaling pathway, by which BPS may act differently compared to 
EE2.  
The first plausible mechanism to consider is the possibility that BPS can bind 
the receptor and induce conformational changes, which may affect downstream 
events and ultimately lead to increased expression of ERα. Although ER can 
adapt to the molecular structure of diverse ligands (Anstead et al. 1997; Heldring 
et al. 2007), the changes in conformation associated with diverse ligands in turn 
alter coactivator or corepressor recruitment to the ligand receptor complex 
(Heldring et al. 2007; Katzenellenbogen et al. 2000; Klinge et al. 2004; Nilsson et 
al. 2001). Thus, differences in coregulators or in the subsequent transcriptional 
activation after binding to the estrogen response element (ERE) may be 
differentially affected by BPS and EE2 (Heldring et al. 2007; Klinge et al. 2004).  
Non-classical ER signaling may also be involved in regulating expression of 
ERα via interactions with transcription factors such as activator protein-1 (AP-1), 
specificity protein-1 and others, which influence transcription at their response 
elements (Heldring et al. 2007).  Additional non-canonical ERα signaling includes 
membrane-associated induction of signaling pathways such as MAPK and cAMP 
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response element binding protein (CREB) signaling cascades (Heldring et al. 
2007; Liu and Shi 2015). BPS is capable of activating non-genomic pathways via 
membrane ERs in vitro (P Vinas and CS Watson 2013). 
It remains to be tested whether the effects we observed in BPS treated dams 
were due to transcriptional changes. ERα regulation In brain is region specific 
and not yet fully understood (Liu and Shi 2015), Further, a number of studies 
have demonstrated that ERα mRNA is not always directly translated into protein 
due to post-translational processing (Liu and Shi 2015), thus, there may have 
been differences between BPS and EE2 exposure at this level. Gene expression 
analyses are needed to address questions regarding genomic effects.  We have 
collected brain punches from the MPOA and VTA of F0 dams exposed to BPS, 
which will allow us to further investigate potential effects on ER-mediated gene 
expression in this brain region. Additionally, because methylation of the ERa1b 
promoter has been associated with quality of maternal care (Champagne et al. 
2006) it is evident that behavior also plays a role in the dynamic expression of 
the receptor.  
BPA is considered capable of acting on nuclear ERα and ERβ, membrane 
associated ERs and membrane bound G protein coupled receptors (GPR30, 
GPER) (Wolstenholme et al. 2011). When comparing BPA to estradiol, BPA 
interacts differently with the ER ligand-binding domain (Gould et al. 1998; Richter 
et al. 2007; Welshons et al. 2006b) and coregulators (Routledge et al. 2000; 
Welshons et al. 2006b) and it has been proposed that BPA may induce a 
conformational change in the receptor (Welshons et al. 2006b).  This would 
potentially allow for differences in the binding of coactivators or corepressors, 
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which would further affect transcription (Heldring et al. 2007; Klinge et al. 2004).  
The sensitivity and physiological effects of a hormone or EDC are dependent 
on receptor affinity, abundance of the receptor, and the presence of cofactors 
(Zoeller et al. 2012). A number of studies provide evidence that BPS may act as 
an EDC; one in vitro study demonstrated that it can act as an agonist for both 
ERα and ERβ (Molina-Molina et al. 2013b). Competitive binding assays indicate 
that BPS binds to nuclear ER (Grignard et al. 2012; Kitamura et al. 2005; Molina-
Molina et al. 2013b; Rochester and Bolden 2015). One study using the 
uterotrophic assay concluded that BPS has “weak” affinity for the ER (Rochester 
and Bolden 2015; Yamasaki et al. 2004). However, it is clear that receptor 
binding affinity is not a good predictor for potency. For example, BPA has 
relatively “weak” affinity for ERα and β, but has been shown to stimulate similar 
responses with similar potency as 17β-estradiol in certain endpoints (Welshons 
et al. 2006b). Given the differences in ERα expression after exposures to EE2 
and BPS in the MPOA, it will take additional studies to determine whether the 
effect of BPS was due to alternate mechanism of action at ERα. We also cannot 
rule out the possibility that these differences may be dose related.  BPA can 
induce responses at nano and picomolar ranges, well below doses that activate 
classical receptors and below ranges of human exposures (Vandenberg 2014; 
vom Saal et al. 2007; Watson et al. 2007; Welshons et al. 2006b).   
While evidence demonstrates the critical importance for ERα in the MPOA for 
the display of maternal behavior in the mouse (Ogawa et al. 1998; Ribeiro et al. 
2012), ERβ is also expressed in the MPOA and there is co-expression of these 
receptors in a number of neurons (Shughrue et al. 1998). Both receptors were 
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individually found capable of regulating the rapid phosphorylation of cAMP 
response element binding protein (CREB) in the MPOA in response to estrogen 
and appear to act in a compensatory manner (Abraham et al. 2004). Additionally, 
both receptors were found to be required for estrogen actions on mitogen-
activated protein kinases (MAPK). Ultimately, our studies lead to further 
questions, and demonstrate that ER expression in the MPOA is dynamic and the 
regulation of ER appears to be plastic; receptor expression appears to be 
selective and sensitive to environmental as well as developmental impacts. 
Regardless of potential mechanism, our studies indicate that BPS affects this 
endpoint at a dose selected in the range of human exposures. 
 
Dopamine, the VTA, and maternal behavior 
 
The VTA is critical for maternal behavior, and is considered important for 
maternal motivation.  Lesion of the VTA interferes with the display of maternal 
behavior (Gaffori and Le Moal 1979; Numan and Smith 1984) and more specific 
6-Hydroxydopamine lesion of dopaminergic neurons in the VTA reduces pup 
retrieval (Hansen et al. 1991). In our study, both doses of EE2 in the F0 
generation reduced TH expression in the VTA, without demonstration of effects 
on traditional maternal behavior, suggesting compensation by the remaining 
dopaminergic neurons. One recent study found that reduction in phasic 
dopaminergic signaling in the VTA played a role in OCD-like behavior (Sesia et 
al. 2013). It will be important to examine whether our results are due to cell loss 
in the VTA (Johnson et al. 2010). 
In one model of maternal behavior, Numan et al. proposed that MPOA 
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projections to dopaminergic neurons in the VTA act upon the nucleus accumbens 
to regulate “motivational” aspects of maternal behavior (Numan 2006; Numan 
and Stolzenberg 2009). Estrogen sensitive oxytocin neurons have been shown to 
project from the MPOA to the VTA (Fahrbach et al. 1986; Morrell et al. 1984; 
Shahrokh et al. 2010). These neurons play a role in the increased levels of 
dopamine in the nucleus accumbens in mothers demonstrating high levels of 
maternal care; infusion of oxytocin directly into the VTA enhances the dopamine 
signal in the shell of the nucleus accumbens during periods of pup licking and 
grooming (Shahrokh et al. 2010). Further, infusion of an oxytocin -receptor 
antagonist into the VTA abolishes behavioral differences in high and low licking 
dams. Thus, dopamine activity in the MPOA may interact with estradiol and affect 
the VTA, which induces dopamine release in the nucleus accumbens as part of 
the mesolimbic circuit considered integral to maternal motivation (Numan and 
Stolzenberg 2009; Stolzenberg and Numan 2011). Alterations in TH expression 
in the VTA may differentially influence the response in the nucleus accumbens.  
Investigation of the role of the VTA in the stereotypies or OCD-like behavior 
we observed (e.g tail retrieval) is further complicated by its multiple sites of 
connectivity; the VTA receives innervation from a number of glutamatergic sites 
in the brain such as the medial prefrontal cortex (Geisler and Wise 2008; Sesack 
and Pickel 1992). Loss of TH immunoreactivity in the VTA, as we have observed 
in our EE2-treated dams, might also affect the inhibitory influence on the activity 
of neurons in the prefrontal cortex as these neurons project onto subcortical 
structures (Pirot et al. 1992; Tseng et al. 2006). Thus, loss of inhibition in this 
circuit may be posited as one of a number of potential causes for the repetitive or 
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OCD-like behavior we observed.  
It will be important to test whether induced loss of dopaminergic cells in the 
VTA can replicate repetitive tail retrieval to provide evidence of a correlation 
between reduction in TH-ir and OCD-like or displaced maternal behavior.  
Although dopaminergic neurons of the VTA play a role in motivation and reward, 
we did not test these behaviors, thus it will be important to do so using a bar 
press test to examine pup reinforcement (Hauser and Gandelman 1985; Lee et 
al. 2000) or signal attenuation (Joel and Avisar 2001) to uncover the potential 
provenance of tail retrieval using additional tests for repetitive or OCD like 
behaviors (Crawley 2007; Garner and Mason 2002; Gross et al. 2012; Joel 2006; 
Low 2003).  
Even though traditional measures of maternal behavior were not affected in 
the F0 generation exposed to EE2, more subtle alterations in the generalized 
behavior of treated dams and alterations to TH immunoreactive cells are 
important research question to pursue. In humans, postpartum OCD has 
implications for both child development and interactions between mother and 
child (Ross and McLean 2006).  
F1 females exposed to EE2 or BPS spent more time nest building compared 
to controls, although these effects were seen at different postpartum stages. 
Increased nest building and increased time spent on self care observed in F1 
females suggest OCD-like behavior (Albelda and Joel 2012; Greene-Schloesser 
et al. 2011; Korff and Harvey 2006). The presentation of these behaviors may be 
associated with the repetitive tail retrieval or stereotypy we observed in the F0 
generation.  
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Future Directions 
 
Are the effects of developmental BPS exposure on maternal behavior 
direct, or an indirect result of altered maternal behavior in F0 dams?  
F1 females exposed to BPS display changes to a number of maternal 
behaviors. These females were directly exposed to the compound during 
gestation and perinatal development, yet, these females were also raised by 
dams that were directly exposed and affected by these exposures. Thus, the 
effects observed in F1 females may be due to direct alterations to these females, 
disrupted maternal behavior in their mothers, or a combination of these factors. 
Furthermore, changes in maternal behavior (displayed by either F0 or F1 dams) 
could be responses to changes in their nursing pups. 
In prior studies, cross fostering of pups has been used to separate the 
effects of exposures on the mother’s behavior from potential indirect effects on 
offspring; hormone and EDC exposures can alter pups behaviors, which in turn 
can alter the dam’s maternal responsiveness (Cummings et al. 2005). Our 
studies demonstrate that the F1 dams exposed to BPS in utero and during the 
perinatal period have striking alterations to their maternal behavior in adulthood. 
It will be important to design cross fostering experiments to delineate whether the 
effects of exposures on the F1 generation are direct or indirect.  While there are 
limitations to cross-fostering studies (D Francis et al. 1999; Maccari et al. 1995), 
the Rissman group recently reported attempts to control for these effects by 
cross fostering across all experimental groups (Emillie Rissman, personal 
communication).   
 A potential cross-fostering study might use the following design. After 
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exposing dams to vehicle or BPS during pregnancy, these F0 females will be 
divided into four groups: controls fostering only vehicle-exposed pups, controls 
fostering only BPS-exposed pups, BPS-treated dams fostering only vehicle-
exposed pups, and BPS-treated dams fostering only BPS-exposed pups. 
Although it may stretch feasibility, additional groups using mixed litters of pups 
(50% each, control and BPS-treated) could provide additional insights.  These 
dams would be used for maternal behavior assays and brain analyses.  
Evaluations may also extend to maternal behavior assays in the F1 generation. 
Again, a cross-fostering design like the one proposed above could be used.  
 
Moving beyond cell division to ask whether BPS exposure disrupts the 
process of neurogenesis 
We took initial steps towards testing our hypothesis that neurogenesis 
might underlie estrogen regulated maternal behavior, and that xenoestrogen 
exposure during pregnancy may lead to alterations in neurogenesis by assessing 
cell proliferation. We found a small number of dividing cells in the MPOA in dams 
on LD2, suggesting that cell division is taking place at this time. We also 
confirmed the presence of cell division in the SVZ as an internal positive control. 
Finally, we determined that BPS affected lactation-induced cell division in the 
MPOA and VTA. 
To determine whether the changes in cell division suggest changes in 
neurogenesis, future studies will evaluate whether the BrdU-positive cells also 
express neural or glial markers. Traditional markers that could be used are RC2 
and GFAP (radial glia), Ki-67 and doublecortin (progenitor phenotype), Tuj1 
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(immature neurons) and Neu-N (mature neurons).  We may initially identify the 
time point during pregnancy or lactation when BrdU incorporation in the MPOA 
and VTA is the greatest, to focus our studies on specific time-points with 
enhanced proliferation. If evidence for neurogenesis were found, we would then 
ask whether new neurons become functionally incorporated into the maternal 
circuitry. This future work would contribute to our knowledge of neural plasticity 
and cell renewal in brain regions important for the regulation of maternal 
behavior, which are not generally considered actively neurogenic. 
 
Broader implications 
 
Given the continued use of pesticides, plastics and other EDCs, chemical 
exposures during the maternal period may have consequences on human 
populations. After heeding the clarion call of Rachel Carson in Silent Spring 
(Carson 1962) regarding the dangers of overuse of the pesticide DDT, followed 
by alarms rung by Theo Colborn and her collaborators, Dianne Dumanoski and 
John Peterson Myers in Our Stolen Future (Colborn 1996), a great deal of 
evidence from numerous research groups worldwide continues to accrue, 
indicating that EDCs have a range of effects on physiology and behavior. Expert 
groups of scientists from the UNEP/WHO, Endocrine Society, and others have 
found strong evidence for the contribution of EDCs to disease in both humans 
and wildlife (Bergman Å 2013; Gore et al. 2015).  
The structural similarity between BPA and many of its replacement chemicals 
including BPS highlights the need for more stringent testing guidelines for 
chemicals prior to their use in consumer products. Our studies indicate that BPS 
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is likely a regrettable replacement for BPA (Vandenberg and Catanese 2014; 
Vandenberg 2015), and thus consumers that purchase “BPA free” products in the 
hope that these are ‘safer’ are given an empty promise.  
Although the lesson of DES is often viewed for the scientific and clinical 
knowledge that was gained, its prescription to women in the 1940’s-70’s without 
adequate knowledge of potential harm has not induced similar social lessons.  
BPA, first investigated for use as a pharmaceutical estrogen in the 1940s, was 
later widely added to a range of consumer products with little concern for 
widespread human exposures.  The effects of BPA have by now contributed to 
two decades of research on its deleterious effects on wildlife, laboratory animals 
and humans alike.  The social parallels between the prescription of DES and the 
use of BPA (and other bisphenol analogs) in consumer products should not be 
ignored.  
Maternal behavior is complex, encompassing numerous behavioral 
components influenced by emotional, psychological, physiological, 
neuroendocrine and social factors and as such, it is a model for complex 
behaviors (Numan 2003; Pereira and Ferreira 2015).  Our work has 
demonstrated alterations to components of maternal behavior and effects on the 
maternal brain in CD-1 mice after low dose EE2 and BPS exposures in the F0 
and F1 generation.  From an evolutionary perspective, maternal behavior is often 
defined in light of its importance for the survival of offspring; the importance of 
maternal care in humans stems from its contribution to the physical, emotional 
and psychological development of children. Therefore, uncovering mechanisms 
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that might influence proper maternal care have broad social and public health 
implications.  
Our studies also add to evidence that the developmental period is profoundly 
sensitive to low doses of EDCs.  Hormones play an important role in 
neurodevelopment (Arnold and Gorski 1984; Bakker et al. 2003; McCarthy et al. 
2009; Phoenix et al. 1959) and even slight perturbations in hormone levels can 
lead to deleterious effects on behavior and brain (Gore 2010; Richter et al. 2007; 
Walker and Gore ; Wolstenholme et al. 2011). Although the vast majority of 
studies examining developmental effects of EDCs view the mother as merely a 
vessel by which to expose the offspring (Catanese et al. 2015; Cummings et al. 
2010), we show that the period of pregnancy and lactation is itself sensitive to 
xenoestrogens.  Changes to maternal brain and behavior may negatively affect 
offspring, underscoring the importance for including observations of maternal 
behavior as well as cross fostering when conducting studies of EDCs.   
 
Conclusions 
 
Human exposures to BPA are widespread (Vandenberg et al. 2007) and 
exposures to BPS, a common replacement, appear also to be widespread (Liao 
et al. 2012a). Furthermore, biomonitoring studies using tissues and fluids 
collected from pregnant and lactating women have revealed the presence of 
hundreds of environmental chemicals, many of which have estrogenic properties 
(Massart et al. 2005; Woodruff et al. 2011). Thus, in humans, exposures to 
xenoestrogens occur during both pregnancy and lactation, having implications for 
the developing child.  
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A number of studies of estrogenic EDCs have shown more potent effects after 
developmental exposures compared to the effects observed on adults (Gore et 
al. 2006a; Vandenberg et al. 2013a; vom Saal et al. 2007). However, there is 
growing evidence from rodent studies examining the effects of adult exposure 
which indicate that the adult brain and behavior, including maternal behavior, are 
sensitive to environmental chemicals (Aloisi et al. 2001; Della Seta et al. 2005; 
Funabashi et al. 2003; MacLusky et al. 2005). Understanding how the mother’s 
physiology, behavior, and disease risk may be influenced by EDC exposure is an 
important area of scientific inquiry. In the case of maternal behavior, deficient 
parental care has important implications for the well-being and development of 
offspring (Bale et al. 2010; Batten et al. 2004; Bifulco et al. 2002; Gilbert et al. 
2009; Gunnar et al. 2006; Heim and Nemeroff 2001).  
The work summarized in this dissertation indicates that low doses of the 
synthetic estrogens EE2 and BPS can alter aspects of behavior and brain in 
pregnant/lactating females, providing evidence that adults are not immune to the 
disruptive effects of these compounds. Our findings also suggest that the 
developmental period is vulnerable to exposures, which may influence maternal 
behavior later in adulthood. 
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